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Abstract 
 
Currently, there is a gap between pharmacological treatment and joint replacement for the 
management of cartilage degradation diseases, such as osteoarthritis. It may be possible to use 
cartilage substitution materials to treat small defects in cartilage tissues, delaying the need for joint 
replacements, which have a limited lifetime in vivo, so are not suitable for many patients. A major 
barrier to the use of cartilage substitution materials is suitable in vitro testing of cartilage materials. 
Therefore mechanical and enzymatic models of cartilage degeneration were developed, which may 
be used to assess novel cartilage substitution materials.  
  A single station pin-on-plate rig with a variable load was used to degrade the cartilage tissue 
of osteochondral pins and plates to produce two mechanical models of degradation denoted “mild” 
and “moderate”. A Ringer’s solution and serum based lubricant were chosen to hydrate cartilage 
tissues during articulation. The lubricants used during mechanical degradation were collected and 
analysed quantitatively for glycosaminoglycan (GAG) and collagen content. In addition, a method for 
isolating and imaging the cartilage wear particles in the lubricant was developed. A chondroitinase 
ABC enzyme was used to enzymatically degrade cartilage tissues.  
  The mechanical and enzymatic degradation in the models was characterised using a broad 
range of mechanical and biological assessment techniques. The mechanical degradation and wear of 
the tissues created using the pin-on-plate rig was evaluated using cartilage height measurements, 
friction measurements, surface profilometry, histological and immunohistological staining, and 
quantitative biochemical assays. The wear on the surface of the tissue was observed using 
environmental scanning electron microscopy and the tissue ultrastructure was observed using 
transmission electron microscopy. The tissues degraded using chondroitinase ABC were analysed 
using indentation testing, histological and immunohistological staining, quantitative biochemical 
assays, and transmission electron microscopy.  
  It was determined that an increased load used during pin-on-plate testing resulted in an 
increase in tissue degradation. Mechanical degradation under the “moderate” loading condition 
caused the surface of the cartilage tissue to become fibrillated and areas of tissue loss were 
observed. Under the mild condition the cartilage surface remained relatively smooth however, 
several small fissures were observed in some specimens. The surface of the tissue degraded under 
moderate conditions was significantly rougher than that degraded under the mild condition.  There 
was a small loss of GAGs in the mild condition whereas a large volume of GAGs were lost from the 
tissue under the moderate condition, and the aggrecan network in the tissue was heavily disrupted. 
iv 
 
There was no significant difference between the friction measurements or the height measurements 
recorded for the specimens under the two variable loading conditions. Immunohistochemical 
staining for minor tissue components showed that collagen VI and cartilage oligomeric matrix 
protein (COMP) were not altered by the mechanical degradation, whereas a loss in biglycan was 
observed in specimens loaded under the moderate condition. It was observed that the serum 
lubricant may protect the cartilage tissue from degradation during articulation. An increased number 
of wear particles were observed in the lubricants recovered from the moderate loading condition 
tests. Digestion of tissues with chondroitinase ABC led to an increase in tissue deformation during 
indentation. The level of GAGs in the tissues was reduced and the GAGs associated with the 
aggrecan network in the tissue were no longer visible. Collagen VI and COMP were not significantly 
affected by chondroitinase ABC digestion, however biglycan staining was reduced at the superficial 
to middle zone of the tissue. 
  The models produced have potential to be used in the assessment of novel cartilage 
substitution materials. The parameters used in this study will also be useful in the development of in 
vitro whole joint simulators.    
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hydroxyproline assay. The results indicated that 0.5ml of 6M hydrochloric 
acid was suitable for digestion of 1ml of lyophilised mild Ringer’s solution 
lubricant. Data is presented as the mean (n=3) ± 95% confidence limits. 
107 
Figure 3.16. The absorbance profile of standards diluted in assay buffer and 
chondroitin sulphate in Ringer’s solution that has been digested with 50 
U.ml of pure papain. Green triangles represent digested standards in 
Ringer’s solution that were not diluted in assay buffer. Black circles 
represent standards in assay buffer. Data is presented as the mean (n=3) ± 
95% confidence limits. 
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Figure 3.17. The absorbance profile of standards diluted in assay buffer and digested 
standards in Ringer’s solution diluted one to one with assay buffer. Green 
triangles represent digested standards diluted one to one with assay 
buffer. Black circles represent standards in assay buffer. Data is presented 
as the mean (n=3) ± 95% confidence limits. 
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Figure 3.18. Effect of papain concentration on lubricant digestion. There was no 
significant difference found in the GAG concentration of specimens 
digested with the different papain concentrations (One way ANOVA, P > 
0.05). Data is presented as the mean (n=6) ± 95% confidence limits. 
112 
Figure 3.19. Effect of digestion buffer volume for lubricant digestion. It was 
determined that 0.5 ml of 40 µg.ml of pure papain in digestion buffer was 
sufficient for complete digestion of moderate Ringer’s solution lubricant. 
Asterisks represent a P value of P ≤ 0.01 determined by one way ANOVA. 
Data is presented as the mean (n=3) ± 95% confidence limits. 
113 
Figure 3.20 The absorbance profile of standards diluted in assay buffer and standards 
diluted one in five with assay buffer. Black circles represent standards 
diluted in assay buffer. Green triangles represent standards in digested 
lubricant diluted one in five with assay buffer. Data is presented as the 
mean (n=3) ± 95% confidence limits. 
115 
Figure 3.21 Effect of pure papain concentration for serum lubricant digestion. It was 
concluded that a 40 µg.ml-1 pure papain concentration was suitable for 
serum lubricant digestion. Data is presented as the mean (n=4) ± 95% 
confidence limits. 
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Figure 3.22. Osteochondral pin specimens after mild condition degradation in Ringer’s 
solution. The pins shown represent the typical damage patterns seen on 
osteochondral pins after degradation. The third pin has been bisected in 
preparation for histological analysis. A. Specimen A did not appear to have 
any obvious damage to the surface, however the cartilage did appear 
swollen. B. This pin had a small crack across the surface of the tissue 
(arrow). The remaining tissue did not appear damaged however the 
surface did appear to be duller than control specimens. C. This pin which 
has been bisected, shows the most severe type of damage that was 
observed after mild condition degradation. Several cracks can be seen on 
the surface of the swollen cartilage (arrow). 
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Figure 3.23. Osteochondral pin specimens after moderate condition degradation in 
Ringer’s solution. The pins shown are representative of the typical damage 
patterns observed on osteochondral pins under the moderate degradation 
conditions. A. This specimen was damaged primarily around the 
circumference of the pin (arrow) which was unusual as the remaining 
specimens primarily lost tissue from the central region of the pin rather 
than the edges. The surface of the tissue appeared dull and scratched. B. 
Apart from two cracks across the pin surface (arrows), this pin was not 
heavily damaged and represented the lower end of the damage scale seen 
on specimens that underwent moderate condition degradation with 
Ringer’s solution lubricant. C. This specimen was heavily damaged and 
represented the most severe end of the scale of damage seen on 
moderate condition pins in Ringer’s solution lubricant. A large volume of 
cartilage tissue was lost from the pin leaving less than one half of the pin 
depth remaining. 
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Figure 3.24. Osteochondral pin specimens after moderate condition degradation with 
serum lubricant. The pins shown here represent the typical damage 
patterns observed macroscopically on osteochondral pins under the 
specified loading conditions. The pin to the left of the image had lost a 
large volume of tissue. The middle pin and right hand pin showed cracks in 
the surface (arrows). 
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Figure 3.25.   Osteochondral pin cartilage height recovery post static loading under 
mild conditions (200 N load applied for 6 hours). Data is presented as the 
mean (n=6) ± 95% confidence intervals. The data was analysed by repeated 
measures analysis of variance followed by determination of significant 
differences between groups using a Tukey post test; ** equates to P ≤ 0.01 
; *** equates to P ≤ 0.001. 
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Figure 3.26. Osteochondral pin cartilage height recovery post static loading under 
moderate conditions (478 N load applied for 6 hours). Data is presented 
as the mean (n=6) ± 95% confidence intervals. The data was analysed by 
repeated measures analysis of variance followed by determination of 
significant differences between groups using a Tukey post test; * equates 
to P ≤ 0.05 ; *** equates to P ≤ 0.001. 
121 
Figure 3.27. Osteochondral plate cartilage recovery post static loading under mild 
conditions (200 N load applied for 6 hours). Data is presented as the mean 
(n=6) ± 95% confidence intervals. The data was analysed by repeated 
measures analysis of variance followed by determination of significant 
differences between groups using a Tukey post test; * equates to P ≤ 0.05 ; 
**** equates to P ≤ 0.0001. 
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Figure 3.28 Figure 3.28 Osteochondral plate cartilage recovery post static loading 
under moderate conditions (478 N load applied for 6 hours). Data is 
presented as the mean (n=6) ± 95% confidence intervals. The data was 
analysed by repeated measures analysis of variance followed by 
determination of significant differences between groups using a Tukey 
post test; * equates to P ≤ 0.05.  
122 
Figure 3.29. Cartilage height of osteochondral pins following mild condition dynamic 
mechanical degradation in Ringer’s solution lubricant.  Data is presented 
as the mean (n=6) ± 95% confidence intervals. The data was analysed by 
repeated measures analysis of variance, no significant differences were 
found. 
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Figure 3.30. Cartilage height of osteochondral pins following moderate condition 
dynamic mechanical degradation with Ringer’s solution lubricant.  Data is 
presented as the mean (n=6) ± 95% confidence intervals. The data was 
analysed by repeated measures analysis of variance followed by 
determination of significant differences between groups using a Tukey 
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post test; * equates to P ≤ 0.05. 
Figure 3.31. Cartilage height of osteochondral pins following moderate condition 
dynamic mechanical degradation with serum lubricant.  Data is presented 
as the mean (n=6) ± 95% confidence intervals. The data was analysed by 
repeated measures analysis of variance, no significant differences were 
found. 
125 
Figure 3.32. Height of osteochondral plates following mild condition dynamic 
mechanical degradation with Ringer’s solution lubricant.  Data is 
presented as the mean (n=6) ± 95% confidence intervals. The data was 
analysed by repeated measures analysis of variance, no significant 
differences were found. 
125 
Figure 3.33. Cartilage height of osteochondral plates following moderate condition 
dynamic mechanical degradation with Ringer’s solution lubricant.  Data is 
presented as the mean (n=6) ± 95% confidence intervals. The data was 
analysed by repeated measures analysis of variance, no significant 
differences were found. 
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Figure 3.34. Cartilage height of osteochondral plates following moderate condition 
dynamic mechanical degradation with serum lubricant.  Data is presented 
as the mean (n=6) ± 95% confidence intervals. The data was analysed by 
repeated measures analysis of variance followed by determination of 
significant differences between groups using a Tukey post test; * equates 
to P ≤ 0.05. 
126 
Figure 3.35. The mean surface roughness of pin replicas directly after degradation and 
after 24 and 48 hours of recovery. A. Post refers to post degradation, 24 
denotes 24 hours of recovery, 48 denotes 48 hours of recovery. Data is 
presented as the mean (n=6) ± 95% confidence intervals. The data was 
analysed by repeated measures analysis of variance followed by 
determination of significant differences between groups using a Tukey 
post test. B. The individual Ra measurements for the pins degraded under 
moderate conditions in serum lubricant immediately after loading, after 2 
hours of recovery (C) and after 48 hours of recovery (D). 
129 
Figure 3.36. The surface roughness of plate replicas directly after degradation and 
after 24 and 48 hours of recovery. Post refers to post degradation, 24 
denotes 24 hours of recovery, 48 denotes 48 hours of recovery. Data is 
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presented as the mean (n=6) ± 95% confidence intervals. The data was 
analysed by repeated measures analysis of variance followed by 
determination of significant differences between groups using a Tukey 
post test.  
Figure 3.37. The co-efficent of friction recorded between osteochondral pins and 
plates during mechanical degradation protocols (N=6). A. The friction 
data recorded for all mechanical degradation conditions including error 
bars. Data is presented as the mean friction coefficient (n=6) ± 95% 
confidence intervals. The data was analysed by one way analysis of 
variance which revealed no significant difference in the friction levels at 
any time point between the three conditions B. The friction data recorded 
for all mechanical degradation conditions excluding error bars 
134 
Figure 3.38. Haematoxylin and eosin stained section of undegraded bovine articular 
cartilage pin control tissue. The complete tissue section showing the 
superficial, middle and deep zones of the tissue. 
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Figure 3.39 Haematoxylin and eosin stained section of bovine articular cartilage pins. 
A. The superficial zone of the cartilage tissue showing chondrocytes at the 
surface in flattened lacunae (arrows). B. The middle zone of the tissue 
showing chondrocytes in rough columns. C. The deep zone of articular 
cartilage showing chondrocytes in columnar forms within large irregularly 
shaped lacunae (arrows).   
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Figure 3.40. Haematoxylin and eosin stained section of cartilage pin specimens 
following mild degradation in Ringer’s solution.  Both images A and B 
show specimens without visible degradation to the tissue. C. This specimen 
was one of two specimens showing damage to the tissue (arrow). D. This 
specimen contained a fissure in the surface that extended less than 50% of 
the cartilage height (arrow). Scale bars represent 500 µm. 
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Figure 3.41 Haematoxylin and eosin stained section of cartilage pin specimens 
following moderate degradation in Ringer’s solution. A. This specimen 
had a relatively smooth superficial zone however the tissue appeared to 
have become detached at the calcified zone (arrow). B. Away from the 
fissure in the cartilage surface the surface of the tissue remained smooth. 
C. A large volume of tissue loss was observed from this specimen in which 
the tissue had been lost progressively across the pin resulting in less than 
139 
xxvi 
 
50% of tissue height remaining at the pin edge.  D. Tissue loss and 
fibrillation was observed in this specimen (arrows).  Scale bars represent 
500 µm. 
Figure 3.42. Haematoxylin and eosin stained sections of cartilage pin specimens 
following moderate degradation with serum lubricant. A-B. The cartilage 
surface away from the obvious areas of tissue damage remained smooth. 
C. Severe tissue damage was seen in one specimen in which tissue loss was 
observed. D. Fissures in the tissue were a typical form of damage (arrow). 
Scale bars represent 500 µm. 
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Figure 3.43. Alcian blue stained control cartilage pin section. Image shows an 
undegraded control pin section with superficial, middle, deep and calcified 
zones. 
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Figure 3.44. Alcian blue stained cartilage pin specimens following mild degradation 
using Ringer’s solution lubricant. A, C. A reduction in staining was 
observed in the deep zone of some specimens (arrows). B. Around areas of 
tissue damage a reduction in alcian blue staining was seen (arrow head). D. 
An overall loss of staining intensity compared with the undegraded control 
tissue was evident. Scale bars represent 500 µm. 
142 
Figure 3.45. Alcian blue stained cartilage pin specimens following moderate 
mechanical degradation in Ringer’s solution (N=6). A. Specimens 
appeared washed out due to a severe reduction in alcian blue staining. In 
this specimen the majority of GAG loss appeared to be in the middle to 
deep zone. B, C, D. Specimens with torn or fibrillated areas showed a 
greater reduction in focal alcian blue staining than areas with a clean 
fissure as was observed in A (arrows).  Scale bars represent 500 µm. 
143 
Figure 3.46. Alcian blue stained cartilage specimens following moderate degradation 
with serum lubricant (N=6). A. An overall reduction in alcian blue staining 
intensity was observed, however it was particularly evident in the 
superficial zone and in a band through the mid zone. B. Specimens showed 
a reduction in alcian blue uptake across the whole tissue. C. A reduction in 
alcian blue uptake was observed around areas of tissue damage (arrow). D. 
Tissue was seen breaking away from the bone (arrow). Scale bars 
represent 500 µm. 
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Figure 3.47. Biglycan distribution in control cartilage pin specimens. A. Image shows 
an undegraded control pin section. B. Image shows the isotype control, 
which was negative. 
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Figure 3.48 A-D. Biglycan distribution in pin specimens degraded under mild 
mechanical conditions in Ringer’s solution. Staining was reduced in the 
calcified zone of two specimens (B, C). Scale bars represent 500 µm. 
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Figure 3.49 Biglycan distribution in pin specimens degraded under moderate 
mechanical conditions in Ringer’s solution. Scale bars represent 500 µm. 
Stronger staining was observed in the upper-middle to superficial zone 
(arrows). 
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Figure 3.50 Biglycan distribution in cartilage pin specimens degraded under 
moderate mechanical conditions in serum based lubricant. Light staining 
was observed in the superficial zones of two specimens (arrows). Scale 
bars represent 500 µm. 
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Figure 3.51. A. Characterisation of undegraded pin control tissue using a cartilage 
oligomeric matrix protein antibody. B.  Image shows the isotype control, 
which was negative. 
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Figure 3.52. COMP distribution in cartilage pin specimens degraded mechanically 
under moderate conditions with Ringer’s solution lubricant. Scale bars 
represent 500 µm. 
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Figure 3.53. COMP distribution in cartilage pin specimens degraded mechanically 
under moderate conditions with Ringer’s solution lubricant. Scale bars 
represent 500 µm. 
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Figure 3.54. COMP distribution in cartilage pin specimens degraded mechanically 
under moderate conditions with serum lubricant. Scale bars represent 
500 µm. 
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Figure 3.55. Collagen VI distribution in control cartilage pin specimens. A. Image 
shows an undegraded control pin section. B. Image shows the isotype 
control, which was negative. 
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Figure 3.56. Collagen VI distribution in cartilage pin specimens degraded mechanically 
under mild conditions (N=6). Scale bars represent 500 µm. 
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Figure 3.57. Collagen VI distribution in cartilage pin specimens degraded mechanically 
under moderate conditions with Ringer’s solution lubricant. Scale bars 
represent 500 µm. 
152 
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Figure 3.58. Collagen VI distribution in cartilage pin specimens degraded mechanically 
under moderate conditions with serum lubricant. Scale bars represent 
500 µm. 
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Figure 3.59. Characterisation of undegraded control cartilage pins and mechanically 
degraded articular cartilage pin surfaces using environmental scanning 
electron microscopy (ESEM). A. The undegraded control cartilage surface. 
B. The cartilage surface after mild mechanical degradation. C. The 
moderately mechanically degraded surface articulated in Ringer’s solution. 
D.  The moderate mechanically degraded surface articulated in serum 
lubricant. 
155 
Figure 3.60. Features of degraded cartilage pin surfaces observed by ESEM. A. The 
mild surface showing a crack in the surface and increased creasing of the 
cartilage surface (arrows). B. The moderate condition surface articulated in 
Ringer’s solution showing a deep crack in the surface containing 
protrusions. C. The moderate condition surface articulated in Ringer’s 
solution showing a torn area of the cartilage surface (arrow). D. The 
moderate condition surface articulated in serum lubricant showing wear 
particles accumulating in the edge of a crack in the surface. 
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Figure 3.61. Transmission electron microscopy images of the superficial zone of 
undegraded control cartilage pin tissue stained with cupromeronic blue. 
A. The superficial zone of the tissue including the surface amorphous layer 
and a horizontal collagen band (bracket). B. Part of the band of fine 
collagen fibres running parallel to the cartilage surface where small leucine 
rich proteoglycans were observed (arrows). C. The cartilage tissue towards 
the middle zone of the tissue. 
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Figure 3.62. Transmission electron microscopy images of the middle zone of 
undegraded control cartilage tissue at 11,000 times magnification. A. 
Aggrecan was observed forming a network within the middle zone of the 
tissue (arrows). B. Proteoglycans were observed interacting with the 
surface of collagen fibrils (arrow).   
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Figure 3.63. Transmission electron microscopy of the deep zone of undegraded 
control cartilage tissue at 11,000 times magnification (N=3). A. Thick 
collagen fibrils were observed behind the dense aggrecan network (arrow). 
B. Patchy dark areas of staining were observed where dense areas of 
aggrecan appeared (circle). 
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Figure 3.64. Transmission electron microscopy of the deep zone in undegraded 
control cartilage. A. The image shows the changes in the ultrastructure of 
the cartilage in the deep zone in close proximity to a chondrocyte (nucleus 
not visible). To the right hand side of the dashed line the fine parallel 
collagen fibres that line the perimeter of chondrocytes can be seen   B. The 
structure begins to resemble the tissue in the territorial and interterritorial 
zones as the image is captured further away from the chondrocyte. 
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Figure 3.65. Tissues following mild condition mechanical degradation with Ringer’s 
solution lubricant stained with Cupromeronic blue dye for proteoglycans. 
A. The superficial zone of the tissue; the surface of the tissue is shown in 
the bottom left hand corner of the image. B. The middle zone of the tissue. 
C. The deep zone of the tissue. 
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Figure 3.66. Tissues having undergone moderate condition mechanical degradation 
with Ringer’s solution lubricant stained with cupromeronic blue dye for 
proteoglycans (N=3). A. The surface of the degraded tissue specimen 
possibly showing the hyaluronan network (arrows). B. The middle zone of 
the tissue. C. The deep zone of the tissue. 
162 
Figure 3.67. Chondrocyte ultrastructure in the superficial and deep zones of cartilage 
following moderate mechanical degradation in Ringer’s solution 
lubricant. Stained with Cupromeronic blue A. A chondrocyte in the 
superficial zone of the tissue.  B. A chondrocyte and its nucleus (partially 
shown ; asterisk) in the deep zone of the tissue. C. The transitional zone 
between the chondrocyte environment and the territorial region of the 
tissue in the deep zone. 
164 
Figure 3.68. Tissues following moderate condition mechanical degradation with 
serum solution lubricant stained with Cupromeronic blue dye for 
proteoglycans. A. The superficial zone of the tissue showing gaps in the 
collagen network (arrow). B. The middle zone of the tissue. C. The deep 
zone of the tissue. 
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Figure 3.69. The relationship between absorbance at 570nm and the concentration of 
trans-4-hydroxy-L-proline (mg.ml-1). Data is presented as the mean (n=3) 
±95% confidence limits. 
166 
Figure 3.70.   The collagen content of control cartilage and mechanically degraded 
cartilage. Data is presented as the mean (n=6) ±95% confidence limits. The 
data was analysed using one way analysis of variance followed by 
determination of significant differences between  groups using a Tukey 
post test; * equates P ≤ 0.05. 
167 
Figure 3.71. The relationship between absorbance at 525nm and the concentration of 
chondroitin sulphate B (mg.ml-1). Data is presented as the mean (n=3) 
±95% confidence limits. 
168 
Figure 3.72. The GAG content of control cartilage and mechanically degraded 
cartilage. Data is presented as the mean (n=6) ±95% confidence limits. The 
data was analysed using one way analysis of variance followed by 
determination of significant differences between  groups using a Tukey 
post test; *** equates P ≤ 0.001.   
168 
Figure 3.73. The collagen content of lubricants recovered after mechanical 
degradation protocols. Data is presented as the mean (n=6) ±95% 
confidence limits. The data was analysed using one way analysis of 
variance followed by determination of significant differences between  
groups using a Tukey post test; * equates P ≤ 0.05. 
169 
Figure 3.74. The GAG content of lubricants recovered from mechanical degradation 
protocols. Data is presented as the mean (n=6) ±95% confidence limits. 
The data was analysed using one way analysis of variance followed by 
determination of significant differences between  groups uinsg a Tukey 
post test; * equates P ≤ 0.05. 
170 
Figure 3.75. A summary of the results obtained using a range of methods to 
characterise cartilage mechanical degradation models. Key: *** indicates 
strong presence of the feature, ** indicates Presence, * indicates slight 
presence, - indicates reduction in presence of feature, -- indicates strong 
reduction, --- indicates complete absence of a feature. 
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Figure 4.1. The experimental approach taken in the research described in chapter 4 
in which specimens were treated with chondroitinase ABC. The image 
includes the characterisation techniques that were used to analyse 
specimens and the number of replicates. 
185 
Figure 4.2. The indentation apparatus used to indent untreated control and 
chondroitinase ABC treated cartilage specimens. Image shows the 
indenter rig and components of the rig required for indentation testing. 
189 
Figure 4.3. Representative images of haematoxylin and eosin stained sections of 
cartilage pin tissue treated with chondroitinase ABC. A. The untreated 
control. B,C,D. The chondroitinase ABC treated specimens. The pale band 
of staining has been highlighted (Braces ; N=6). 
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Figure 4.4. Representative images of alcian blue stained sections of cartilage pin 
specimens treated with chondroitinase ABC. A. The untreated control 
B,C,D. The chondroitinase ABC treated specimens. The pale band of 
staining has been highlighted (Braces ; N=6). 
191 
Figure 4.5. Representative images of chondroitinase ABC treated cartilage pin 
sections labelled with a biglycan antibody (N=6). A. Untreated control 
tissue B. The surface and upper middle zone of the treated tissue. The 
arrow shows artifactual staining. C.  The surface and upper middle zone of 
the treated tissue, which showed a reduction in haematoxylin staining 
(brace). D. The middle to deep zones of the tissue. E. The middle to deep 
zones of the treated tissue in which some staining was observed (arrows).    
193 
Figure 4.6. Chondroitinase ABC treated cartilage pin sections stained with a cartilage 
oligomeric matrix protein antibody A. The untreated control tissue. B-E. 
Chondroitinase ABC treated specimens with arrows highlighting artefact 
staining in the calcified zone of specimens D and E (N=6).   
195 
Figure 4.7. Chondroitinase ABC treated cartilage sections labelled with a collagen VI 
antibody (N=6). A. The untreated control tissue. B-E. The chondroitinase 
ABC treated specimens (N=6).  Interterritorial staining is highlighted 
(arrow). 
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Figure 4.8. Chondroitinase ABC treated and untreated control cartilage specimens 
stained with Cupromeronic blue dye viewed with TEM. A. The superficial 
zone of the chondroitinase ABC treated tissue showing the cartilage 
surface in the top left corner. B. The superficial zone of the untreated 
negative control cartilage tissue showing the cartilage surface in the top 
left corner. 
198 
Figure 4.9. Figure 4.9 Chondroitinase ABC treated and untreated control cartilage 
specimens stained with Cupromeronic blue dye viewed with TEM. A. The 
middle zone of the chondroitinase ABC treated tissue where the aggrecan 
network has been disrupted (circle). B. The middle zone of the untreated 
negative control cartilage tissue with examples of intact areas of the 
aggrecan network (circles). 
198 
Figure 4.10. Figure 4.10. Chondroitinase ABC treated and untreated control cartilage 
specimens stained with Cupromeronic blue dye viewed with TEM. A. The 
deep zone of the chondroitinase ABC treated tissue. B. The deep zone of 
the untreated negative control cartilage tissue. 
199 
Figure 4.11 TEM images of cartilage tissue treated with chondroitinase ABC and 
stained with Cupromeronic blue dye to act as negative control images. A. 
The superficial zone of the tissue; the surface of the tissue is visible in the 
top right hand side of the image. B. The upper middle zone of the tissue. 
Hyaluronan was observed in the extensively treated specimens (arrow) C. 
The middle zone of the tissue. D.  The deep zone of the tissue. 
200 
Figure 4.12. The collagen content of untreated control cartilage and cartilage treated 
using chondroitinase ABC at a concentration of 0.1U.ml-1 for 16 hours. No 
significant difference was found between the two values. Data is presented 
as the mean (n=6) ±95% confidence limits. 
201 
Figure 4.13. The glycosaminoglycan content of untreated control cartilage and 
cartilage treated using chondroitinase ABC. A significant difference was 
found between the two values. Data is presented as the mean (n=6) ±95% 
confidence limits. The data was analysed using a Student’s t-test; **** 
equates P ≤ 0.0001. 
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Figure 4.14. The displacement of untreated control tissue and chondroitinase ABC 
treated cartilage tissue during a 60 minute indentation test. A The purple 
line marks the deformation of the chondroitinase ABC treated tissue. The 
orange line marks the deformation of the untreated control tissue. A 
significant difference was found between the values at several time points. 
Data is presented as the mean (n=6) ±95% confidence limits. The data was 
analysed using a Student’s t-test; * P ≤ 0.05, ** P ≤ 0.01. B. The early 
elastic response region which showed no significant differences between 
displacement of control and digested tissues. 
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Chapter Five   
Figure 5.1. Apparatus for cartilage wear particle isolation. A. The vacuum filter 
holder (composed of a measuring cylinder and filter holder with bung), and 
filter flask components. The measuring cylinder and filter holder were held 
together with a clamp. B. The case containing 45 mm diameter 10 µm pore 
filters and the petri dish. C. The electric pump. 
213 
Figure 5.2. A schematic of the filter post filtration, including the area of the filter 
which was removed using a 6mm diameter biopsy punch for imaging 
using ESEM. 
214 
Figure 5.3. Calculation of the percentage area of the filter observed during imaging. 215 
Figure 5.4. The appearances of the cartilage wear particles at a range of humidities. 
As the humidity dropped the clarity of the images was improved. 
Precipitated salt crystals from the Ringer’s solution could be seen clearly 
on the surface of the largest particle in the images taken at 55 and 45 % 
humidity. There was only one feature that was visible on the lowest 
humidity image that was not also clearly visible on the highest humidity 
image (circled). 
217 
Figure 5.5. The average number of particles found in 1 ml of lubricant recovered 
from mild and moderate mechanical degradation protocols. The values 
were normalised to each ml of lubricant. Data is presented as the mean 
(n=5) ±95% confidence limits.  The data was analysed using one way 
analysis of variance followed by determination of significant differences 
between groups using a Tukey post test; * equates to P≤ 0.05; *** equates 
to  to P≤ 0.001. 
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Figure 5.6. A range of images taken of cartilage wear particles in Ringer’s solution 
lubricant recovered from mild condition mechanical degradation using 
ESEM. A-F. Typical images of cartilage particles which were clearly defined. 
Globular particles with smooth edges (asterisks) were observed alongside 
fibrillar particles (arrow heads), irregular particles with rough edges 
(arrow) and irregular shaped particles (crosses). G-I. Examples of images 
that included particles with semi-amorphous boundaries (arrows). Scale 
bar represents 50 µm. Magnification 1500X. 
219 
Figure 5.7. A range of images taken of cartilage wear particles in Ringer’s solution 
lubricant recovered from moderate condition mechanical degradation 
taken using ESEM. A-E. Typical screenshots showing particles recovered 
from moderate condition lubricant including globular particles with both 
smooth (arrow) and rough edges (crosses). F.  An amorphous globular 
particle is shown with pores of the filter visible through part of the particle 
(arrows). G-I.  Images show screenshots that include examples of diffuse 
(arrow), globular (cross) and amorphous particles (asterisk). Scale bar 
represents 50 µm. Magnification 1500X. 
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Figure 5.8. Images showing typical contaminants in the control lubricant taken using 
ESEM. A. Occasionally, granular particles that appeared similar to the 
cartilage particles found in the recovered lubricants were observed in the 
control solutions. B. A sharp granular particle. C. A small spherical 
contaminant particle D. A straight fibrous hair like particle was observed. 
Scale bar represents 50 µm. Magnification 1500X. 
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Chapter Six   
Figure 6.1. Future development of degradation models for assessment of cartilage 
substitution materials. It will be possible to use the simple configuration 
degradation models for assessment of cartilage substitution in a range of 
formats. A. Osteochondral pin against cartilage substitution plate. B. 
Osteochondral pin against osteochondral plate with cartilage substitution 
material insert.  C. Cartilage substitution material pin against 
osteochondral plate. 
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1.1 Introduction to cartilage 
Within the body there are three major types of cartilage: hyaline cartilage, elastic cartilage and 
fibrocartilage. Hyaline cartilage is the most common cartilage found in the body and sub types 
of hyaline cartilage exist, the most typical sub-type being articular cartilage. Articular cartilage 
is an anerual and avascular tissue found at the ends of long bones such as the tibia and the 
femur that contributes to the low friction environment found in synovial joints and helps to 
distribute loads over a relatively broad area. Articular cartilage consists of an extracellular 
matrix phase and a small number of sparsely distributed cells called chondrocytes bathed in a 
fluid phase consisting of water and inorganic salts. Articular cartilage is an anisotropic material 
due to its zonal structure. 
  Articular cartilage is a semi-transparent white material with a glossy glass like surface. 
Articular cartilage, along with synovial fluid and other joint components helps to create an 
almost friction free, congruent environment for the articulation of adjacent long bones. The 
coefficient of friction of fully hydrated normal healthy cartilage articulating on cartilage is very 
low; it is in the range of 0.002-0.02 (Mow & Huiskes 1979). The intrinsic properties conveyed 
on cartilage by its internal components allow it to withstand substantial loads while it 
continues to provide a low friction environment (Greenwald & O’Connor, 1971). This ability is 
reduced in situations where the cartilage has been damaged for example in the disease 
osteoarthritis. 
1.2 Joints and joint components 
1.2.1 The knee joint 
The knee is the largest and most complex joint in the human body. The hard tissues of the 
knee joint are comprised of the medial and lateral condyles of the femur, the tibial plateau and 
the patella (patella not shown; Figure 1.1). The knee is primarily a hinge joint. It allows flexion 
and extension in addition to some limited rotation during flexion. As the knee undergoes 
flexion or extension, the femoral condyles roll across the tibial plateau. The menisci found in 
the knee are important during flexion and extension because they fit between the two 
articulating bones and provide increased congruity. The knee joint is relatively unstable in 
comparison with other joints in the body and is heavily supported by the surrounding muscles, 
tendons and ligaments in the joint.  
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  The joint capsule within the knee consists of an external fibrous layer and an internal 
synovial membrane. The synovial membrane lines any area of the joint space that is not 
covered by cartilage and contains synoviocytes which secrete synovial fluid. The menisci are 
crescent shaped plates of fibrocartillage found on the surface of the tibia that play a role in 
shock absorption as well as providing a more congruent environment between the femur and 
tibia. In cross section they appear wedge shaped with their external edges attached to the 
joint capsule of the knee. 
1.2.1.1 The mechanical environment of the knee 
 The knee undergoes a large range of stresses during normal physical activity. This can result in 
the application of a variety of contact stresses on the cartilage which can range from 2.8 MPa 
during slow walking, 14 MPa during fast walking and 26 MPa during deep flexion of the knee 
(Thambya et al., 2005 ; Yoshida et al., 2006). The normal range of motion in the knee in 
women and men is usually 5 to 143 degrees and 6 to 140 degrees respectively. However, 
hyperextension of the knee is possible which results in a range of motion that includes a 
 
 
Figure 1.1. Anterior view of the human knee joint, showing the major ligaments, bony 
structures and meniscus. Articular cartilage is shown in purple covering the femur above the 
menisci. Taken from http://warwickphysio.com 
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negative value. It has been estimated that to rise from a seated position the knee requires 93 
degrees of flexion, while shoelace tying requires 106 degrees of flexion (Laubenthal et al., 
1972). 
1.3 Cartilage structure 
Cartilage tissue has an inhomogeneous structure because the components of the tissue change 
in quantity, orientation and structure throughout the tissue. The layers or zones are classified 
into the superficial zone, or superficial tangential zone (10-20% of cartilage depth), the middle 
zone (40-60% of cartilage depth) the deep zone (30% of cartilage depth) and the calcified zone 
(Figure 1.2; Wu & Herzog., 2002).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.3.1 Surface amorphous layer (SAL) 
The superficial zone of cartilage is covered by an amorphous layer thought to be up to 450 µm 
in thickness (Crockett et al., 2005). The surface amorphous layer (SAL) can be separated into 
       
Figure 1.2. The zonal arrangement of articular cartilage taken from Poole et al. (2001). The 
image includes details of the territorial and interterritorial regions of the tissue including the 
proteoglycan arrangements in each zone. The images in the beige boxes highlight the variable 
collagen morphologies seen through the tissue.  
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two zones, the surface laminar layer adjacent to the superficial tangential layer and a 
boundary layer found above the laminar layer. The SAL contains lipids, proteins and 
glycosaminoglycans (Graindorge et al., 2006). It does not contain collagen or cells. Treatment 
of the SAL with α-chymotrypsin has been shown to lead to disruption and thinning of the SAL 
and an increase in friction (Teeple et al., 2007). The SAL is thought to protect collagen in the 
tissue from fibrillation and to be responsible to for the low coefficient of friction measured on 
the initiation of motion in load bearing joints after prolonged static periods (Forster & Fisher., 
1999; Graindorge et al., 2005).  
 
1.3.2 Superficial tangential zone (STZ) 
 
The superficial layer has a low proteoglycan content, a dense arrangement of fine collagen 
fibres that lie parallel to the articular cartilage surface and flat disc-shaped chondrocytes 
(Poole, 1997). It is thought that the fine tightly packed collagen in this zone contributes to 
reduction of acute mechanical stress by distributing the stresses evenly across the articulating 
surface. This role seems appropriate due to the high levels of tensile and compressive forces 
which are found in this zone (Nordin & Frankel, 2001).   
 
1.3.3 Middle zone 
 
In this zone the chondrocytes are spherical in shape and the proteoglycan content is at its 
highest concentration.  The collagen fibres become thicker in diameter and more randomly 
orientated which creates a transitional layer into the deep zone (Poole, 1997). Cartilage 
intermediate layer protein (CILP) is found exclusively in this region (Lorenzo et al., 1998). 
 
1.3.4 Deep zone 
 
The deep zone is characterised by rounded chondrocytes arranged in columns and a collagen 
network that is organised into thick bundles perpendicular to the cartilage surface. The 
proteoglycan content is higher than in the superficial zone (Poole, 1997). 
 
1.3.5 Calcified zone 
 
The calcified zone has a low concentration of proteoglycans. Here, bunches of collagen fibres 
anchored perpendicularly to the cartilage surface layer span the tidemark; an undulating line 
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that marks the separation between the deep and the calcified zones.  This arrangement, paired 
with the border that marks the transition from calcified cartilage to subchondral bone (the 
cement line) ensures the cartilage is firmly anchored to the bone (Poole, 1997).  
 
1.3.6 Pericellular, territorial and interterritorial matrices 
 
In addition to the layers described above, the circumferential matrix surrounding the 
chondrocytes within the middle and deep layers can also be divided into zones which are 
determined by their composition and distance from the chondrocytes (Figure 1.2). These zones 
are known as the pericellular, territorial and inter-territorial matrices (Poole, 1997). The 
pericellular matrix is found in the immediate proximity of the chondrocytes and is around 2 µm 
thick. The territorial matrix is regarded as the transitional cell associated matrix found 
separating the pericellular and inter-territorial regions. The majority of the cartilage that is not 
included in the previous two zones that is relatively distant from the chondrocytes is 
designated as the inter-territorial region (Aigner & Stove, 2003). Within the pericellular region 
the collagen fibrils range from 10-25 nm in thickness, however in the more distal regions 
collagen fibres become larger with diameters of up to 300 nm (Mow & Huiskes, 2005). The 
pericellular region is thought to be very important for the biomechanical transduction and 
modulation of signals such as lateral and axial strain from the extracellular matrix (ECM) to the 
chondrocytes. Collagen and proteoglycan content, as well as the fluid volume in the 
pericellular matrix are important factors influencing how the cell is deformed under pressure. 
Using a finite element model, Julkunen et al. (2009), showed that a loss of collagen from the 
pericellular matrix and an increased fixed charge density could reduce lateral strains on 
chondrocytes.  
 
1.4 Cartilage composition 
 
Cartilage is composed of both a fluid and solid phase. Water (interstitial fluid) makes up 
approximately 75% of the cartilage tissue content. Approximately 25% is made up of the solid 
part of the tissue (Kheir & Shaw, 2009). 
 
1.4.1 Interstitial fluid 
Interstitial fluid is composed predominantly of water, the distribution of which varies 
throughout the tissue, with water content being most abundant at the articular surface (Mow 
& Huiskes, 2005). Interstitial water exists internally (intrafibrillarly) and externally 
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(extrafibrillarly) to the collagen fibres in articular cartilage. The volume of intrafibrillar water is 
regulated by the fixed charge density generated by the surrounding proteoglycans (Katz et al., 
1986). Extrafibrillar water is free to move throughout cartilage tissue due to hydraulic and 
osmotic pressure gradients, whereas intrafibrillar water is not. The volume of extrafibrillar 
water varies with age: it has been reported that the volume of extrafibrillar water in the 
cartilage decreases with age (Torzilli, 1988). It is the internal to external (and vice-versa) 
movement of the extrafibrillar water that allows reversible cartilage deformation after 
cartilage has been subjected to loading (Mow & Huiskes, 2005). The ions found most 
commonly in the interstitial water are sodium, chloride, potassium and calcium (Linn and 
Sokoloff, 1965; Mow et al., 1999) and for the most part they can participate in un-restricted 
diffusion between the tissue and its external surrounding environment.  
 
1.4.2 Collagen 
Cartilage has a fibrous ultrastructure composed of collagen. The collagen matrix integrity is 
important for regulation of the structural properties of cartilage, as it provides cartilage with 
tensile strength. Conversely, collagen has a poor compressive resistance (Bader et al., 1992). 
Collagen withstands the swelling pressures created by proteoglycans in the cartilage (Mow & 
Huiskes, 2005). However, this is not the only function of the collagens, which have a broad 
spectrum of roles. Some types of collagen, as of yet, have undefined functions.  
  Collagen consists of three left handed helix procollagen peptide chains, which can be 
heterogeneous or homogeneous. The peptide chains are twisted together to form a tightly 
wound right handed triple helix (Dejica et al., 2008). The triple helix, is stabilised by hydrogen 
bonds. The polypeptide chains themselves are formed from a repeating triplet structure in 
which every third amino acid within the polypeptide chain is glycine. The amino acids, 
hydroxyproline and proline often constitute the remaining residues within the repeating triplet 
structure. Glycine is an amino acid with a small side group. The small size of glycine is 
important for formation of correct collagen structure as it is necessary for the assembly of the 
tightly wound right handed collagen helix. The triple helix formed from the three peptide 
chains is known as a micro-fibril and in fibrillar collagens, many micro-fibrils associate to form 
larger functional collagen fibres which are stabilised by intermolecular cross-links (Figure 1.3 ; 
Dejica et al., 2008). The triple helix collagen domains are flanked by non-collagenous domains 
(Gordon & Hahn, 2010). Non-collagenous domains are involved in several processes including 
alignment, nucleation and folding of the collagen triple helix (Brass et al., 1992).  
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There are over 20 types of collagen all of which contain sequence variations and differ in 
polypeptide length. Cartilage predominantly contains type II collagen.  Other collagens are also 
present in smaller concentrations, for example types VI, IX, X and XI (Bruckner & van der Rest, 
1994; Aigner & Stove, 2003). Collagens do not exist strictly in homogeneous states. In cartilage, 
fibrils are formed from collagen type II that contain a type XI collagen core.  Type IX collagen is 
found distributed on the fibril surface and is known as a fibril associated collagen (Mendler et 
al., 1989). Collagen types VI and X form beaded filaments and hexagonal structures, 
respectively. Collagens are orientated differently throughout the cartilage resulting in 
anisotropic properties and various zones within the tissue. 
 
1.4.2.1 Collagen II 
 
Collagen II represents the largest percentage of the collagen volume in cartilage, accounting 
for up to 60% of the tissue dry weight. Collagen II consists of three identical polypeptide α 
chains. In cartilage it is found associated with collagens IX and XI in an 8:1:1 ratio, respectively 
(Vaughan et al., 1988). Collagen II is synthesised as procollagen and undergoes post-
 
Figure 1.3. The hierarchical structure of a collagen fibre. Initially, three polypeptide chains 
form a left-handed triple helix. From there, several triple helices assemble to 
produce collagen fibrils that in turn align to form a mature collagen fibre. Adapted from Heim  
et al., 2010. 
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translational modification which involves removal of the N and C terminal signal domains, 
hydroxylation and glycosylation.  
  Collagen II exists as two different splice variants: collagen IIA and IIB. Collagen IIB is the 
dominant variant found in mature cartilage. Collagen IIB is produced as a result of differential 
splicing; the second exon is spliced from the primary COL2A1 gene product, resulting in the 
absence of a cysteine-rich 69-amino acid domain from the mature protein. Collagen type IIA is 
present in mature cartilage but in smaller amounts as collagen IIA is usually only produced by 
immature chondrocytes in developing cartilage (Ryan and Sandell, 1990; Matyas et al., 1997). 
The two splice variants can have an effect on chondrocyte morphology: the removal of the 
second exon predisposes cells to a rounded shape. In cells producing collagen IIA, the presence 
of the second exon results in spindle shaped cells (Sandell et al., 1991). Interestingly, collagen 
IIB mRNA is co-expressed with aggrecan mRNA supporting the theory that both components 
are required for a functional extracellular matrix (ECM). 
 
1.4.2.2 Collagen VI  
 
Collagen VI is a trimer composed of three heterogeneous polypeptide α chains. It is a 
combination of α1(VI) and α2(VI), both of which are 140 kDa in size and an α3(VI) chain which 
is 260-300 kDa (Lampe & Bushby, 2005; Gordon & Hahn, 2010).  
  Collagen VI is synthesised as monomers, which aggregate to form tetrameric 
structures through non covalent interactions. Collagen VI has been observed through 
transmission electron microscopy as a highly branched fine network that laces in between and 
around collagen fibrils within tissue (Keene et al., 1988). 
 
1.4.2.3 Collagen IX 
 
Collagen IX is a heterotrimeric molecule composed of three distinct polypeptide chains: α1(IX), 
α2(IX) and α3(IX), that assemble in a 1:1:1 ratio (Bruckner & van der Rest,  1994). Collagen IX 
belongs to a group of collagens known as fibril associated collagens with interrupted triple 
helices (FACIT collagens). Collagen IX contains a glycosaminoglycan side-chain attachment site 
and is found exclusively in tissues that also contain collagen type II (Myllyharju & Kivirikko, 
2001).  
  Collagen IX contains a chondroitin sulphate GAG binding region that exhibits covalent 
bonding to chondroitin sulphate (Mendler et al., 1989). Collagen IX binds externally to the 
collagen fibril network in a regular d-periodic arrangement via its chondroitin sulphate chain 
(Mendler et al., 1989; Vaughan, 1988). Collagen IX is believed to be important for both 
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stabilising the collagen network formed from collagen II and XI and increasing the efficiency of 
fibril formation. Therefore collagen IX assists in resistance to proteoglycan induced swelling 
and tensile stresses generated in cartilage exposed to loading. However, collagen IX is not 
essential for fibril formation and other roles for this collagen remain to be elucidated (Blaschke 
et al., 2000). 
 
1.4.2.4 Collagen X 
 
Collagen X is a network forming collagen like collagen VI. In cartilage, collagen X assembles into 
hexagonal networks (Kwan et al., 1991). There is only one possible collagen X α-polypeptide 
chain variation, which naturally results in the ability of this collagen to form homotrimers only. 
Collagen X is found in hypertrophic cartilage as “filamentous mats”, generally in close 
proximity to hypertrophic chondrocytes, although it has also been observed in association with 
collagen II in regions further from chondrocytes. In healthy adult cartilage it is found in the 
calcified region of the tissue. Collagen X reaches distal zones via diffusion through the 
extracellular matrix, as a result of its small size (Chen et al., 1990; Gannon et al., 1991). 
   There is a correlation between the hypertrophic characteristics of chondrocytes and 
collagen type X production (Gibson and Flint, 1985). Hypertrophic cartilage is observed during 
endochondral bone formation. Ultrastructural studies have shown that within a hypertrophic 
environment, collagen II is coated with type X collagen before tissue calcification begins to 
occur, this leads to a possible role of collagen X in hypertrophic cartilage matrix calcification. 
Collagen X is increased in chondrocytes of the superficial zone of osteoarthritic cartilage and 
may also be important for assisting with degradation of the hypertrophic cartilage matrix. This 
is because collagen X contains collagenase and elastase binding sites. Therefore its presence in 
the pericellular region may facilitate concentration of collagenases for matrix remodelling 
activity (Echtermeyer et al., 2009; Schmid et al., 1990). Collagen X may also designate specific 
collagen fibrils for degradation as bone and marrow replace embryonic cartilage during 
development (Schmid et al., 1990).  
 
1.4.2.5 Collagen XI 
 
Collagen XI participates in the formation of the fibrous collagen network in conjunction with 
collagens II and IX. Collagen XI molecules are attached to collagen type II via covalent 
hydroxylysine-based aldehyde cross links. Collagen XI lies both within and on the surface of 
collagen II fibres (Cremer et al., 1998; Blaschke et al., 2000). The specific role of collagen XI is 
to regulate fibril formation by collagen type II, its presence during fibrilogenesis leads to strict 
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fibril diameter control. In a study by Blaschke et al. (2000), it was suggested that the large N-
terminal domain found attached to collagen XI can span eight adjacent collagen II molecules. 
This mechanism leads to a restriction on atypical growth of the collagen II fibre. 
 
1.4.3 Cartilage proteoglycans 
 
Proteoglycans are a group of highly diverse protein polysaccharides synthesised by stromal 
cells including chondrocytes that account for around a quarter of the dry weight of cartilage. 
   Proteoglycan macromolecules are negatively charged at physiological pH and consist 
of a protein core to which many glycosaminoglycans (GAGs), such as chondroitin sulphate and 
keratan sulphate are attached (Mow and Lai, 1979; Lee et al., 1981).  
  Proteoglycans are integral for the correct functioning of cartilage because they are 
responsible for the regulation of its internal fluid transport and therefore its time-dependant 
viscous properties (Bader et al., 1992). Proteoglycans also confer cartilage with an ability to 
withstand compressive stresses during loading due to their negative fixed charges. A loss of 
proteoglycans has been shown to increase friction in joints, this may be due to a reduction in 
support from the fluid phase during loading (Katta et al., 2007; Naka et al., 2005). 
Proteoglycans are held in place within the cartilage matrix by the tight meshwork of collagen 
fibres. Cartilage proteoglycans include aggrecan, biglycan, decorin, fibromodulin and lumican. 
 
1.4.3.1 Aggrecan 
 
The most common proteoglycan found in cartilage is aggrecan (Figure 1.4). Aggrecan 
constitutes 80-90% of the total proteoglycan content found in cartilage and has a hyaluronan 
binding region (HABR) that facilitates chondrocyte-aggrecan interations (Mow & Huiskes, 
2005).  The bond between hyaluronan and aggrecan is non-covalent and is stabilised by a link 
protein. It is an important bond because it results in mass immobilisation of aggrecan and 
provides structural stability and rigidity within the extracellular matrix. The sheer size of 
aggrecan also helps to retard its movement in situ as it is such a large molecule held in a 
relatively small space. Up to 100 aggrecan molecules can attach to each hyaluronan chain 
(Morgelin et al., 1988). Aggrecan has three globular domains, G1, G2 and G3. The G1 domain 
(HABR) is located at the N terminus. It contains small amounts of keratan sulphate and N-
linked oligosaccharides. The G2 region lies in between the HABR and the keratan sulphate rich 
region found in the G3 domain at the C-terminus (Nordin & Frankel, 2001). 
  Approximately 150 GAG chains are covalently attached to each individual aggrecan 
molecule, which are accompanied by O and N linked oligosaccharides all of which are un-
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equally distributed resulting in the specific individual GAG rich domains described above 
(Nordin & Frankel, 2001). 
  Despite having a generic basic structure, two distinct populations of aggrecans have 
been identified, one present only in adult cartilage that is rich in keratan sulphate and one 
present throughout life that is rich in chondroitin sulphate (Nordin & Frankel, 2001). As 
cartilage ages, its proteoglycan content changes, for example, there is a decrease in 
chondroitin sulphate concentration. Loss of aggrecan due to disturbances in proteoglycan 
metabolism leads to a loss of extracellular matrix integrity and consequently results in joint 
disease (Mow & Huiskes, 2005). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.4.3.2 Small leucine rich proteoglycans 
 
Despite appearing in relatively low quantities within cartilage, small leucine rich proteoglycans 
(SLRPs) are important for the correct organisation and function of cartilage. The SLRP class of 
proteoglycans includes decorin, biglycan, fibromodulin and lumican. Decorin, fibromodulin and 
lumican are known to assist with collagen fibril formation, more specifically, regulation of fibril 
diameter (Danielson et al., 1997; Chakravarti et al, 1998; Svensson et al, 1999). Decorin also 
interacts with collagen VI and collagen II which may help to bolster interactions between these 
 
Figure 1.4. The structure of aggrecan and its interaction with hyaluronan. 
13 
two collagens (Bidanset et al, 1992 ; Hedbom, et al., 1993). Biglycan interacts with collagen VI 
and induces it to form hexagonal networks (Wiberg et al., 2002). Both biglycan and decorin in 
association with maitrilin-1 have been shown to mediate interactions between collagen VI and 
both collagen II and aggrecan (Wiberg et al., 2003). 
  Decorin, fibromodulin and lumican have been reported to protect collagen II from 
degradation via restriction of access to collagen II fibrils by degradative enzymes such as matrix 
metalloprotease 13 (MMP-13 ; Geng et al., 2006; Roughley, 2006). In addition to this function, 
SLRPs can interact with various signalling molecules in the ECM including transforming growth 
factor-β (TGF-β), which is sequestered by SLRPs to regulate the effects of TGF-β on 
chondrocytes (Hildebrand et al, 1994). Decorin is also known to down regulate the production 
of tumour necrosis factor-α (TNF-α ; Yamaguchi et al., 1990). Therefore a loss of small 
proteoglycans can result in deficiencies in collagen organisation and disruption of normal 
metabolic processes within the ECM (Merline et al., 2009). 
 
1.4.4 Glycosaminoglycans (GAGs) 
 
GAGs are linear molecules attached to proteoglycan core proteins that contain many 
negatively charged sulphate and carboxyl groups. The high negative charge of the GAGs in 
cartilage tissue results in the generation of an electrical potential known as the Donnan 
potential. To maintain electroneutrality within the tissue, positive counterions move into the 
cartilage generating a high ion concentration. This draws interstitial fluid into the tissue, 
causing it to swell. This swelling pressure is known as the Donnan osmotic pressure and it 
allows the cartilage to maintain a hydrated state. Under physiological conditions, the unequal 
ion distribution resulting between the cartilage tissue and the external bathing solution, 
reaches an equilibrium referred to as the Donnan equilibrium. Cartilage swelling is important 
because it substantially increases the ability of cartilage to withstand physiological loading 
(Mow & Huiskes, 2005). The various GAGs that are found in cartilage will now be discussed. 
 
1.4.4.1 Hyaluronan (Hyaluronic acid) 
 
Hyaluronan is an unbranched polysaccharide macromolecule found in cartilage and synovial 
fluid. Hyaluronan differs from other GAGs in that it is not sulphated. It is composed of 
disaccharide N-acetyl glucosamine units linked to glucuronic acid (Mow & Huiskes, 2005).  
  Within the synovial fluid, hyaluronan is found twisted into an ellipsoidal configuration. 
Hyaluronan regulates the viscosity of the synovial fluid through water retention and also 
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enables it to display non-Newtonian properties. These properties include thixotropy, the 
property of a fluid becoming less viscous over time when exposed to stresses and elasticity, 
and the property of becoming less viscous when exposed to shear stress, known as 
pseudoplasticity. These functions all enable the synovial fluid to protect and lubricate the 
cartilage. 
  The other role of hyaluronan in cartilage is to facilitate the formation of immobilised 
macromolecular aggregates within the collagen network via interaction with aggrecan and the 
link protein. Additionally, hyaluronan interacts with the cell surface hyaluronan receptor CD44 
of chondrocytes to permit synthesis of the pericellular matrix as well as facilitating attachment 
of chondrocytes to the surrounding extracellular matrix (Knudson & Knudson, 1991; Knudson, 
1993; Jiang et al., 2002).  
 
1.4.4.2 Chondroitin sulphate 
 
Chondroitin sulphate is composed of 25-30 disaccharide units of glucuronic acid and N-acetyl 
galactosamine. Chondroitin sulphate is the most commonly observed GAG found associated 
with aggrecan. Chondroitin sulphate molecules can be sulphated at either the 4 or 6 position 
to form chondroitin 4-sulphate and chondroitin 6-sulphate respectively (Baeurle et al., 2009). 
The species of chondroitin sulphate varies with age and as cartilage ages higher levels of 
chondroitin 6-sulphate have been observed with reduced levels of chondroitin 4-sulphate 
(Bayliss et al., 1999).  
 
1.4.4.3 Keratan sulphate 
 
Keratan sulphate (KS) is a linear polymer composed of 13 disaccharide units of galactose and 
N-acetyl glucosamine. At birth keratan sulphate is present only in small amounts, however its 
concentration increases with age. There are two classes of KS, known as KSI and KSII which are 
commonly found in the cornea and cartilage, respectively. KSII is shorter than KSI and is heavily 
sulphated. The structure of KS can be simplified into three regions: a link region which 
connects the KS to a core protein (G1). A repeat region composed of the disaccharide unit (G2) 
and a chain capping region (G3). Most of the KS in cartilage is O-linked to aggrecan between 
the G2 and G3 regions in a domain characterized by a repeated six-amino acid motif (Flannery 
et al., 1998) 
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1.4.4.4 Dermatan sulphate (DS) 
 
Dermatan sulphate is most commonly found in the skin where it is involved in wound repair, it 
is also present in small amounts in cartilage. Dermatan sulphate is a linear polymer composed 
of repeated disaccharide units containing a hexosamine, N-acetyl galactosamine (GalNAc) or 
glucuronic acid (GlcA) motif joined by ß 1,4 or 1,3 linkages, respectively. Dermatan sulphate 
also contains iduronic acid which appears to participate in binding site specificity for GAG-
binding proteins. 
  The length of the DS molecule is variable, as are the location of its sulphation sites and 
the location of iduronic acid binding, which add to the complex nature of DS and DS-containing 
proteoglycans (Trowbridge & Gallo, 2002) 
  Dermatan sulphate accumulation has implications in mucopolysaccharidosis disorders 
in which there is an absence of lysosomal enzymes or an inability of the enzymes to perform 
their correct functions, which are required for glycosaminoglycan metabolism. These diseases 
can lead to a chronic accumulation of dermatan sulphate in cells and cartilage tissue, resulting 
in severe skeletal dysplasia and short stature. 
   
1.4.5 Non-collagenous proteins 
 
Other minor structural proteins found in the ECM include cartilage oligomeric matrix protein 
(COMP), fibronectin, cartilage intermediate layer protein (CILP) and matrilins 1 and 3.  COMP is 
involved in extracellular matrix assembly and matrix–matrix protein interactions. It also 
interacts with fibronectin (Di Cesare et al., 2002). As its name suggests, CILP, is found primarily 
in the intermediate zone of articular cartilage. Chondrocytes express two isoforms of CILP 
(Johnson, 2003). The matrilins are involved in the organisation of the extracellular matrix, 
including the mediation of interactions between ECM components (Wiberg et al., 2003). 
Maitrilins are found associated with collagens and aggrecan (Wagener et al., 2005). 
 
1.4.6 Chondrocytes 
 
Chondrocytes are the only cell type found in cartilage tissue. Chondrocytes are found sparsely 
distributed through cartilage and account for approximately 3% of the volume of the tissue. 
Chondrocytes are responsible for the maintenance of the extracellular matrix. They are 
supplied with nutrients via diffusion through the synovial fluid and underlying bone and do not 
normally undergo replication after adolescence (Goldring, 2000).  
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  Chondrocytes display both anabolic and catabolic activity, both of which assist the cells 
in performing their metabolic functions. Anabolic and catabolic activity is necessary for 
equilibrated matrix turnover and maintenance of ECM integrity. Catabolic enzymes produced 
by chondrocytes include matrix metalloproteinases and enzymes from the ADAMTS (A 
disintegrin and metalloproteinase with thrombospondin type-1 motif) family, which includes 
the aggrecanases (Aigner & Stove, 2003). These enzymes are implicated in the progression of 
the disease, osteoarthritis. 
  Chondrocytes are surrounded by a narrow membrane known as the pericellular 
matrix. Chondrocytes exhibit changes in shape and population number throughout the 
cartilage resulting in metabolic specialisation which contributes to the depth-related variations 
in cartilage. Chondrocytes in the calcified layer are rounded, this influences the material 
properties of the cartilage in relation to the surrounding collagen fibre network (Wu and 
Herzog, 2002 ; Mow and Huiskes, 2005). Chondrocytes in the superficial layer are less active 
than those found in the middle and deep layers.  In the deeper layers chondrocytes synthesise 
a matrix with a higher proteoglycan concentration and thicker collagen fibrils. 
  The distribution of chondrocytes in cartilage, is far from randomised. Chondrocytes 
have been shown to form four distinct morphological patterns within the tissue depending on 
their anatomical origin, namely, strings, clusters, pairs of chondrocytes and single 
chondrocytes. There is usually one dominating pattern of chondrocyte distribution in each 
cartilage zone. For example in samples of the  superficial cartilage of the femoral condyles of 
the knee joint, over half of the chondrocytes were found in a string formation, whereas over 
two thirds of cells in the radial head were positioned in clusters  (Rolauffs, et al.,  2008). 
Chondrocyte numbers are specifically adapted to provide optimal conditions within cartilage 
depending on the zone in which they are found. Chondrocyte populations decrease from the 
surface to the deep zone and this is thought to provide mechanical stability to the cartilage 
(Wu and Herzog, 2002) 
  As chondrocytes age there is an alteration in their metabolic activity. Chondrocytes 
can undergo senescence which is thought to contribute to the development of osteoarthritis 
due to alterations in chondrocyte metabolism (Skaalure et al, 2012 ; Martin & Buckwalter, 
2002). 
 
1.4.7 Synovial fluid 
 
Synovial fluid is secreted by cells known as synoviocytes that are found within the synovium, 
into the joint cavity. It is an ultrafiltrate of plasma and contains various molecules that are 
speculated to assist the fluid in its role of contributing towards a friction free environment 
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within joints. Molecules in synovial fluid include hyaluronan, lubricin, superficial zone protein 
and surface active phospholipids. 
  For some time it was believed that hyaluronan was the main lubricating component of 
synovial fluid however under heavy loads hyaluronan was shown to fail to provide effective 
boundary lubrication (McCutchen, 1966). This led to the hypothesis that other components of 
synovial fluid, especially lubricin and superficial zone protein (SZP) could be responsible for the 
lubricating properties of synovial fluid. 
  Lubricin is a PRG4 proteoglycan meaning it is synthesised from the proteoglycan 4 
gene. Lubricin has been shown to display lubricating properties that are identical to those of 
synovial fluid as a whole (Swann et al., 1981). However Schwarz and Hills (1998), later 
published work showing that lubricin is actually a water soluble carrier for surface active 
phospholipids such as di-palmitoyl phosphatidyl choline, which were responsible for the 
lubrication abilities of lubricin.  
  Lubricin is believed to provide lubrication in synovial fluid by depositing hydrophobic 
surface active phospholipids on the surface of articular cartilage. Lubricin exists in two 
populations within a synovial joint: both as an unbound molecule in solution and also as a 
bound molecule, which is attached to the surface of articular cartilage (Gleghorn et al., 2009). 
  Lubricin has been postulated to partake in various roles aside from lubrication due to 
its various structural motifs, including cell proliferation and cytoprotection (Flannery et al., 
1999). 
 
1.6 The Lubrication, wear and mechanical 
properties of cartilage 
 
1.6.1 Tribology 
 
The word tribology is used to describe the friction, lubrication and wear properties of a 
material. Cartilage tribology is interesting because cartilage has various mechanical properties 
such as viscoelasticity that affect its biotribology and allow it to provide a low friction 
environment in joints subject to large forces. 
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1.6.2 Viscoelasticity 
 
The term viscoelasticity is used to refer to materials that undergo a variable time-dependent 
deformation response followed by recovery when they are exposed to loading and unloading. 
The specialised properties needed for viscoelastic materials to perform this function arise from 
the combination of their elastic and viscous properties.  
 
1.6.2.1 Creep 
  
This occurs when viscoelastic solids are subjected to a constant load. Generally, viscoelastic 
solids initially display a rapid deformation which is followed by a slower (time dependant) 
progressive response (creep) until a state of equilibrium is reached (Figure 1.5). In simple 
terms, creep describes deformation of a material at a slow rate after initial rapid deformation.  
 
1.6.2.2 Stress relaxation 
 
This describes the response of a viscoelastic solid exposed to a constant deformation. 
Generally a viscoelastic solid will initially display a rapid, high initial stress followed by a slower 
stress that gradually reduces to maintain the deformation. 
  The extent to which a viscoelastic material is deformed relies on the speed at which 
the load is applied or removed. In engineering viscoelasticity is represented by two models 
known as the Kelvin-Voigt and Maxwell models which consist of a spring and a dashpot 
connected in parallel and a spring and a dashpot connected in series, respectively.  
  Cartilage is viscoelastic and its response to loading can represented by the Kelvin-Voigt 
model. This is due to the elastic properties of cartilage which give it the ability to undergo 
reversible deformation; internally storing strain energy supplied by an applied load and then 
consequently being able to return to its original expanded state instantaneously, with some of 
the strain energy being dissipated as heat. The reason that the response of cartilage is 
viscoelastic rather than elastic, is due to the involvement of fluid flow in the cartilage tissue. 
The fluid regulates the return of the cartilage to its pre-loaded state, preventing an 
instantaneous return. The interstitial fluid in cartilage contributes to a time-dependant 
response due to frictional drag created between the fluid and the ECM, both when cartilage is 
being loaded and after the load is removed. Therefore the contribution of this viscous fluid 
results in viscoelastic properties. 
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Figure 1.5. A typical creep and recovery curve of the cartilage of the superomedial portion 
of the femoral head with a corresponding curve fit of the creep. This is the typical response 
curve of a viscoelastic material in a creep and recovery test showing rapid initial deformation 
which slows down as it reaches an equilibrium (Athanasiou et al., 1994) 
 
1.6.3 Wear 
 
Wear is the progressive loss of a substance from the surface of an operating body as a result of 
relative motion at the surface (Jin et al., 2006). Wear is an important factor in the design of 
joint prosthesis because wear particles that are shed from these replacements are detrimental 
to the health of the joint. They cause adverse tissue reactions that lead to osteolysis and 
therefore loosening of the prosthesis (Jin et al., 2006). 
  Cartilage can become degraded due to wear. In cartilage, wear is caused via 
mechanical means and is exacerbated by biological degradation. Mechanical wear can be 
classified into interfacial wear and fatigue wear.  
 
1.6.3.1 Interfacial wear 
 
 Interfacial wear occurs as a result of contact between two surfaces in the absence of 
boundary or fluid-film lubrication mechanisms. It can be further classified into adhesive and 
abrasive wear.  
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1.6.3.1.1 Adhesive wear 
 
Adhesive wear occurs when surface protrusions on the bearing surfaces come into contact and 
attach to each other, followed by movement of the bearing surfaces in opposing directions 
during which the adhered protrusions are torn from their surfaces.      
 
1.6.3.1.2 Abrasive wear 
   
Abrasive wear is a result of a hard material scraping the surface of a softer material. In a joint 
this could involve wear particles scratching the cartilage surface. It is thought that in cartilage, 
there are relatively insignificant levels of interfacial wear taking place because of low 
occurrences of contact between bearing surfaces, however, in degenerated cartilage the 
chance of this type of wear may be higher as it may be easier for the fluid film to leak away. 
This is due to the increased softness and permeability of degenerated cartilage, which is a 
result of a higher concentration of water in the tissue (Armstrong & Mow, 1982). Abrasive 
wear can also occur because of loose particles between bearing surfaces, this specific action is 
known as three-body wear (Nordin & Frankel, 2001 ; Mow & Huiskes, 2005 ). 
 
1.6.3.1.3 Fatigue wear 
 
This process occurs in bearing materials undergoing repetitive stresses that cause the material 
to deform and subsequently lead to the production and accumulation of microscopic 
impairments within it. This can occur under acute and chronic circumstances with repeated 
short term application of large loads or after repeated application of smaller loads over a long 
period of time, respectively (Nordin & Frankel, 2001). Within cartilage, fatigue wear could 
foreseeably accumulate as a result of two mechanisms, the first being through disruption and 
loosening of the collagen fibres and disruption of proteoglycans and/or the interaction 
between them and the second through the loss of degraded proteoglycans from the ECM by 
“wash-out”, where fluid exudation gradually removes the proteoglycans from the ECM. 
 
1.6.4 Cartilage wear particles 
 
When cartilage tissue becomes degraded it can reduce the lubricating ability of the tissue. This 
means the friction between cartilage interfaces increases resulting in wear particles being 
created between the two opposing surfaces during loading. It is thought that wear particles 
can cause inflammation in the joint, therefore augment the progression of degenerative joint 
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disease (Van den berg, 1999). It has been observed that the shape of wear particles from 
cartilage tissue varies depending on their zone of origin and on the level of degradation within 
the tissue (Podsiadlo et al., 1997). For example, as wear increases, wear particles become 
more complex and less rounded in shape (Graindorge & Stachowiak, 2000). Particles have 
traditionally been assessed via two dimensional images, however, recently researchers have 
focused on finding additional useful details about the surface of wear particles that could be 
added to the list of parameters that are currently considered when grading particles using a 
numerical system (Tian et al., 2011 ; Tian et al., 2012). The additional features could reveal 
more information about how cartilage wear progresses and might lead to the establishment of 
a link between particle surface features and cartilage degeneration. 
 
1.6.5 Cartilage lubrication theories 
 
There is currently no consensus on the definitive lubrication method(s) functioning in synovial 
joints. Generally it is believed that there is more than one mechanism at work due to the 
excellent ability of joints to maintain low friction levels under variable conditions (Naka et al., 
2005). From an engineering perspective, there are two fundamental types of lubrication: 
boundary and fluid-film lubrication. Boundary lubrication refers to lubrication caused by a 
single layer of molecules adsorbed onto bearing surfaces. Fluid-film lubrication consists of a 
thin fluid film between the two bearing surfaces that leads to a wider separation of the two 
bearing surfaces so that no boundary lubrication occurs (Nordin & Frankel, 2001).  
 
1.6.6 Boundary lubrication 
 
During boundary lubrication an absorbed layer of lubricant is found on the surface of each 
articulating surface (Figure 1.6).  The lubricating layer which could be composed of a variety of 
synovial fluid components including lubricin and surface active phospholipids, prevents direct 
surface to surface contact (Nordin & Frankel, 2001 ; Schmidt et al., 2007). Boundary lubrication 
has been proposed as a lubrication method for cartilage because cartilage continues to 
articulate at low levels of friction in the absence of synovial fluid. Because of the low fluid 
levels associated with boundary lubrication it is regulated less by fluid viscosity and speed of 
surface articulation and more by the physiochemical properties of the bearing surfaces (Nordin 
& Frankel). 
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1.6.7 Fluid-film lubrication 
 
There are various sub-types of lubrication that involve the use of fluid film lubrication which 
are discussed below.  
 
1.6.7.1 Hydrodynamic lubrication 
 
This process occurs when two non-parallel rigid surfaces undergoing fluid-film lubrication slide 
across each other at speed and create a wedge of fluid that produces a lifting pressure. In a 
synovial joint, the lifting pressure is formed by viscous synovial fluid that is forced between the 
narrow wedge shaped gap formed by the two bearing surfaces, thereby separating them 
(Figure 1.7).  
 
1.6.7.2 Squeeze-film lubrication 
 
Squeeze film lubrication is the result of two bearing surfaces travelling perpendicularly 
towards each other where the fluid film becomes pressurised due to the viscous resistance of 
the synovial fluid, which delays its exudation from the space between the cartilage (Figure 1.7). 
This method is likely to occur under heavy loads for short periods of time before boundary 
lubrication begins to take place as a consequence of asperities present on the cartilage surface 
(Nordin & Frankel, 2001). 
 
 
 
 
 
 
 
 
Figure 1.6. Boundary lubrication between opposing articular cartilage surfaces. 
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1.6.7.3 Elasto-hydrodynamic lubrication 
 
This type of lubrication can occur during hydrodynamic or squeeze-film regimes. It refers more 
specifically to the action of the bearing surfaces than that of the synovial fluid because the 
bearing surfaces must be soft enough to undergo deformation when pressure is exerted on 
them for elasto-hydronamic lubrication to occur. In a synovial joint the deformation works to 
decrease friction by increasing the surface area of the cartilage while simultaneously 
decreasing the asperities on its surface thereby creating a more congruent environment. The 
larger surface area helps to hinder the loss of the fluid from between the surfaces, so the fluid 
film can persist for a longer period of time (Nordin & Frankel, 2001). 
 
1.6.8 Mixed lubrication 
 
Mixed lubrication is used to describe the combination of boundary and fluid film lubrication 
regimes that can occur in cartilage. Boosted lubrication is the term used to describe the 
transient conversion observed as the joint switches from fluid-film lubrication to boundary 
lubrication at one defined point on the cartilage within the joint. During boosted lubrication, 
fluid moves from the space between the articulating surfaces into the cartilage followed by 
small solutes leaving a synovial gel that lubricates the cartilage. Boosted lubrication is most 
likely to occur during periods of high impact after long exposure time to loading, when fluid-
film lubrication is not possible. 
 
Figure 1.7. Hydrodynamic and squeeze film lubrication in the context of a joint. Adapted 
from Nordin and Frankel, 2001. 
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  The other type of mixed lubrication refers to the temporary existence of both 
boundary and fluid-film lubrication at “spatially distinct locations” in the joint at the same 
point in time. For example when fluid-film lubrication is functioning dominantly but a surface 
asperity on the cartilage causes contact of the two articulating surfaces and boundary 
lubrication occurs (Nordin & Frankel, 2001).  
 
1.6.9 Biphasic lubrication 
 
Cartilage is a biphasic material in the sense that it is composed of a porous solid phase and an 
incompressible fluid phase. The fluid phase is composed of water and electrolytes while the 
solid phase consists of collagen (predominantly type II), proteoglycans, non-collagenous 
proteins and chondrocytes. The biphasic nature of cartilage partly explains why it is so good at 
maintaining a low friction environment in the joint. 
   When cartilage becomes loaded, there is a rapid efflux of interstitial fluid from high 
pressure regions of the joint, through the solid matrix into the low pressure regions of the 
joint. The initial rapid fluid flow progressively decreases until the maximum volume of fluid has 
been squeezed from the matrix. The low permeability of the extracellular matrix to the 
interstitial fluid is key to the success of initial fluid phase loading because movement of the 
interstitial fluid through the ECM causes high frictional drag forces within the cartilage which 
causes compaction or “pressurisation”. As a result the fluid phase supports up to 90% of the 
load, relieving the solid phase of high loads until all the interstitial fluid has been excluded 
from the tissue. When the equilibrium strain is reached (this typically takes around 4-6 hours 
for human cartilage samples with a thickness of 2-4mm) creep ceases and the compressive 
stress within the ECM is sufficient to allow the solid phase to bear the whole of the applied 
stress. In these circumstances other lubrication methods such as boundary lubrication must 
become active to prevent friction in the joint due to the articulating surfaces coming into close 
proximity of each other (Nordin & Frankel, 2001).  
  This mechanism of successive loading onto two phases is known as biphasic 
lubrication. Biphasic lubrication leads to reduced friction between the two articulating 
surfaces.  Experimental data has shown that long loading times are the parameter most likely 
to cause larger friction coefficients in reciprocating motion simulations inferring that friction 
increases as the fluid phase depletes (Forster & Fisher, 1999). The frictional drag force created 
by pressurisation due to loading contributes to the viscoelasticity and energy dissipation 
functions of cartilage which are essential for its low friction capabilities (Mow & Huiskes, 
2005).  Additionally, as more pressure is applied to the cartilage over time, it is more difficult 
to squeeze fluid from it (Mow & Huiskes, 2005). The exudation of fluid from the cartilage also 
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results in an increased concentration of proteoglycans in cartilage as it becomes compacted, 
this contributes to the cartilage’s ability to resist compression 
  A triphasic model of cartilage has been developed which includes reference to the 
monovalent ions found in the interstitial fluid described previously. It was developed to explain 
the ion-induced swelling effects and other electromechanical behaviours of cartilage (Mow 
&Huiskes, 2005). 
 
1.7 Osteoarthritis and cartilage degeneration  
 
The avascular and anerual nature of cartilage means it has only a limited ability to repair itself. 
This inability leads to progressive cartilage damage through acute and chronic injuries and 
potentially an eventual diagnosis of osteoarthritis. Osteoarthritis (OA), which can occur in 
primary and secondary forms, is a chronic and debilitating disease primarily characterised by 
loss of cartilage within the affected joint.   
  Osteoarthritis is the most common form of joint disease. Approximately 8.75 million 
people in the UK have sought treatment for OA and more than one million adults consult their 
GP every year about the disease (arthritisresearchuk.org). OA has a higher prevalence in 
people over 45 and is more common in women. In the year 2011, over 66,000 primary hip 
replacements and over 77,000 primary knee operations were performed due to OA in England 
and Wales (National Joint Registry, 2012).  
1.7.1 Primary and secondary osteoarthritis 
 
Primary OA develops progressively over time and has no known cause. It is therefore linked to 
aging and is usually diagnosed in people aged 60 years old and above. Secondary OA refers to 
OA caused by damage that is initiated after acute trauma to a specific joint component occurs, 
for example, the meniscus, ligaments, cartilage and subchondral bone. Various factors are 
believed to contribute to the progressive biological and mechanical degeneration of articular 
cartilage such as trauma in the joint, enzymatic degradation and abnormal mechanical forces. 
The development of OA also has links to age, genetics, gender and environmental factors such 
as activity levels and the nature of an individual’s employment. For example, a common 
problem for ballet dancers is joint pain in the ankles caused by large and abnormally frequent 
loads (Mow & Huiskes, 2005). Treatment for both primary and secondary OA is usually the 
same however joint replacement therapies are less suitable for younger patients with 
secondary OA due to the limited life span of implants.  
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  Temple-Wong et al. (2009) concluded that cartilage degeneration is due to 
degradation and loss of collagen and proteoglycan matrix components, abnormal collagen 
network remodelling, consequences of decreased cellularity, and mechanical wear. 
Consequences of osteoarthritis include joint deformation, cartilage destruction, capsular 
fibrosis, subchondral bone remodelling and sclerosis and osteophyte formation (Aigner & 
Stove, 2003). 
 
1.7.2 Early stage osteoarthritis 
 
 
Early osteoarthritic changes to cartilage include fibrillation at the superficial tangential zone 
(STZ), cracking and a decreased concentration of proteoglycans through the STZ and middle 
zones. At this stage, the tidemark becomes enlarged and the subchondral bone begins to 
penetrate the calcified layer (Nerlich et al., 1993). Morphological changes in osteoarthritic 
cartilage include softening, discolouration and an irregular surface. 
  At a molecular level, the ECM shows changes in content compared to healthy ECM. In 
the early stages of OA there is a both a loss of proteoglycans and a decrease in their size. This 
leads to weakening of the cartilage and a lack of turgor resulting in susceptibility to further 
mechanical damage and subsequent weakening, resulting in a progressive cycle of damage 
(L’Hermette et al., 2005). The damage occurs partly because proteoglycan loss reduces the 
fixed charge density in cartilage, therefore the optimum time-dependant efflux of fluid under 
loading is diminished (Katta et al., 2007). The disruption of fluid phase loading capabilities 
could affect the various lubrication methods in action within the joint leading to a reduction in 
chondrocyte viability resulting in additional damage to the cartilage tissue. Additionally 
proteoglycan loss and collagen network disruption could result in increased loading on areas of 
the macromolecular framework, increasing its vulnerability to subsequent mechanical insults.  
  The collagen network also begins to show signs of deterioration which allows 
expansion of the proteoglycan network resulting in an increased matrix permeability and 
increased pore size between collagen fibres. This promotes an increase in water retention that 
reduces cartilage stiffness (Lorenz & Richter, 2006). This disruption to the collagen component 
of the tissue could also form part of a cycle of damage leading to further tissue deterioration. 
Dissociation of collagen-proteoglycan interactions due to cartilage damage could also affect 
the rate of OA progression. After this primary damage is sustained, chondrocytes react by 
attempting to repair the damage by increasing production of collagen and proteoglycans. 
Increased production can continue for several years, until chondrocytes eventually cease to 
produce elevated levels of these components (Goldring, 2000). Following this, cartilage tissue 
is lost and osteophytes begin to develop from the subchondral bone. 
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  Osteophytes begin as outgrowths of cartilage which subsequently undergo ossification 
(Felson, et al., 2005). The exact reason for osteophyte development is not clear however their 
development is thought to be part of a reparative process (Claassen & Tschirner, 2003). It may 
be a response to abnormal loading forces experienced by cells in the bone. 
  Fragments of proteins such as fibronectin found in osteoarthritic joints may aggravate 
tissue degradation. Fibronectin is elevated in the synovial fluid, on the surface of osteoarthritic 
cartilage in early osteoarthritis and also within the middle/ deep zones and proximally to OA 
lesions in late stage OA. The fibronectin is a result of ECM degradation and can enhance 
synthesis and activation of proteases through interaction with receptors on chondrocytes and 
synovial fibroblasts. More specifically, stromelysin, gelatinase and collagenase from cartilage 
which can induce ECM degradation (Homandberg et al., 1992; Yasuda et al., 2003).  
Additionally, fibronectin expression is increased in osteoarthritic chondrocytes, especially in 
early degeneration (Aigner et al., 2001). 
  Damage associated molecular patterns (DAMPs) are tissue damage signals caused by 
certain molecules that can initiate inflammatory responses. DAMPs can also be known as 
alarmins (Lukic et al., 2009). DAMPs are thought to initiate inflammatory reactions in tissues 
through interaction with specific receptors such as toll like receptors 2 and 4 (Kim et al., 2006). 
DAMP molecules include members of the S100 protein family, such as S100A8, which has been 
implicated in juvenile idiopathic arthritis (Lukic et al., 2009). It has also been speculated that 
fibronectin has the potential to be a DAMP. DAMPs are important because it is likely that some 
DAMPs are involved in the pathogenesis of OA, in addition to certain receptors, including toll 
like receptors (Scanzello, et al., 2008).Therefore DAMP pathways and receptor interactions are 
of interest in terms of drug development because inhibition of DAMP pathways may serve to 
alleviate inflammation in diseases such as OA (Lukic et al., 2009). 
  Collagen II breakdown products commonly found in osteoarthritic cartilage can lead to 
the release of a small collagen peptide sequences called CB12-II and CB12-IV. These peptide 
sequences are capable of increasing collagenase activity and aggrecan cleavage, respectively, 
as well as promoting an increase in MMP-13 expression by chondrocytes leading to the 
potential formation of a cycle of catabolism (Yasuda et al., 2006). It is clear however that not 
all peptide residues contribute to the catabolism of cartilage as some studies have shown that 
a peptide identical in sequence to the N-terminal of link protein can increase synthesis of 
proteins including collagen by acting as a growth factor (Liu et al., 2000). 
 
1.7.3 Advanced stage osteoarthritis 
 
In advanced OA, full thickness defects penetrate the whole depth of the cartilage and into the 
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subchondral bone. Deformation of the bone can be seen in addition to exostotic bone 
formation and there is a severe loss of proteoglycans. Blood vessels are occasionally observed 
in highly damaged cartilage that penetrate from the sub-chondral bone through the tidemark 
(Nerlich et al., 1993).  
  Full thickness defects unlike partial thickness defects, can initiate a wound healing 
response by bone marrow progenitor cells that differentiate into chondrocytes to produce 
ECM. A hematoma is formed within the defect that is replaced by a fibrin clot and finally an 
ECM that resembles a matrix with elements of both hyaline cartilage and fibrocartilage. 
Unfortunately however, the resulting repair cartilage has inferior properties compared to 
native cartilage and can easily become damaged once more (Buckwalter, 1998). 
  The full thickness cartilage defects seen in advanced osteoarthritic cartilage affect 
strain distribution over the tissue, with tissue in the proximity of the defects experiencing 
increased levels of axial lateral and shear strain. In studies in which defects have been loaded 
in ex vivo joints, results have shown collapse of tissue adjacent to the defect, into the defect, 
with the opposing articulating surface bulging into the void created by the degeneration. Full 
thickness defects also influence applied normal stress, surface lubrication, friction, sliding path 
length and the characteristics of the contacting surfaces, all of which influence the rate of wear 
of the cartilage, this therefore creates a cycle of damage in the tissue. It is also very likely to 
affect biomechanical transduction to chondrocytes (Gratz et al., 2009). As described above, in 
advanced stages, chondrocytes are unable to maintain native matrix synthesis indefinitely 
resulting in total cartilage breakdown and loss (Lorenz & Richter, 2006).  
 
1.7.4 Chondrocytes in osteoarthritis 
 
In the early stages of OA the migratory properties of inflammatory cells through the cartilage 
tissue are limited. This implies that the source of destructive enzymes found in osteoarthritic 
tissues, are the chondrocytes. Additionally, it has also been observed that cartilage 
degeneration originates around chondrocytes in the superficial zone (Hollander & Pidoux, 
1995). One obvious stimulus that could explain the catabolic changes to chondrocyte 
phenotype could be abnormal loading. Various studies have explored the effects of load 
changes on chondrocyte phenotype and have shown that variable forces can influence either 
an anabolic or catabolic phenotype of the cells (Smith et al., 2004). In support of this, obesity is 
a risk factor for osteoarthritis. Increased loading on the joints due to excess body mass may 
put chondrocytes under abnormal loading conditions which leads to production of catabolic 
factors that degrade the extracellular matrix. 
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  Degenerative changes to the extracellular matrix induce the chondrocytes to undergo 
proliferative activities in addition to the synthesis of components to repair the surrounding 
matrix. However, competent repair is not possible if loss of ECM components occurs more 
rapidly than the speed at which chondrocytes can replace them and if there is an insufficient 
number of chondrocytes to perform the reparative processes (Buckwalter, 1998).  Overall, the 
activity of chondrocytes throughout the progression of cartilage degeneration is 
heterogeneous which is to be expected due to the heterogeneous nature of the cartilage 
tissue itself. Chondrocyte phenotypes change, and different levels of activity are observed 
within cells depending on their zonal location. This heterogeneity is reflected by the large 
variation in the products that chondrocytes synthesise, including variable collagen types. In 
early OA superficial cells begin producing type III collagen, while deeper cells do not (Aigner et 
al., 1993). The deeper cartilage layers still contain active chondrocytes while the superficial 
zone is undergoing degeneration (Aigner and Dudhia, 1997). Adjacent cells in the same 
environment have been observed to be undergoing variable macromolecule production at the 
same period in time (Nerlich et al., 1993). Tardif et al. (1999), reported on two populations of 
chondrocytes: H and L chondrocytes, in osteoarthritic cartilage that displayed different 
response patterns to cytokines. L chondrocytes showed low collagenase 3 (MMP-13) basal 
synthesis levels and high sensitivity to IL-1β stimulation and growth factors. H chondrocytes 
had high collagenase 3 basal synthesis levels and low IL-1β inducibility with a variable response 
to growth factors.  
  At the start of disease progression, chondrocytes in the superficial layer cease to be 
flattened, become rounded and exhibit hypertrophic activity. Chondrocytes in the medial and 
deep zones show mild to moderate proliferation leading to hypercellularity, with cells in 
individual layers producing variable levels of specific collagenases (Fernandes et al., 1998; 
Lorenz and Richter, 2006). At early stages of OA the synovial membrane also becomes 
thickened, fibrous and the synoviocytes undergo hyperplasia (Pelletier et al. 1985). 
  The Outerbridge scale is a commonly used grading system for ex-vivo cartilage 
specimens (Table 1.1). In stage II of OA chondrocytes start to form cell clusters. In the final 
stages of OA, chondrocyte hypertrophy can be observed in areas with advanced levels of 
collagen II damage. (Saklatvala, 2003). Chondrocytes also become elongated and fibroblast 
like, and stain for collagen I and III due to pericellular deposits of these collagens throughout 
the depth of the cartilage. Levels of these collagens become highest in the latter stages of the 
disease (Nerlich et al., 1993). Some chondrocytes however continue to produce collagen II at 
healthy levels during disease progression (Miosge et al., 1998 ; Miosge et al., 2004).  
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Table 1.1. The Outerbridge system for grading of ex vivo cartilage damage severity, 
(Outerbridge, 1961). 
 
 
1.7.5 Collagen in degenerated cartilage 
 
Damage to collagen in articular cartilage has been shown to weaken its tensile properties, and 
stiffness (Bader et al., 1981; Temple-Wong et al., 2009). Although the literature on the role and 
distribution of collagen in osteoarthritic cartilage still contains certain disparities, there are 
some trends to be found in the results of different research groups. It is likely that many of the 
conflicting results could be explained by the heterogeneity of samples and testing 
methodologies used by different groups and by the largely variable phenotypes of 
chondrocytes in osteoarthritic cartilage. 
  Normally in healthy adult articular cartilage, collagen II expression levels are very low 
and antibody staining reveals an even distribution of type II collagen throughout the ECM. In 
both early and late OA the levels of collagen II production by the cells is upregulated signified 
by an increase in collagen II mRNA production (Aigner et al., 1992; Aigner et al., 2001; Grimmer 
et al., 2006). In stage II of OA, collagen II is upregulated in the middle and deep zones of the 
cartilage and remains the dominantly produced collagen in degenerating cartilage, despite the 
increased presence of other collagen types. Despite continued collagen II production the tissue 
does not become effectively repaired. It may be that the collagen may not sufficiently 
integrate into the ECM due a loss of other components in the tissue which assist in the 
integration of collagen into the matrix for example biglycan. Studies that show disparities 
between collagen expression and actual collagen content observed in tissues stained with 
collagen antibodies in addition to in situ hybridisation signal experiments support the theory 
that collagen II is not deposited correctly in the matrix despite increased mRNA levels (Aigner 
et al., 1992).  
  Damage to type II collagen has been thought to occur initially around the pericellular 
region of the STZ and then spread through the cartilage into the deeper zones (Hollander et 
Grade Distinguishing Features 
I Softening and swelling of the cartilage. 
II Fragmentation and fissuring of cartilage in an area half an inch or less in diameter. 
III Fragmentation and fissuring of cartilage in an area larger than half an inch in 
diameter 
IV Erosion of cartilage to the bone. 
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al., 1995). A study by Saarakkala et al. (2010) observed that in early osteoarthritic cartilage 
collagen fibrils in the STZ show increased disorganisation with the fibres adopting an 
orientation that was no longer parallel to the cartilage surface. The authors saw no significant 
decrease in collagen concentrations until the late stages of OA and deduced that the causes of 
the early fibril disorganisation were mechanical. The same authors also postulated that loss of 
collagen in very late stages of OA was due to further mechanical wear, reduced lubrication and 
enzymatic degradation, which leads to a reduction of fibril diameter and the breakdown of 
fibrils into smaller fragments, allowing them to leach from the tissue. Disruption of fibril 
orientation was also seen in the deep zones of tissue taken from patients suffering from more 
advanced stages of the disease. 
  Increased levels of collagen II have also been found in areas that have suffered from 
fibrillation, areas that have developed cracks along the cartilage surface or in fibrocartilaginous 
deposits (Zhang et al., 2007). Subsequent to this damage, the collagen I/III layer in the 
superficial zone of cartilage becomes thickened and collagen I is deposited primarily in the 
superficial interterritorial matrix (Nerlich et al., 1993).   Miosge et al, (2004), found a 100-fold 
increase in the amount of collagen I mRNA in stage III OA compared with healthy cartilage. This 
is significant because type I collagen is not usually present in any great quantity in healthy 
cartilage.  
  Osteoarthritic cartilage shows an increase in collagen III, which is not found in healthy 
cartilage apart from in some occasional small amounts in the superficial layer and as a thin 
endosteal lining of subchondral bone (Nerlich et al., 1993). These increases occur within the 
superficial and upper middle zones, in the pericellular matrix of chondrocytes and also in 
pannus structures that either form over, or within the damaged areas of articular cartilage in 
the advanced stages of OA. The latter structures may help to provide resistance to mechanical 
degradation (Aigner et al., 1993 ; Nerlich et al., 1993).  
  Collagen VI levels are altered during the progression of OA. In healthy cartilage, 
collagen VI is found concentrated around the pericellular matrix of chondrocytes throughout 
all of the cartilage zones. Collagen VI can also be found in the interterritorial matrix of the 
middle and deep zones. In normal cartilage, collagen VI is expressed continuously at a basal 
rate. In early OA however, collagen VI expression is significantly increased particularly in the 
deep and middle zones coupled with a decrease in collagen VI mRNA expression in the calcified 
and superficial zones. In the advanced stages of OA progression, increased collagen VI 
expression is observed in the matrix and the pericellular regions of chondrocyte clusters. There 
is also positive staining for collagen VI in the territorial matrix of the deep zone, however this 
could be due to collagen VI fragments, produced as a result of increased protease presence in 
the cartilage, that are small enough to diffuse through the matrix into more distal regions. The 
32 
physiology of collagen VI is altered during OA. Normally collagen VI is found as fine filaments 
however a band-like form of type VI collagen has been increasingly observed during disease 
progression (Aigner et al., 2001; Söder et al., 2002; Pullig et al., 1999).  
   
1.7.6 Proteoglycans in degenerated cartilage 
 
As previously described, proteoglycan loss results in a decrease in the compressive stiffness of 
cartilage leaving it more susceptible to damage. A decrease in proteoglycan concentration in 
degenerating cartilage could be due to increased proteoglycan degradation or decreased 
synthesis, or possibly both. In synovial fluid taken from knee trauma patients and sufferers of 
OA, large cleaved aggrecan fragments were found which were composed of a short NH2-
terminal stretch of the interglobular domain, the G2 domain, the keratan sulphate domain, 
and variable lengths of the chondroitin sulphate domain(s) (Sandy et al., 1992). This infers that 
large pieces of proteoglycan are cleaved and leach out of the tissue. The primary site of 
cleavage resulting in aggrecan degradation by MMPs is at a Glu 373/Ala 374 motif in the 
interglobular domain resulting in the removal of the G1 domain from the remaining molecule.  
  Aggrecan expression is upregulated in the deep zones of osteoarthritic cartilage but a 
reduction is seen in the STZ when compared to healthy cartilage samples (Aigner et al., 2001). 
In advanced OA, proteoglycan loss spreads from the superficial zone into the deep zones 
sometimes resulting in complete proteoglycan loss, shown by a lack of safranin O staining 
(Lorenz & Richter, 2006).  
  Lubricin continues to be produced in advanced osteoarthritic cartilage near to the 
subchondral bone, suggesting that the fibroblast-chondrocytes found here still attempt to 
provide boundary lubrication in the damaged joint (Zhang et al., 2007). 
  As cartilage becomes increasingly damaged, levels of decorin and biglycan within 
different regions of the tissue begin to vary, creating a more heterogeneous distribution than 
is observed in normal cartilage. However, overall the mean ratio of biglycan and decorin in the 
tissue remains the same. In healthy cartilage these two small proteoglycans are primarily 
concentrated in the upper middle zone close to the STZ; the greatest concentration of biglycan 
has been found in the STZ (Poole, 1996). In osteoarthritic cartilage there is a reduction in 
biglycan and decorin concentrations in the STZ, which is correlated with collagen degradation 
observed in this zone (Poole, 1996). 
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1.7.7 Grading systems for degenerated cartilage tissues 
Several grading systems have been developed to assess the extent of cartilage degradation 
that has occurred in the tissues of patients with osteoarthritis. A commonly used system for 
grading cartilage tissues in vivo via arthroscopy is the Outerbridge system (Table 1.1) which 
uses simple observations such as swelling and lesions to grade the degradation of cartilage 
tissues. Recently, the Outerbridge scoring system was incorporated into the International 
Cartilage Repair Society (ICRS) grading system. The ICRS grading system provides a 
comprehensive in vivo grading system that includes both patients and surgeons, which can 
determine the extent of degradation in affected cartilage tissues. The ICRS grading system is 
frequently used to determine whether a patient with osteoarthritis requires surgical 
intervention to treat their condition. Another frequently used assessment system for ex vivo  
cartilage tissues is the Mankin grading system, which  is a histopathological system that grades 
histological and cellular changes to cartilage tissues affected by osteoarthritis (Mankin et al., 
1971). 
 
1.8 Inflammatory changes in degenerated cartilage 
Various factors have been reported to contribute to an imbalance of steady state conditions in 
cartilage leading to its biological degradation. Cytokines play an important role in the 
progression of healthy cartilage into a degenerated osteoarthritic condition because they can 
stimulate the production of enzymes such as matrix metalloproteinases (MMPs) by 
chondrocytes that promote breakdown of cartilage. Catabolic cytokines are those cytokines 
which stimulate the production of catabolic enzymes cause the breakdown of molecules while 
anabolic cytokines promote the production of ECM components. 
  Although many cytokines have been reported to be involved in OA, the primary pro-
inflammatory and catabolic cytokines that promote OA progression are interleukin-1β and 
TNF-α, with IL-1 β being the most potent of the two. Anabolic activity is promoted by TGF-β, 
bone morphogenic proteins, fibroblast growth factors (FGFs) 2, 4, 8 and insulin like growth 
factor (IGF-1) (Sandell and Aigner, 2001). The network of activation created by cytokines is 
highly convoluted. It includes processes of self activation, activation of other cytokines and 
synergistic and antagonistic actions between cytokines. The degradation of cartilage tissue 
that is caused by cytokine and enzyme activity represents the biological axis of cartilage 
degradation that in combination with the mechanical degradation of cartilage tissues forms 
the basis cartilage degradation.  
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1.8.1 Major pro-inflammatory / catabolic cytokines 
1.8.1.1 Interleukin-1 
The term Interleukin-1 refers to two pyrogenic cytokines known as IL-1α and IL-1β. IL-1α and -
β are pro-inflammatory cytokines that are a vital component of the immune defence 
mechanism that fights infection. IL-1 is produced by a variety of cells but importantly in terms 
of OA development, by synovial cells and chondrocytes which can result in cartilage 
breakdown. There is little difference in the biological activity seen between IL-1α and IL-1β. For 
example, they are both able to initiate IL-2 production in activated lymphocytes. Despite this, 
they only share a 26% sequence homology (March et al., 1985). However, pro IL-1α is active as 
a precursor, whereas the IL-1β precursor is not.  
  Both IL-1α and IL-1β can induce the degradation of proteoglycans in cartilage, for 
example aggrecan, via the stimulation of aggrecanase production. It is thought that IL-1α is the 
most dominant of the two cytokines in terms of aggrecan degradation (Sumer et al., 2006). 
Work by Williams et al. (2000) concluded that IL-1β was the more dominant of the two IL-1 
cytokines concerning the promotion of collagen degradation in OA. IL-1β is not normally 
expressed in healthy cartilage tissue, however in osteoarthritic cartilage its expression has 
been shown to be upregulated (Attur et al., 1998). The activity of IL-1 is transmitted through 
IL-1 receptors on the chondrocyte cell surface. There are two IL-1 receptors, known as IL-1 
receptor type 1 (IL-1RI) and IL-1 receptor type 2 (IL-1RII). IL-1RI is a signal transducer, whereas 
IL-1RII is a soluble decoy receptor for IL-1β. IL-1RII together with IL-1 receptor antagonist (IL-
1Ra) are inhibitors of IL-1β, preventing its capability to induce inflammatory responses 
(Daheshia & Yao, 2008). IL-1 can also induce the production of nitric oxide (NO) (Attur et al., 
1998). This is significant because NO is a cytotoxic free radical that has been shown to 
contribute to cartilage degeneration and chondrocyte apoptosis (Taskiran et al., 1994 ; Blanco 
et al., 1995).  
1.8.1.2 Tumour necrosis factor-α  
Tumour necrosis factor-α is a soluble 17 kD protein produced primarily by monocytes and 
macrophages, however, it is also produced by synovial cells. TNF-α can induce to the cleavage 
of aggrecan by stimulating the production of A disintegrin and a metalloprotease with 
thrombospondin motif proteins-4 and -5 (ADAMTs-4 and -5), alongside IL-1 (Tortorella et al., 
2001). TNF-α has also been shown to suppress link protein expression preventing stabilisation 
of the extracellular matrix via in-efficient linking of aggrecan to hyaluronan (Séguin et al., 
2003). In mice that over-expressed TNF-α, but not IL-1, inflammation was observed in the 
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joints, but no cartilage breakdown was seen, suggesting that IL-1 was not essential for 
inflammatory cell recruitment and that TNF-α mediates the inflammation that can be seen in 
diseased joints (Milner et al., 2001)  
1.8.2 Minor pro-inflammatory/ catabolic cytokines 
There are a number of cytokines that have been reported to be involved in cartilage tissue 
degradation that are not as prolific as IL-1 and TNF-α (Table 1.2). IL-6 has been included in both 
the catabolic and inhibitory cytokine tables (Table 1.2 and Table 1.3) because of its dual 
catabolic and inhibitory activity.  
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Table 1.2. The minor pro-inflammatory cytokines that promote cartilage degradation. 
 
 
Cytokine Action References 
IL-6 IL-6 increases inflammatory cell populations in the joint and mediates IL-1 mediated 
proteoglycan synthesis inhibition in addition to increasing proteoglycan catabolism in 
cartilage explants. In IL-6 knockout mice, collagen induced arthritis was not observed. 
Sui et al., 2009 ; Nietfeld et al 1990 ; Alonzi, 
1998. 
IL-8 IL-8 attracts cells of the immune system to sites of inflammation leading to further 
inflammation and oxidative activity. IL-8 is increased in the synovial fluid of patients with 
OA. 
Henkelsa et al., 2011 
Kaneko, et al., 2000. 
IL-17 Upregulates a number of pro-inflammatory mediators including nitric oxide, MMP-13 and IL-
1. IL-17 supresses proteoglycan production. 
Jovanovic, 1998. ; Hwang et al., 2004 ; Attur et 
al., 1998 ; Martel-Pelletier et al., 1999 ; Lubberts, 
et al., 2000 ; Benderdour et al., 2002. 
IL-18 IL-18 increases the expression of catabolic gene products such as stromelysin and stimulates 
nitric oxide production. IL-18 also causes release of proteoglycans from cartilage tissue 
Olee et al., 1999. 
Leukeamia 
Inhibitory 
factor 
LIF inhibits proteoglycan synthesis and promotes proteoglycan release augmented by IL-Iα, 
IL-lβ and TNF-α. 
 
Carroll & Bell, 1993 ; Hui et al ., 1998. 
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1.8.3 Inhibitory cytokines 
Inhibitory cytokines work to inhibit the activity of catabolic cytokines within the cartilage tissue 
and the joint. These cytokines therefore help to prevent cartilage degeneration and protect 
cartilage against osteoarthritic progression. 
1.8.3.1 Interleukin receptor antagonist (IL-Ra) 
This antagonist is a member of the IL-1 family of cytokines and can be found within the 
cytoplasm of some cells for example, fibroblasts or can be secreted by cells such as 
macrophages (Arend et al., 1998). IL-Ra binds competitively to the same receptor as IL-1 to 
abrogate the effects of IL-1, such as IL-1 mediated tyrosine kinase activity (Dripps et al., 1991). 
Subsequent to IL-Ra and IL-1 receptor binding, IL-1 receptor accessory protein binds to the 
complex to complete suppression, which quenches catabolic activity in the tissue. 
    Research by Economides et al. (2003) presented an efficient method of 
blocking cytokine activity entitled “cytokine trapping”. This system takes into account that 
initial IL-1 and receptor binding is weak and is reinforced by subsequent receptor accessory 
protein binding to create a high affinity interaction. Economides et al. generated soluble 
receptors that contained both the receptor and receptor accessory protein components to 
create potent IL-1 antagonists.  This study overcame previous concerns over rapid IL-Ra 
clearance in vivo and inefficient receptor occupancy.  A combined IL-4 and IL-13 trap has also 
now been developed (Economides et al., 2003). In clinical trials on rheumatoid arthritis 
patients the IL-1 trap has shown promising results and has recently been approved by the 
American Food and Drug Administration (Guler, et al., 2001; Ratner, 2008). 
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Table 1.3. Minor inhibitory cytokines that inhibit catabolic cytokines. 
 
 
Cytokine Action References 
IL-4 IL-4 and IL-10 can work synergistically to cause potent suppression of IL-1β, IL-6 and IL-8. IL-
4 can also inhibit TNF-α production and induces IL-1Ra production. IL-4 inhibits type 1 
helper T cell activation in vitro, which subsequently decreases in IL-1, IFN gamma and TNF-α 
production. 
Van roon et al., 1995 ; Hamblin, 1993 ; Chomarat  
et al., 1995 ; Sugiyama et al., 1995. 
IL-6 IL-6 knock-out mice develop more severe arthritis than wild type mice upon ageing. A lack 
of IL-6 in mice has also been shown to increase proteoglycan loss compared with wild type 
mice. Injection of IL-6 into the joint cavity of IL-6 deficient mice has been shown to 
significantly reduce cartilage destruction. IL-6 can induce TIMP-1 activity which decreases 
MMP levels. 
van de Loo et al., 1997,  Lotz, 1991,  de Hooge et al., 
2005. 
IL-11 IL-11 inhibits prostaglandin mediated inflammatory activity induced by TNF-α, and reduces 
cyclooxygenase 2 levels. IL-11 can also work alone or synergistically with IL-10 to inhibit 
TNF-α and increase TIMP-1 levels. 
Hermann  et al., 1998 ; Alaaeddine, 1999. 
IL-13 IL-13 has been shown to inhibit nitric oxide production in macrophages via effects on the 
inducible nitric oxide synthase gene and increases IL-1Ra production in ex vivo synovial 
membrane fibroblast cells. IL-13 has been shown to inhibit the synthesis of IL-1β and TNF-α 
mRNA in addition to inhibiting stromelysin activity.   
Jovanovic et al., 1997 ; Bogdan et al., 1997. 
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1.8.4 Anabolic cytokines 
 
These factors promote regeneration of the cartilage tissue, thereby actively ameliorating the 
degradation that occurs during the progression of OA. 
 
1.8.4.1 Insulin like growth factor-1 (IGF) 
IGF exists in two isoforms known as IGF-1 and IGF-2. These two isoforms are functionally 
different despite being related structurally and immunologically (Blumenfeld & Livne, 1999). 
IGF-1 is important for cartilage ECM maintenance, for example IGF-1 has been shown to 
stimulate proteoglycan and collagen synthesis (Guenther et al., 1982 ; Schalkwijk, 1989 ) in 
addition to inhibition of IL-1 induced cartilage degeneration via upregulation of the IL-1 decoy 
receptor (Tyler, 1989 ; Wang et al, 2003).  
1.8.4.2 Transforming growth factor-β (TGF-β) 
TGF-β has three primary functions: it inhibits cell growth, with chondrocytes and osteoblasts 
being an exception; it also produces an immunosuppressive effect on cells such as 
lymphocytes and it promotes deposition of ECM components such as GAGs, proteoglycans and 
collagen in cartilage ECM (Blumenfeld & Livne, 1999). TGF-β has also been shown to promote 
proteoglycan synthesis in cartilage tissue, however at excessive concentrations over prolonged 
time periods TGF-β began to promote degeneration initially within the deeper layers of 
cartilage, rather than preventing it, suggesting an opposing, detrimental role for this growth 
factor in some circumstances (van Beuningen, 2000). 
1.8.4.3 Bone morphogenic proteins (BMP) 
Of the BMP proteins, BMP-7 and BMP-2 appear to afford the most significant protective 
functions in cartilage tissue. A study by Flechtenmacher et al. (1996) showed that BMP-7 
increased collagen and proteoglycan production by human articular chondrocytes, particularly 
collagen II and aggrecan production.  BMP-7 is considered to have value as a therapeutic agent 
to treat osteoarthritis. In combination with microfracture, BMP-7 has been shown to act in a 
synergistic manner to create cartilage repair tissue that histologically resembles native hyaline 
articular cartilage. However, the quality of the mechanical and functional properties of this 
repair tissue remains to be fully characterised (Kuo et al., 2006). 
   BMP-2 has been shown to stimulate increased collagen II and aggrecan mRNA 
synthesis in articular cartilage chondrocytes (Grunder et al., 2004). Despite these protective 
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functions however, some evidence exists that BMPs can initiate production of catabolic MMP-
13 (van der Kraan, et al., 2010). 
 
1.9 Matrix metalloproteases (MMPs) 
The MMPs are a family of zinc dependent endo-peptidases. They are produced by 
chondrocytes, although not exclusively, and are key mediators in the turnover of the ECM, 
facilitating morphogenesis, tissue remodelling and resorption. MMPs exhibit low activity levels 
in healthy steady-state tissues. They are important factors in the progression of cartilage 
degradation because they cleave molecules such as proteoglycans and collagens, they also 
cleave non matrix components (Chakraborti, 2003). The MMP family contains at least 12 
enzymes which can be grouped into major sub-categories: collagenases, gelatinases and 
stromelysins, membrane type MMPs and adamalysins (Bonassar et al., 1996; Koopman & 
Moreland, 2005).    
1.9.1 Matrix metalloprotease regulation 
Due to the destructive nature of MMPs, it is important that they are tightly regulated to 
maintain healthy steady state conditions. Regulation occurs on a multitude of levels that 
include transcriptional and post transcriptional controls. MMPs are secreted as zymogens 
which is a factor that contributes to their control. Regulation of the MMP proteins via their 
inhibitors and activators also occurs and lastly their cell surface localisation is important for 
their regulation. MMP transcription is primarily regulated by cytokines, growth factors, 
hormones and cellular transformation. MMP activation pathways are highly complex and 
include differential regulation, some of which occurs via activation of proteolytic cascades.  
 
1.9.2 Matrix metalloproteases in osteoarthritis 
 MMPs are major promoters of cartilage degradation, an imbalance of these proteins in 
cartilage tissue leads to destruction of the ECM. Their levels have been shown to be 
significantly increased in osteoarthritic cartilage. Their expression is also higher in degenerated 
areas of cartilage.  
  Salminen et al. (2002) investigated MMP expression in osteoarthritic mouse models 
and discovered that MMP mRNAs exhibited distinct expression patterns during osteoarthritic 
disease progression. The most noted increase in mRNA expression was for MMP-13 which was 
detected at increased levels in the subchondral bone, deep zones of cartilage and in the 
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synovial membrane. Despite this increase it is thought that MMP-13 does not play a direct role 
in the initiation of cartilage degeneration, as it has not been found in sites of damage in early 
stage OA such as fibrillated areas of the superficial zone (Salminen et al., 2002). 
  Freemont et al. (1997) showed, in human knee cartilage, that MMP-1 expression was 
increased in the superficial zone in early OA and that MMP-3 and -9 were increased in the 
deeper zones in later stages. MMP-9 and MMP-1 expression were highest in the early stages of 
the disease and MMP-3 expression was bi-phasic. MMP-1 has also been identified as the most 
common MMP found in osteoarthritic synovial membranes. This indicates that it could be 
involved in the initial inflammatory phase of the disease (Koopman & Moreland, 2005). It has 
been possible to observe co-expression patterns in osteoarthritic development. A study by 
Aigner et al. (2001), observed that MMP-13 appeared to be co-regulated with MMP-2, 
indicating a synchronised action involving of these both collagenases. It is important to note 
however that due to the complex heterogeneity of cartilage tissue undergoing degeneration, 
which could display temporal and spatial variation, that it is difficult to draw conclusions on 
mRNA expression patterns in reference to whole sections of cartilage tissue in joints.  
1.9.3 MMP subgroups  
There are several sub-species of MMP thought to be involved in cartilage degeneration, which 
are described in Table 1.4. 
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Table 1.4. The MMP subgroups implicated in cartilage degeneration. 
 
Group MMP  Action References 
Collagenases MMP-1 Cleaves the α chain of interstitial collagens. Cleaves collagen III preferentially. Mitchell, 1996; Vankemmelbeke, 
1998; Koopman & Moreland, 
2005; Tortorella et al., 2001 
MMP-8 Cleaves the α chain of interstitial collagens. Cleaves collagen I preferentially and can also 
cleave aggrecan. 
MMP-13 Cleaves the α chain of interstitial collagens. Cleaves collagen II preferentially. 
Gelatinases MMP-2 Cleaves collagen via two successive cleavage events.  MMP-2 activation is facilitated by 
membrane type MMP 1 and tissue inhibitor of MMP 2 (TIMP-2). 
Patterson et al., 2001; Sato and 
Takino, 2010; Kim et al., 2012. 
MMP-9 Possible role in MMP-13 activation. 
Stromelysins MMP-3 Broad substrate specificity. The dominant stromelysin in cartilage tissue. Cleaves aggrecan at 
the Asn341-Phe342 bond found in the interglobular domain. Plays a role in the activation of 
collagenases. 
Flannery et al., 1992; Murphy et 
al., 1987; Knauper et al., 1993; 
Koopman & Moreland, 2005; 
Hooper, 1996 MMP-10 Broad substrate specificity. Plays a role in activation of collagenases. 
Membrane 
Type- MMPs 
MT- MMPs Sub-set of the MMP family containing transmembrane C-terminal domains which anchor 
them to the cell surface. Assist in activation of other MMPs such as MMP-13 and MMP-2.  
Mort, 2001; Mort and Billington, 
2001; Koopman and Moreland, 
2005. 
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1.9.4 Tissue inhibitors of metalloproteinases 
  
MMPs in healthy cartilage are under strict regulation by endogenous inhibitors known as 
tissue inhibitors of metalloproteinases (TIMPs), and to a lesser extent α2-macroglobulin and 
tissue-factor pathway inhibitor-2 (Brew et al., 2000). TIMPs are produced by chondrocytes and 
synovial fibroblasts and bind to MMPs with a 1:1 molecular stoichiometry causing their 
permanent inactivation (Murphy, 2011).  
  There are four known TIMPs found in humans (TIMPs-1, -2, -3 and -4; Brew et al., 
2000). TIMPS are maintained at substantial concentrations in chondrocytes during normal 
steady-state conditions to prevent aberrant ECM degradation. TIMPs inhibit MMPs via their N-
terminal domains while their C-terminal domains determine their MMP binding affinity (Brew 
and Nagase, 2010). 
  TIMPs can be specific for certain proteolytic enzymes. For example TIMP-3 inhibits 
ADAM-TS4 and 5 (Kashiwagi et al., 2001; Isenberg, 2004). TIMP-4 exhibits inhibitory action 
against MMP-1, MMP-2, MMP-3, MMP-7, and MMP-9 but shows a preferential specificity 
towards MMP-2 (Liu et al., 1997). TIMPs-2 and -3 are effective inhibitors of the MT-MMPs 
while TIMP-1 is not (Koopman and Moreland, 2005). TIMP-3 is the only MMP that is bound to 
the ECM.  In early disease states TIMPs have been reported to be down-regulated, tentatively 
suggesting that a metabolic imbalance begins to occur here which facilitates disease 
progression however due to variation in the results of different studies, only tentative 
conclusions may be drawn.  
   
1.9.5 Aggrecanases 
 
Aggrecanases are members of the matrix metalloprotease family and are classified as either 
ADAMs (a disintegrin and metalloproteinase protein) or ADAMTs (a disintegrin and a 
metalloprotease with thrombospondin motifs; which are a sub-group of the ADAM family). 
They are also known as aggrecanases because they facilitate the cleavage of aggrecan into 
large proteoglycan fragments with MW values of 144000-380000 depending on the cleavage 
site used (Loulakis et al., 1992 ; Tortorella et al., 2000). Nineteen ADAMTs have been identified 
to date and can be placed into four categories (Table 1.5). 
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Table 1.5 ADAMTs categories, adapted from (Jones and Riley, 2005). 
 
ADAMs can perform a variety of functions; these include cleavage of proteins using their 
metalloproteinase domain, adhesion via their disintegrin domain and cell-cell fusion, in 
addition to cell signalling (Sternlicht & Werb, 2001).  
  Unlike typical ADAM proteins that are membrane-anchored and have a 
transmembrane domain and cytoplasmic domain in the C-terminal region, the ADAMTs are 
secreted and their C terminus contains a varying number of thrombospondin type-1 (TSP-1) 
motifs. ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) are thought to be the 
primary aggrecan degrading enzymes in osteoarthritic cartilage, with both ADAMTs cleaving 
preferentially between the glutamic acid-1667 and glycine-1668 residues of aggrecan 
(Tortorella et al., 2001; Westling et al., 2002).  
  Aggrecanase-1 and -2 are not just found in damaged cartilage and can be found 
degrading aggrecan in healthy tissue helping to maintain a homeostatic balance. Aggrecanase-
1 (ADAMTS-4) cleaves aggrecan using its thrombospondin type-1 (TSP-1) motif, it cannot 
cleave aggrecan that does not contain GAGs (Tortorella et al., 2000). Aggrecanse-2 is the most 
strongly expressed aggrecanase and has been shown to be the predominant aggrecan 
degrading protease in murine models of OA. Aggrecanase-1 has been reported to be expressed 
in small amounts in healthy cartilage and its expression is only slightly elevated in OA 
(Koopman & Moreland, 2005).  
 
1.9.6 Other molecules found in osteoarthritic cartilage tissue  
 
Tenascin is an extracellular matrix (ECM) glycoprotein whose expression is increased in 
articular cartilage that has been damaged during OA progression. In human hip tissues, 
tenascin distribution has been reported to be increased in the superficial and middle zones of 
the cartilage in very advanced OA, especially in the cellular and pericellular environment, but 
in mild OA its levels were increased only in central cartilage regions of the superficial zone 
(Veje et al., 2003). Tenascin has been found in increased quantities in areas of the cartilage 
tissue that have a significant proteoglycan loss (Pfander et al., 2004). Topographic variation 
Category ADAMT(s) 
Hyalectanases -1, -4, -5, -8, -9, -15 and -20 
Procollagen N-propeptidases -2, -3 and -14 
Von Willebrand factor-cleaving protease -13 
Others -6, -7, -10, -12, -16, -17, -18 and -19 
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highlights the importance of accounting for the location of cartilage tissue samples that are 
removed for use in studies because it is not just in the zonal layers that the biochemical 
properties change and this could affect the interpretation of results obtained from samples. It 
could be that the increased tenascin levels reflect a reparative attempt by chondrocytes 
because tenascin is involved in cell growth and motility and has been localised to areas of cell 
migration (wound healing) and tissue morphogenesis (Murphy-Ullrich et al., 1996). 
Interestingly tenascin is one of a few molecules that has been shown to have the potential to 
be a biomarker of advanced OA (Schmidt-Rohlfing et al., 2002). 
  Human cartilage glycoprotein-39 (HC-gp39), also known as YKL-40, has been found at 
increased concentrations in osteoarthritic cartilage, however it is usually not found in healthy 
cartilage. HC-gp39 has a high sequence similarity with the enzyme family known as the 
chitinases which are involved in digestion and are used by some organisms to allow 
remodelling of polysaccharide networks. Therefore it has been speculated that HC-gp39 plays 
a role in cartilage remodelling potentially via interaction with glycan structures on proteins or 
the cell surface. Like tenascin, it is a protein that exhibits topographical as well as zonal 
variations in its distribution in osteoarthritic cartilage. HC-gp39 has been found at increased 
levels in chondrocytes at points on the femoral head in which there is known to be an 
increased biomechanical load. Additionally, chondrocytes in the superficial and middle zones 
of osteoarthritic cartilage showed an increased presence of HC-gp39 compared with 
chondrocytes in the deep zone and any zone in normal cartilage (Volck et al., 1999). 
  CD44 is a cell adhesion molecule that is a member of the hyaluronan binding-protein 
family. Cell adhesion molecules are important mediators in processes such as cell anchorage 
and matrix metabolism. In normal cartilage CD44 has been shown to be expressed in higher 
quantities by chondrocytes in the superficial zone compared to those in the deep zone 
whereas in OA CD44 expression is increased in the deep zone as well as fibrous pannus 
structures formed at the STZ meaning that the distinct expression pattern of CD44 in normal 
cartilage is lost as OA progresses (Ostergaard et al., 1997). 
 
1.10 The biotribological properties of degraded 
cartilage tissues  
The tribological properties of cartilage tissues become altered as the tissue becomes 
increasingly degraded during the osteoarthritic disease process. The friction co-efficient of ex-
vivo degenerated human cartilage is higher than that of healthy cartilage tissues and has been 
shown to increase as degradation of the tissue increases (Pickard and Fisher, 2000; Lee et al., 
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2013). The increase in friction seen in degraded tissues may result from an increase in the 
surface roughness of cartilage (Lee et al., 2013). The interest in the surface features of 
degraded cartilage has culminated in advanced surface characterisation protocols to 
determine the texture of degraded cartilage (Tian et al., 2011).   
  Studies of the changes in cartilage surface characteristics as a result of degradation are 
closely linked with studies that have investigated particles of cartilage that are generated 
through the wear of the tissue. The numerical descriptors used to characterise the cartilage 
wear particles have shown that the area and length of particles increases as cartilage in joints 
becomes increasingly degraded in comparison to controls (Kuster et al., 1998). Since the study 
by Kuster et al. was completed, methodologies to study cartilage wear particles created during 
cartilage degradation have been developed. This has allowed the surface topography and 
biomechanical properties of cartilage particles to be determined at the nanoscale using atomic 
force microscopy (Wang et al., 2013). With further development, it may be possible, in the 
future, to grade cartilage degradation in vivo through examination of cartilage wear particles. 
  Other mechanical properties of degraded cartilage have been investigated using 
indentation testing. For example, Wang et al. (2012) used micro indentation to investigate 
various grades of degradation in sheep knee cartilage. The cartilage damage was generated in 
vitro. The study found that the indentation modulus of degraded cartilage was lower in 
comparison to undegraded controls, which could have been due to collagen disruption (Wang 
et al., 2012). Indentation testing of human osteoarthritic cartilage on a macroscopic scale has 
also shown that the properties of degraded cartilage are altered. These alterations include, for 
example, the permeability of osteoarthritic tissues, which is increased. In addition to this the 
compressive stiffness and tensile strength of degraded cartilage tissues are reduced (Silver et 
al., 2001; Kleeman et al., 2005; Boschetti and Peretti, 2008; Marticke et al., 2010). These 
changes across the cartilage extracellular matrix are reflected in the pericellular matrix 
surrounding chondrocytes of degraded cartilage tissue, in which the Young’s modulus is 
decreased and the permeability is also increased (Alexopoulos et al., 2005). Interestingly, it has 
been observed that collagen fibrils from the superficial zone and bone-cartilage interface of 
patients with early to severe OA (Outerbridge grade) have lower compliance than those with a 
zero OA grade. The collagen fibres in the middle zone of grade 3 and 4 damaged tissues have 
also been shown to have reduced compliance (Wen et al., 2012). 
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1.11 Treatment and management of osteoarthritis 
 
The majority of treatment for OA is palliative in that it attempts to ease pain and temporarily 
reduce progression of the disease. In some cases it has been observed that certain treatments 
may aggravate the condition over the long term so there is a lot of interest in development of 
novel early intervention therapies that could provide effective treatment of the disease and 
delay the need for total joint replacements. 
 
1.11.1 Drug therapy 
 
Disease modifying drugs are not available for the treatment of osteoarthritis however many 
OA patients use painkilling drugs to alleviate the painful symptoms of the disease. Non-
prescription painkillers may not always be strong enough so many patients are prescribed with 
strong opiate based medicines or non-steroidal anti-inflammatory drugs (NSAIDs). 
  Strong prescription pain killers such as Tramadol hydrochloride which are given to OA 
patients cause a variety of common symptoms such as nausea and dizziness in addition to 
rarer side effects such as headaches, skin rashes and circulatory problems such as palpitations 
(www.NHS.uk). These side effects can be especially problematic for patients that are in 
continued employment, especially for example, those partaking in manual jobs such as those 
operating machinery in which the side effects might lead to increased risk of accidents. 
   NSAIDs such as aspirin are prescribed to patients with inflammation and swelling in 
joints. The most common side effect of NSAIDs after long term use are indigestion and 
stomach ulcers as they affect the lining of the gastrointestinal tract. NSAIDs also increase the 
risk of stroke or heart attack in patients so they are not always suitable for smokers or people 
with conditions such as diabetes. Another major issue with long term use of either prescription 
or non-prescription painkillers is that they can damage the liver and can increase the risk of 
some cardiovascular events such as myocardial infarction (Bhala & Emberson et al., 2013).  
 
1.11.2 Arthroscopy 
 
Arthroscopy refers to the use of an arthroscope during surgery to allow examination and/or 
treatment of damage within joints with minimal invasion (Figure 1.8). Arthroscopic treatments 
include debridement and lavage of tissue and joint cavities. These two treatments are 
commonly performed together. The debridement removes loose cartilage while the lavage 
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flushes out unwanted fluids and debris from within the joint cavity. A recent comprehensive 
review has shown however that debridement of the knee appears to have a very low potential 
to improve pain or ability to function compared to placebo via sham surgery. It was also 
concluded that when compared with lavage, debridement leads to little or no difference in 
pain or ability to function (Laupattarakasem et al., 2008). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.11.3 Autologous chondrocyte implantation (ACI) 
 
This technique includes an initial procedure where a biopsy of healthy cartilage tissue from a 
non-load bearing region of the joint is taken. Chondrocytes from the tissue are then isolated 
and cultured before being implanted at the defect site within the joint to allow their 
development into new cartilage. They are held in position by a periosteal patch which in the 
case of the knee joint can be harvested from the proximal tibia. This procedure has been 
shown to provide a suitable repair of articular cartilage injuries for up to 11 years post 
operation (Peterson et al., 2002).  
  Matrix assisted chondrocyte implantation is similar to ACI, however with this 
technique chondrocytes are cultured on a collagen matrix before being transferred into the 
defect and subsequent attachment of the matrix with glue and/or sutures. This approach 
increases the possibility of performing an arthroscopic procedure rather than using open 
surgery. The membrane is also easier to apply than in ACI (Getgood et al., 2009). There are 
uncertainties about the effectiveness of this treatment due to heterogeneous results from 
 
Figure 1.8. An image taken during arthroscopy of the knee of a patient with cartilage 
degradation. Taken from www.icartilage.com. 
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studies and there are also risks of side effects such as locking of the knee and periosteal 
hypertrophy. The treatment is also very expensive, costing at least £2000 per patient for in 
house chondrocyte expansion alone (NICE Guidelines TA89, 2005). Additionally due to the 
autologous cellular expansion step, the cells returned into the defect have become aged. This 
could present problems with the repair of the defect. 
 
1.11.4 Marrow stimulation 
 
This technique utilises the ability of mesenchymal stem cells to produce a fibro-cartilaginous 
repair tissue within defects created by drilling into the sub-chondral bone plate below the 
cartilage. The perforations drilled into the bone are 3-4 mm in depth, the holes created are 
then filled by mesenchymal stem cells, platelets and other chemotactic factors.  The 
fibrocartilage produced is unfortunately mechanically and biochemically inferior to native 
articular cartilage, however some studies have shown that the technique can provide effective 
symptom relief for up to two years (Getgood et al., 2009). In the future, marrow stimulation 
techniques may be supplemented with a collagen membrane composed of collagens I and III, 
which have shown improved results in filling defects, as a result of the collagen membrane 
providing a scaffold for cells to reside in (Dorotka et al., 2005).  
 
1.11.5 Mosaicplasty 
 
This technique which is also referred to as osteochondral transplantation, uses osteochondral 
plugs from non-weight bearing areas of the cartilage to fill defects within a joint (Figure 1.9). 
The technique can involve the use of allografts or autografts, however autografts are the 
preferred choice due the lack of immune rejection. The disadvantage of this technique is that 
the plugs taken from the donor do not perfectly fit the defects within the cartilage. This means 
that often more than one plug is needed which can present problems due to limitations of 
donor cartilage availability. This is in addition to donor site morbidity and issues with surface 
congruency of the repair, due to gaps between the circular plugs (Polster & Recht, 2005). 
Mosaicplasty has shown mixed success in patients and the quality of the repair may depend on 
which area of the joint undergoes mosaicplasty (NICE Guidelines IPG162, 2006) 
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1.11.6 Unicompartmental Knee Arthroplasty (UKA) 
 
During early stages of osteoarthritis it is often the case that only one component of the knee 
joint is affected. This means only one joint component needs to be replaced, hence the term 
unicompartmental knee arthroplasty. In this technique a prosthesis is used to partially replace 
a joint surface such as the medial femoral condyle as opposed to both the medial and lateral 
sides (Newman, 2000). The advantages of this technique are that it is less invasive and is 
accompanied by shorter recovery times than those of total knee arthroplasties. This treatment 
also leaves the option for revision to total knee replacement open and these follow up 
operations are often successful. Unfortunately, for this technique to take place early diagnosis 
is required which is a rare occurrence. It can also lead to increased wear due to inferior 
lubrication properties of the prosthetic surface in comparison with cartilage. UKA is usually 
recommended for patients that are over 60 years of age, weighing less than 80 kg that place 
low activity demands on their knees (Bourne, 1990).  
 
1.11.7 Total knee replacement (TKR) 
 
This technique involves replacement of the diseased knee surfaces with an implant comprised 
of highly polished metal alloys and an ultra high molecular weight polyethylene tibial tray, 
which are designed to mimic the shapes of the natural joint components to allow normal 
 
Figure 1.9. An image showing the surface of the articular cartilage in a knee joint after a 
moisaiclasty procedure. Taken from Hangody et al., 2010. 
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geometric motion. Total knee replacements usually consist of a femoral component, tibial tray 
and insert and sometimes the patellar component is also replaced (www.orthoinfo.aaos.org). 
Total knee arthroplasty is usually only considered after other less advanced treatment options 
are exhausted and the cartilage and subchondral bone are severely damaged. 
  One of the associated disadvantages with TKR is that its components have inferior 
frictional properties to cartilage and so produce wear particles which can aggravate certain 
cells of the immune system (McGloughlin & Kavanagh, 2000). This eventually leads to 
loosening and failure of the replacement. Once the prosthesis has failed, a revision surgery is 
required which comes with increased risk of morbidity and complications during surgery. 
However for many patients TKR significantly reduces pain and improves quality of life for as 
long as the replacement is viable (0-15years). 
 
1.11.8 Novel Cartilage replacement therapies 
 
Due to the limitations of current treatments for cartilage defects, novel treatments are being 
developed. These prospective treatments include the use of biomaterials and tissue 
engineered constructs as early intervention solutions that can be used to repair tissue before 
joint replacement becomes necessary. Tissue engineering aimed at cartilage tissue 
regeneration is currently pursued in many research centres across the world 
   Naturally, engineering cartilage tissue is a complex procedure that involves the use of 
scaffolds that are seeded with cells, for example chondrocytes, which are placed into defects. 
The aim is for the scaffold to create a 3D environment for the production of cartilage tissue. 
Scaffolds can be either synthetic, natural or natural acellular. Growth factors such as TGF-β can 
be incorporated into the scaffolds to aid ECM regeneration (Chung & Burdick, 2008; Tilwani et 
al., 2012). 
   Examples of products that aim to regenerate and repair areas of damaged cartilage 
include NeoCart® (Figure 1.10) which is manufactured by Histogenics and Salubria®, 
manufactured by Salumedica. With NeoCart®, cells from the patient are implanted into a 
patented 3D matrix and cultured in a bioreactor that mimics conditions found in the body. The 
cultured matrix is then implanted into the site of cartilage damage. Salubria is a cartilage 
replacement material that can be implanted into sites of cartilage damage. 
  Hydrogels are highly hydrated, cross-linked hydrophilic polymers. They have been 
investigated for use as replacements for damaged articular cartilage, but also have potential 
for use as scaffolds in tissue engineering. Hydrogels can be natural or synthetic (Cheung et al., 
2007). As with tissue engineered cartilage, whether the successful clinical application of 
hydrogels will occur over the long-term, remains to be seen.  
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1.11.9 Preclinical assessment of cartilage substitution materials 
 
The recent increase in interest regarding novel cartilage substitution therapies has led to the 
production of a plethora of different natural and synthetic substitution materials. Part of the 
problem that arises in engineering tissues is the replication of the anisotropic zonal 
arrangements that many tissues have, including cartilage. Without replication of zonal regions 
in tissues, the biomechanical properties of constructs are not likely to be similar to the native 
tissues. This raises an important question; which of these materials actually provides the best 
treatment solution for patients with early stage cartilage defects? Many of the materials 
currently taken forward into animal trials do not undergo rigorous assessment with both 
biological and mechanical efficacy testing. Often researchers working on substitution materials 
are predominantly working within either an engineering or biological field and this leads to 
suboptimal testing of potential biomaterials in the complementary field. With this in mind it is 
evident that taking materials that have not be thoroughly assessed both biologically and 
mechanically into animal trials, is a premature step.  
  In response to this it is apparent that there is a need for the development of an 
effective in vitro system to assess cartilage substitution materials before animal testing to 
prevent use of animals unnecessarily. An example of an in vitro preclinical method to assess 
novel cartilage substitution materials could be a simulator containing a whole joint running 
under physiological loading regimes that could be used to determine whether a material has a 
beneficial or detrimental effect on the surrounding tissues. Given that potential cartilage 
substitution materials would be used in joints that had been subject to some degree of 
 
Figure 1.10. The NeoCart® matrix used for articular cartilage repair by Histogenics. 
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degeneration, it would be necessary to test these novel therapies in pre-clinical models that 
mimic the biotribological conditions of degenerating cartilage. 
 
1.12 Models of cartilage degeneration  
 
A variety of in vitro and in vivo models have been used in an attempt to replicate the large 
number of complex changes to joint tissues that take place during the progression of cartilage 
degeneration. Researchers have attempted to find an ideal model that can reproduce the 
alterations to tissues that are accumulated over many years, and which will allow investigation 
into how degenerative changes alter the composition and properties of cartilage tissue. A large 
variety of animals have been used as models for investigating in vivo cartilage degeneration, 
including mice, rats, guinea pigs, rabbits, dogs, sheep and  horses (Smith et al., 2007). The 
tissues from these, and other animals including cows have also been used to create in vitro 
models of cartilage degeneration.  
 One reason why it has not been possible to establish a “gold standard” model may be 
due to the complexity of cartilage degeneration. It is possible that no single model can mimic 
all of the changes accurately, including the biochemical and mechanical abnormalities that 
occur, not only in the cartilage but also in the bone and other joint tissues. With this is mind 
many models have been developed to match the aims of the study as closely as possible and 
the limitations of the model are taken into account.  
 
1.12.1 In vivo models of cartilage degeneration 
 
This section will introduce the different types of in-vivo animal models of osteoarthritis 
including surgery models and spontaneous models. 
 
1.12.1.1 Spontaneous models of osteoarthritis 
 
 
Hartley Albino guinea pigs are often used in studies regarding OA as this breed of guinea pig 
begins to develop areas of fibrillation, chondrocyte death in the upper mid region of the 
cartilage tissue and proteoglycan loss bilaterally in the medial tibial plateau by approximately 6 
months of age. By approximately 12 months of age the guinea pigs will have developed 
osteophytes and profound degenerative changes in all aspects of the medial compartment of 
the knee including proteoglycan loss and cellular cloning (Bendele & Hulman, 1988). This 
model is therefore useful for prophylactic testing and assessment of drugs which may 
potentially be inhibitors of OA. 
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  Mice are also commonly used as spontaneous models of OA as most mice will develop 
some form of degeneration as they age, which has the potential to develop into OA (Bendele, 
2001). Spontaneous OA in primates have also been studied to attempt to elucidate the natural 
history of OA development. However, due to the difficulties in gaining ethics for primate 
studies and heterogeneous development of OA in the primates studied they may not be a 
suitable choice for general study (Carlson et al., 1996).  
 
1.12.1.2 Surgical models of osteoarthritis 
 
One of the most commonly used surgical methods for the study of OA is anterior cruciate 
ligament transection. The surgery causes instability in the joint which leads to development of 
OA in a style that aims to mimc OA development after traumatic injury in humans (Pond and 
Nuki, 1973). One problem with this model is that the animals will tend to decrease loading 
onto the operated limb by carrying it and loading their remaining limbs. The dogs require large 
housing areas which is very expensive and not all the lesions developed by the dogs are 
homogeneous. However the model is useful for studying the development of OA. 
  Rabbits are also used as animal models, one example being the rabbit partial 
meniscectomy model. In this model the cartilage begins to degrade represented by loss of 
proteoglycans, chondrocyte proliferation and osteophyte formation (Moskowitz et al., 1973). 
The model provides consistent results relatively quickly (within 6 weeks). Due to the rapidity of 
OA onset the model is more useful for studies of OA pathogenicity.  
 
1.12.1.3 Intra-articular Injection 
 
A variety of substances have been injected into animal joint cavities with the aim of producing 
tissue degradation. These substances include papain, iodoacetate and IL-1. Iodoacetate 
injection is commonly used with rats where the iodoacetate inhibits chondrocyte glycolysis 
and causes cell death. This leads to proteoglycan loss and general cartilage degradation. The 
chondrocytes in the edges of the joint often survive the injection and begin to form 
osteophytes (Guingamp et al., 1997).   
 
1.12.2 In vitro models of cartilage degeneration 
 
 Several in vitro studies have been performed on degraded cadaveric tissues, which have 
become damaged in vivo. For example Wong et al. (2008) used human cadaveric lateral 
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condyle pins to investigate the effects of cartilage degeneration on shear. While, Caligaris et al. 
(2009) used degenerated human cartilage to investigate lubrication mechanisms of cartilage 
tissue. However, the use of in vitro mechanical damage models is relatively unusual.  
  Researchers have used in vitro models to determine the effects of degeneration on 
cartilage properties with mixed results. For example, crude methods have involved the use of 
sandpaper to investigate how the friction coefficient is altered in cartilage that has impaired 
synovial fluid lubrication. In work by Tanaka et al. (2005), the friction in porcine 
temporomandibular joints was measured and compared to the friction in the same group of 
joints after the joints had been washed in phosphate buffered saline (PBS) and scoured with 
sandpaper.  The authors showed that washing and scouring the cartilage caused an increase in 
friction of 350%. These authors also concluded that the application of hyaluronic acid to the 
scratched joint reduced the friction coefficient in the joint. However, the relevance of this 
work to a physiological environment remains unclear. Other work has involved the use of 
simplistic methods such as removing full thickness pieces of cartilage from small osteochondral 
blocks to investigate cartilage contact mechanics and cartilage deformation (Gratz et al., 2009; 
Wong and Sah, 2009). Again it is questionable whether the methods used in these studies 
were sophisticated enough to accurately portray scenarios occurring in vivo. 
  Stachowiak et al. (2006) developed an automated classification system for cartilage 
surface wear that they postulated could become a diagnostic tool for assessment of cartilage 
wear in patients. The wear on the cartilage surface was generated either using a pin on disc 
system without lubricant, or manually with sandpaper. This raises issues in terms of the 
relevance of the study because the classification system that was developed was based on 
wear of the cartilage surface that was not necessarily physiological and therefore may not 
accurately be able to identify physiological degradation of the cartilage surface. The authors 
used a physiological sliding speed and contact stress, but it was not clear if the non-reciprocal 
motion of the pin on disc set up may have also contributed to the generation of cartilage wear 
which may not represent that observed in vivo.  
  Other more complex studies have investigated the effects of tissue degradation on 
chondrocyte activity and the initiation of collagen degradation (Quinn et al., 2001; Wilson et 
al., 2006). In the study by Wilson et al. (2006) an indenter tip was used to investigate the effect 
of mechanical overloading on collagen degradation. The investigators found that “cartilage 
degradation” was initiated at excessive loads, which caused excessive shear strain along 
collagen ﬁbrils. However, no attempt was made to investigate how proteoglycans in the tissue 
had been affected by the indentation. Therefore the conclusion that cartilage degradation was 
caused by collagen fibre breakdown may only be partly true. In addition to this the loading 
conditions were not completely physiologically relevant. 
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  Several mechanically based in vitro studies have also been conducted in the Institute 
of Medical and Biological Engineering at the University of Leeds. These studies help to 
contextualise the work carried out in the current study. Early studies in the Institute focused 
on investigation of bovine cartilage tribology under variable test conditions using a pin on plate 
rig. Changes to the conditions included alterations in lubricants, materials articulated and 
loading times. The studies found that boundary lubrication was important for reducing friction 
in joints and that the parameter that most affected friction between specimens was the 
loading time. The authors concluded that the ability of the cartilage to carry loads on its fluid 
phase was reduced with extended periods of loading (Forster and Fisher, 1996; Forster and 
Fisher, 1999).  
  Other in vitro studies aimed to assess how proteoglycan depletion changed the 
biotribological properties of bovine cartilage tissue (Pickard et al., 1998; Katta et al., 2007; 
Katta et al., 2009). Ex vivo tissue from patients has also been investigated using a siding in vitro 
friction rig which highlighted differences between cartilage tissue degraded in vivo and 
undegraded control tissues; a study by Pickard et al. (2000) found that friction was increased in 
ex vivo degraded cartilage tissue in comparison with controls. The cartilage structure of 
degraded specimens was fibrous and and an increase in displacement of cartilage tissue was 
observed during indentation tests. In vitro studies have also been used to investigate how 
cartilage tribology may be affected in vivo following surgery such as hip hemiarthroplasty 
(McCann et al., 2009; Lizhang et al., 2011). In the study by Lizhang et al. (2011) cartilage pins 
were articulated on cobalt chrome plates under a range of conditions and mechanical 
characterisation techniques were used to assess the tissues after simulation. It was found that 
in long term studies (24 hours) with a contact stress equal to or below 4 MPa, the coefficient 
of friction between bovine osteochondral pins and metal plates remained below 0.35. 
However, severe damage to the cartilage was observed at a contact stress of 8 MPa and 
catastrophic damage was observed at contacts stresses of 12 MPa and above. In the long term 
studies, friction was not affected by the contact area of the pin and sliding distances and 
velocity of articulation only affected the coefficient of friction under contact stresses ranging 
from 0.5 to 2 MPa. In the short term studies (1 hr) it was observed that the friction coefficient 
decreased when the contact stress was increased from 0.5 MPa to 2 MPa, but from 2 MPa to 
16 MPa the coefficient of friction was increased. Finally an increase in the wear of the cartilage 
surface, which resulted in a decrease in cartilage height, was observed with increases in 
contact stress, sliding distance and sliding velocity. 
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1.13 Rationale 
Cartilage degradation has both mechanical and biological origins. The aim of this study was to 
replicate, in vitro, the biotribology of in vivo degraded cartilage tissue. Therefore a simple 
configuration rig was used to create mechanical damage within cartilage specimens. 
Mechanical degradation was applied using conditions that had been observed in vivo e.g. 
clinically relevant loads and contact stresses were applied in the models. Biological 
degeneration of cartilage tissue frequently results in loss of GAGs from the tissue. GAG loss 
was replicated using a chondroitinase ABC in a biological degradation model. The changes that 
occurred in the cartilage tissue were extensively characterised, which built on the previous 
work done at Leeds. The study also focused more specifically on the effects of lubricants and 
loads on cartilage degradation. Finally the study also represents a preliminary step in the 
development of a natural whole joint simulator for assessment of novel chondroplasty 
materials, something which has also been investigated previously at Leeds using a pin on plate 
rig (Northwood and Fisher, 2007). 
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1.14 Aims and Objectives 
 
The aim of this project was to develop mechanical and biological cartilage degradation 
methodologies, to replicate the biotribological conditions of degenerated cartilage. A second 
aim was to assess the degeneration in the models and to collect and analyse wear particles 
generated by the model. 
 
1.14.1 Objectives 
 
 To characterise healthy bovine articular cartilage from the medial condyle using a 
range of methodologies, including geometrical height measurements, friction 
measurements, surface roughness profilometry, histology, immunohistochemistry, 
electron microscopy, indentation testing and quantitative biochemical assays. 
 
  To generate mechanical degradation models of cartilage using a pin-on-plate friction 
rig. 
 
 To generate biological degradation models of cartilage using the enzyme, 
chondroitinase ABC. 
 
  To investigate the characteristics of degenerated cartilage via the methods described 
previously to determine the alterations that take place in cartilage tissue after 
mechanical or enzymatic degradation. 
 
 To develop new methodologies to generate, collect and characterise cartilage wear 
particles and degradation products in the lubricants recovered during mechanical 
degradation testing. 
 
59 
 
Chapter 2  
 
Experimental Materials and Methods 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
60 
 
2.1 Materials 
 
2.1.1 Equipment 
Equipment used during this study is listed in Table 2.1. 
 
Table 2.1 Equipment that was used in this study. 
Equipment    Model Supplier 
-25°C freezer Beko Jencons 
-80°C freezer Ultralow Sanyo 
Autoclave PS/MID/C40 Priorclave 
Automatic pipettes Gilson P2-P1000 Anachem Ltd 
Balances(4 & 2 Figure) GR200/GX200 Jencons Plc 
Centrifuge Megafuge 1.0 Heraeus Sepatech 
Class II safety cabinet Herasafe Heraeus 
Copper grids   
Corer- drill bit Made in house University of Leeds 
Corer- serrated Made in house University of Leeds 
Corer- smooth Made in house University of Leeds 
Cryostat CM1850 Leica 
Digital camera EOS 450D digital SLR Canon 
Disposable vinyl specimen 
mould 
Cryomold standard Sakura Tissue Tek 
Filter (0.2µm) Minisart Sartorius stedim biotech 
Filter (10µm) 47mm hydrophillic Whatman 
Filtration Kit  Milipore 
Freeze dryer Modulyo Thermo Fisher Scientific Inc 
Fridge Medicool Sanyo 
Fume Hood Airone-R Safe Laboratory Sytems 
Hacksaw   
Heated forceps Speci-ceps System II Bios Europe 
Histology cassettes (plastic) Histosette Thermo Fisher Scientific 
Hot air oven Sanyo OMT225 Sanyo Biomedical Europe BV 
Hot plate  E18.1 hotplate Raymond A Lamb 
Hot wax dispenser E66 wax dispenser Raymond A Lamb 
Ice blocks Medicool MC28 Laminar Medica 
Incubator (orbital) Stuart S150 Scientific Laboratory Supplies 
Jig Made in house University of Leeds 
Magnetic stirrer  Heated Stirrer Fisher Scientific 
Magnetic stirrer Bar   
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Microcentrifuge Microcentaur MSE 
Microplate reader Multiskan Spectrum Thermo Fisher Scientific Inc 
Microshaker AM69 Microshaker Dynatech AG 
Microtome RM 2125 RTF Leica Microsystems 
Orbital shaker Pos-300 Scientific Laboratory systems Ltd 
Paraffin section mounting bath  - Barnstead Electrothermal 
Parafilm  - Sigma-Aldrich Ltd 
pH meter Jenway 3510 VWR International 
Pipette boy Acu classic Scientific Laboratory Systems 
Plastic sheeting   
Repeat pipetter AutoRep E RAININ 
Scanning electron microscope Quanta 200 FEG 
ESEM 
FEI 
Shadowgraph   
Shaking table IKA KS 130 basic Jencons Plc 
Silicone mould kit 50ml system Microset 
Spatula   
Glass Slides Superfrost Plus Scientific Laboratory Supplies 
Talysurf   Taylor-Hobson 
Transmission electron 
microscope 
Spirit G2 12 BioTWIN FEI 
Tissue processor Leica TP 1020 Leica Microsystems 
Ultracut microtome  Reichert-Jung 
Upright microscope Olympus BX51 Microscopes, Medical Diagnostic 
Systems and Olympus Patient 
Systems Ltd (Olympus UK Ltd) 
Vortexer MS2 minishaker IKA 
Waterbath Clifton  Scientific Laboratory Supplies 
Wax oven - Scientific Laboratory Supplies 
Water purifier Purelab Option Triple Red Laboratory 
Technology 
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2.1.2 Reagents 
Reagents used during in this study are detailed in Table 2.2  
Table 2.2. Reagents that were used in this study. 
Chemical/ reagent Supplier 
  
Acetic acid Fisher Scientific  
Alcian blue Raymond A Lamb 
Ammonium oxalate Fisher Scientific 
Amphoteracin B  
Anhydrous sodium hydrogen phosphate (Na2HPO4) AnalaR 
Aprotonin Nordic Pharma 
Araldite CY212 Agar 
Bovine serum albumin Sigma-Aldrich 
Chloramine T Sigma-Aldrich 
Chondroitin sulphate B Sigma-Aldrich 
Citric acid Fisher Scientific 
Cupromeronic blue dye Sigma-Aldrich 
DakoCytomationEnVision®+ Dual Link System-HRP (DAB+) Dako 
Dodecenyl succinic anhydride (DDSA) Agar 
1,9 Dimethylene blue Sigma-Aldrich 
Dibasic sodium phosphate AnalR 
Di-sodium hydrogen orthophosphate VWR International  
Disposible microtome blades Raymond A Lamb Ltd 
DMP30 (2,4,6-tri(dimethylaminoethyl) phenol) Agar 
DPX mountant Thermo Fisher Scientific Ltd 
Dulbecco’s PBS with calcium & magnesium Lonza 
Ehrlich’s reagent (P-dimethylaminobenzaldehyde) Sigma Life Science 
Eosin VWR International 
Ethanol  
Ethylenediaminetetraacetic acid Sigma-Aldrich 
Formic acid Sigma-Aldrich 
Gentamicin Sigma-Aldrich 
Glacial acetic acid VWR International 
Gluteraldehyde (50%) Sigma-Aldrich 
Haematoxylin (Mayer’s) Raymond A Lamb 
Hydrochloric acid Sigma-Aldrich 
Hydrogen peroxide Sigma-Aldrich 
Hydrophobic marker pen (ImmEdge) Vector Laboratories 
Imipenem (Primaxin Intravenous) Merck  Sharpe & Dohme LTD 
L-cysteine hydrochloride Sigma-Aldrich 
Magnesium choride hexahydrate MP  
Methylated spirits Bios Europe Ltd 
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Monobasic sodium phosphate AnalR 
Neutral buffered formalin (10% w/v) Genta Medical 
Nystatin  Sigma-Aldrich 
OCT embedding matrix Raymond A Lamb 
Oxalic acid VWR International 
Papain (crude) Sigma-Aldrich 
Papain (pure) Sigma-Aldrich 
Paraffin wax pellets Thermo Fisher Scientific Ltd 
Phosphate buffered saline tablets Oxoid 
Perchloric acid 60% (w/v) BDH 
Periodic acid shiff kit Sigma 
pH solutions Scientific Laboratory supplies 
Phosphoric acid  
Picric Acid Sigma-Aldrich 
Polymixin B Fluka Analytical 
Potassium permanganate Thermo Fisher Scientific Ltd 
Propan-1-ol VWR International 
Propylene oxide Agar 
Ringer’s solution tablets Oxoid 
Sirius red VWR International 
Sodium acetate AnalaR  
Sodium azide 1% (w/v) Sigma-Aldrich 
Sodium chloride Thermo Fisher Scientific Ltd 
Sodium di-hydrogen orthophosphate VWR International 
Sodium formate VWR International 
Sodium hydroxide pellets  Thermo Fisher Scientific Ltd 
Sodium tungstate MP Bio 
Trizma base Sigma-Aldrich 
Tween 20 Sigma-Aldrich 
Uranyl acetate Agar 
Vancomycin Sigma-Aldrich 
Wax block moulds (base mould) Fisher Scientific 
Wax pellets- Shandon Histoplast Fischer-Scientific 
Xylene Genta Medical 
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2.1.3 Antibodies 
Antibodies used throughout the study for immunohistochemical analysis of cryosections are 
detailed in Table 2.3. 
 
Table 2.3. Antibodies for labelling of cryosections using Immunohistochemical analysis. 
Antibody Isotype Concentration Dilution Supplier/ 
Product code 
Incubation 
time 
Primary antibodies 
Biglycan IgG3 1-10 mg/ml 1/800 AbCam- 
ab64695 
1 hour 
Collagen VI IgG 50 µg 1/500 AbD Serotech- 
AHP2049 
1 hour 
Cartilage 
Oligomeric 
Matrix Protein 
IgG 0.4 mg/ml 1/80 AbCam- 
ab74524 
2 hours 
Isotype controls 
IgG3 (Biglycan) - 0.1 mg/ml 1/8 AbD Serotech- 
MCA2063 
1 hour 
IgG (Collagen VI) - 0.2 mg/ml 1/200 AbCam- 
ab27478 
1 hour 
IgG (COMP) - 0.2 mg/ml 1/200 AbCam- 
ab27478 
2 hours 
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2.2 Consumables 
2.2.1 Glassware 
Unless otherwise stated, all laboratory glassware was obtained from Fisher Scientific, 
Loughborough, UK.  Glass ware was cleaned by immersion into a 1% (v/v) solution of 
Neutracon phosphate free detergent overnight followed by thorough rinsing in tap water. The 
glassware was then rinsed three times in distilled water before being sterilised using dry heat 
for 4 hours at 180°C. 
2.2.2 Sterile Plasticware 
Uncoated Nunc 96 well flat bottomed plates were purchased from Fisher Scientific 
Loughborough, UK.  Disposable pipettes were supplied by Sigma-Aldrich Company Ltd., Poole, 
Dorset, UK. Pipette tips were purchased from Starlab, Hamburg, Germany. All other sterile 
plasticware was purchased from Scientific Laboratory Supplies, Hessle, UK. 
2.2.3 Dissection Equipment 
A size 22 scalpel handle and standard forceps were purchased from Seward Thackray, Gwent, 
UK and disinfected in 1% (w/v) virkon for 10 minutes at room temperature after each use. Size 
22 scalpel blades were purchased from Thermo Fisher Scientific Ltd., Loughborough, UK. 
 
2.2.4 Stock Solutions  
2.2.4.1 Ethylenediaminetetraacetic acid (EDTA) solution 12.5% (w/v) at pH 7   
Two litres of 12.5% (w/v) EDTA solution were made by adding 250 g of EDTA to 1500 ml of 
distilled water. The solution was stirred using a magnetic stirrer. Sodium hydroxide pellets 
were added to bring the pH closer to pH 7 then 1M sodium hydroxide solution was added to 
bring the pH to 7. Following this distilled water was used increase the solution volume to 2 
litres. The solution was stored at room temperature for up to 12 months.  
2.2.4.2 Sodium hydroxide solution (6M)  
Sodium hydroxide pellets (120 g) were added to 500 ml of distilled water. The solution was 
stirred using a magnetic stirrer until the pellets had dissolved. This solution was stored at room 
temperature for up to 12 months.  
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2.2.4.3 Ringer’s solution 
Eight Ringer’s solution tablets were added to one litre of distilled water and left to dissolve at 
room temperature. The solution was stored at room temperature until required. 
2.2.4.4 Phosphate buffered saline (PBS)  
One PBS tablet was added per 100 ml of distilled water and left to dissolve at room 
temperature. The solution was stored at room temperature for up to 2 weeks. 
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2.3 Methods  
2.3.1 pH Measurement  
A Jenway 3510 pH meter was used to measure the pH of solutions. The pH meter was 
calibrated with premade solutions of pH 7, pH 10 and pH 4. The pH of the solutions was 
measured using the automatic temperature compensation within the meter. To adjust the pH 
of solutions, 1-6 M hydrochloric acid or 1-6 M sodium hydroxide was added drop-wise whilst 
the solution was agitated using a magnetic stirrer. 
2.3.2 Microscopy  
Bright field microscopy was performed on an Olympus BX51 Microscope. Digital images were 
captured using an Olympus XC50 camera via Cell B imaging software.  
2.3.3 Filter Sterilisation 
Filter sterilisation was used to sterilise bovine serum albumin solution for 
immunohistochemistry. The bovine serum albumin solution in a disposable syringe was passed 
through a 0.2 µm pore filter into a sterile plastic container in a class II safety cabinet. 
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2.4 Tissue Retrieval  
Femurs from 18 month old cattle were obtained from the local abattoir within 48 hours of 
slaughter. Before dissection, surfaces were covered in plastic sheeting for cleanliness. The 
femur was clamped firmly using a vice. Circular osteochondral pins approximately 10-15 mm in 
length and 9 mm in diameter were taken from the medial condyles of the femur (Figure 2.1). 
To do this, the surface of the condyle was marked with a smooth 9 mm diameter corer 
followed by a serrated corer to enhance the impression on the tissue. A drill with a serrated 
coring attachment was then used to drill around the circumference of the impressions. The 
smooth corer was then used again to snap the pin from the base and therefore extract the pin 
from the tissue. A hacksaw was used to extract one osteochondral plate 45 mm in length and 
18 mm in width from the medial patellar groove of each of the femurs. The bone at the back of 
the osteochondral plate was removed using a jig designed and built in house. The plates and 
pins were stored -25°C in labelled plastic pots containing tissue paper soaked in Ringer’s 
solution before undergoing further processing.  
 
 
 
 
 
 
 
 
 
 
 
A B
 
Figure 2.1. Images displaying the areas of the medical condyle and medial patellar groove 
from which osteochondral pins and plates were dissected. A. The medial condyle of the 
bovine femur showing areas marked for osteochondral pin extraction and a cylindrical void 
where a pin has been extracted. B. A drawing showing the outline of the bovine patellar 
groove with a shaded region indicating the area from which osteochondral plates were 
removed. 
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2.5 Basic histological techniques 
The methods described below were used to prepare the osteochondral specimens for 
histological examination. 
2.5.1 Decalcification of bovine osteochondral plugs  
Decalcification of bovine osteochondral pins was carried out in 12.5% (w/v) 
ethylenediaminetetraacetic acid (EDTA) at pH 7 and at 40°C with gentle agitation in an orbital 
incubator. Prior to decalcification, each pin was placed into 20 ml of 10% (v/v) NBF for 48 
hours. After they had been fixed, each pin was immersed into 20 ml of 12.5% (w/v) EDTA 
which was changed every 24-48 hours for approximately 2-3 weeks until complete 
decalcification was confirmed using a calcium oxalate test (Section 2.5.2) and the bone was 
soft enough to be cut using a scalpel blade.  
2.5.2 Calcium oxalate test  
2.5.2.1 Dibasic sodium phosphate solution (0.2M)  
To 14.1 ml of distilled water, 0.4 g of anhydrous sodium hydrogen phosphate (Na2HPO4) was 
added and dissolved using a magnetic stirrer.  
2.5.2.2 Citrate phosphate buffer, pH 3.4  
To a volume of 14.1 ml of 0.2 M dibasic sodium phosphate solution, 35.9 ml of citric acid was 
added. The solution was adjusted to pH 3.4 using citric acid and mixed using a magnetic stirrer. 
The mixture was then increased to 100 ml with distilled water. 
2.5.2.3 Saturated ammonium oxalate solution  
Ammonium oxalate powder was added to 80 ml of distilled water in a 100 ml duran bottle 
until it would no longer dissolve after vigorous shaking by hand for 40-60 seconds.  
After specimens had been incubated for approximately 24 hours in fresh EDTA subsequent to 
the previous EDTA change, 0.5 ml of EDTA was removed from each specimen container and 
was mixed with 2.5 ml of saturated ammonium oxalate and 1 ml of citrate phosphate buffer. 
The specimens were placed on a shaking table for 20 minutes after which the formation of a 
white precipitate confirmed the presence of calcium in the solution. No precipitate formation 
confirmed an absence of calcium in the solution and indicated that the specimen was ready for 
processing.  
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2.5.3 Paraffin wax embedding of cartilage samples  
Post dissection, tissue specimens destined for histological examination were stored in 20 ml of 
10% (v/v) neutral buffered formalin (NBF) for 48 hours at room temperature prior to 
decalcification. Following decalcification, specimens were placed into 10% (v/v) NBF for a 
further 48 hours before being bisected from the cartilage through to the bone with a scalpel 
blade and placed into plastic cassettes before dehydration in an automatic tissue processor. 
For histological specimens, the tissue processor was set on programme 9 which had a total 
duration of 22 hours and involved sequential immersion of tissue samples into various 
solutions (Table 2.4).  
Table 2.4 Tissue Processor programme 9 for processing of bovine osteochondral pins for wax 
embedding. 
 
Once the tissue processing cycle was complete, the specimens were removed from the 
cassettes one at a time, orientated in wax block moulds with heated forceps and covered in 
molten wax, they were then left to dry on ice blocks for 1 hour. Once the wax was hardened, 
the wax blocks were removed from the moulds and excess wax around the block was trimmed 
away with a spatula. 
 
Station  Time  Solution  
1  1 hour  10% (v/v) NBF  
2  1 hour  70% (v/v) Ethanol  
3  1 hour  90% (v/v) Ethanol  
4  2 hours 20 minutes  100% (v/v) Ethanol  
5  3 hours 20 minutes  100% (v/v) Ethanol  
6  4 hours 20 minutes  100% (v/v) Ethanol  
7  1 hour  Xylene  
8  1 hour 30 minutes  Xylene  
9  2 hours  Xylene  
10  1 hour 30 minutes  Molten wax  
11  2 hours  Molten wax  
12  2 hours  Molten wax  
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2.5.4 Tissue sectioning  
A microtome was used to section samples embedded in paraffin wax. Sections were cut at 6 
µm intervals and floated in a water bath set at 40°C. Sections were then transferred onto 
Superfrost glass slides that were baked on a hotplate at 55°C for 2 hours. The slides were 
stored in slide holders for up to 48 hours. 
2.5.5. Dewaxing and rehydration of paraffin embedded tissue 
Slides were placed into a slide holder and submerged into two successive pots of xylene for 10 
minutes each to remove wax. Slides were then placed into three successive pots of 100% (v/v) 
alcohol for 3, 2 and 1 minutes respectively. Following this slides were submerged into 70% 
(v/v) alcohol for 30 seconds before being submerged into a pot irrigated by running tap water 
for 3 minutes. 
2.5.6 Tissue dehydration and mounting 
Post staining, sections were dehydrated through immersion in 70% (v/v) alcohol for 5 seconds 
followed by successive immersion into three pots of 100% alcohol for 1 minute each and finally 
sections were placed into two pots of xylene for 10 minutes each. In a fume hood, slides were 
mounted one at a time using DPX mountant and a coverslip. Slides were left to dry for a 
minimum of 4 hours at room temperature before visualisation with a light microscope.  
2.5.7 Tissue retrieval for cryoembedding 
For cryoembedding, cartilage was removed from the bone of specimens using a scalpel. 
Cartilage disks  cut from the bone were cut in half using a scalpel blade. The flat cut edge of 
the cartilage disk was placed face down in a disposable vinyl specimen mould. OCT embedding 
matrix was poured over the sample until it was submerged. The samples were then frozen at -
80°C overnight. The samples were then removed from -80°C and placed into -20°C for long 
term storage in plastic pots. 
2.5.8 Tissue sectioning and slide preparation of cryoembedded tissues  
Cartilage was sectioned at a thickness of 6 µm using a cryostat set at -21°C. Sections were 
mounted onto Superfrost Plus slides which were baked on a hotplate at 55°C overnight. After 
baking, the slides were used within 24 hours. 
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2.6 Histological staining methods 
2.6.1 Haemotoxylin and eosin staining 
Haematoxylin and eosin staining was used for visualising the architecture of the cartilage 
tissues in this study. Haematoxylin stains acidic components of tissues such as the cellular 
nuclei which can be seen at higher magnifications, while eosin which is an anionic dye, stains 
the basic cellular components, such as the cytoplasm. Haematoxylin requires oxidation to 
haematin and subsequent attachment to the tissue via a mordant in the stain solution before 
staining can occur. The eosin counterstain, stains the cytoplasm of the cell and the majority of 
connective tissues in varying shades of pink and red. 
Sections were rehydrated and immersed into haematoxylin solution for 1 minute. Sections 
were then rinsed in running tap water until the water ran clear and were subsequently 
immersed into eosin solution for 3 minutes prior to dehydration and mounting followed by 
microscopic evaluation. 
2.6.2 Alcian blue staining  
Alcian blue is a cationic dye that stains glycosaminoglycans (GAGs) in tissue samples. It is often 
counterstained with eosin but can also be counterstained with neutral red. Healthy cartilage 
contains significant levels of GAGs within its ECM that include chondroitin sulphate and 
keratan sulphate. The alcian blue dye molecule can be described as a copper phthalocyanin 
dye which at low pH (<2.5) binds to fixed negative charges found on the carboxyl and sulphate 
groups in GAG chains via electrostatic bonding. 
Specimens were stained using an alcian blue periodic acid schiff kit. Alcian blue dye stains 
acidic and sulphated mucins.  As mucins are heavily glycosylated proteins, GAGs are stained 
during the alcian blue incubation. The periodic acid and Schiff dyes stain neutral mucins.  
Paraffin sections were brought to water before being stained with the Sigma periodic acid Shiff 
kit. After rehydration slides were immersed in 1% (w/v) alcian blue solution for 15 minutes 
followed by immersion into a pot of running tap water until the water ran clear, then a rinsing 
step in distilled water. Slides were immersed into periodic acid for five minutes then rinsed in 
distilled water. Slides were then immersed into Schiff’s reagent for 15 minutes. Slides were 
then rinsed in a pot of running tap water for five minutes before being immersed into 
haematoxylin for 90 seconds. Following this, slides were immersed into a pot of running tap 
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water. Slides remained in the pot until the water in the pot ran clear. This step was followed by 
dehydration and mounting as  previously described in Section 2.5.6. 
2.6.3 Immunohistochemical staining of bovine osteochondral specimens. 
 
2.6.3.1 Tris solution (2 M) 
In 800 ml of distilled water, 242.26 g of tizma base was dissolved using a magnetic stirrer. The 
pH was adjusted to pH 7.6 using sodium hydroxide or hydrochloric acid and the solution was 
increased to one litre using distilled water. 
2.6.3.2 Sodium chloride solution (3 M)  
To 175.32 g of sodium chloride, one litre of distilled water was added. A magnetic stirrer was 
used to mix the solution until the sodium chloride had dissolved. 
2.6.3.3 Tris buffered saline pH 7.6 (TBS) 
To 25 ml of 2 M tris solution, 50 ml of 3 M sodium chloride solution was added. Sodium 
hydroxide solution at 1M and 1M hydrochloric acid were used to change the pH of the solution 
to pH 7.6 as the solution was mixed using a magnetic stirrer bar.  The solution was made up to 
1 litre with distilled water and stored at room temperature until required. 
2.6.3.4 Tris buffered saline containing 0.05% (v/v) tween 20 pH 7.6 (TBS tween) 
To 9999.5 ml of tris at pH 7.6, 0.5 ml of tween 20 was added and dissolved using a magnetic 
stirrer.  
2.6.3.5 Hydrogen peroxide solution 3% (v/v) 
To 90 ml of PBS, 10 ml of 30% (v/v) hydrogen peroxide solution was added and mixed using a 
magnetic stirrer.    
2.6.3.6 BSA solution 
To 50 ml of PBS, 2.5g of bovine serum albumin was added and dissolved using a magnetic 
stirrer. The solution was passed through a filter with a pore size of 0.2 µm into a sterile 
collection container in a class II cabinet. 
2.6.3.7 Antibody diluent 
 To 50 ml of TBS, 60 µl of 1% (w/v) sodium azide and 300 µl of 5% (w/v) BSA solution was 
added. The pH of the solution was adjusted to pH 7.6 using hydrochloric acid or sodium 
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hydroxide and mixed using a magnetic stirrer. The solution volume was increased to 60 ml 
using TBS. 
Ultra V endogenous enzyme blocking kit (Dako Cytomation EnVision Kit)  
Labelled polymer horseradish peroxidise (Dako Cytomation EnVision Kit)  
Substrate chromagen (Dako Cytomation EnVision Kit)  
All of the following steps were performed at room temperature. Prior to staining, cryosections 
were rehydrated in running tap water for 3 minutes. Following this, sections were immersed in 
3% (v/v) hydrogen peroxide for 10 minutes followed by immersion into running tap water for 3 
minutes. A hydrophobic marker was used to circle around sections. After the marker ink had 
dried the slides were rinsed in TBS.  One drop of endogenous enzyme block was applied to 
each section and left to incubate for 10 minutes. The slides were then washed twice in TBS for 
10 minutes each. Each section then had 50 µl of primary antibody applied. Before use primary 
antibodies were diluted accordingly with antibody diluent (Table 2.3). The tissues were 
incubated with either collagen VI or biglycan antibodies for 1 hour, or with the COMP 
antibody, for 2 hours. Incubation was carried out in a moist atmosphere. The slides were then 
washed in TBS Tween twice for 10 minutes each followed by two 10 minute washes in TBS. The 
sections were then incubated with labelled polymer horseradish peroxidise for 30 minutes in 
the dark in a humid chamber before undergoing two 10 minute washes in TBS Tween. The 
slides were then washed twice for 10 minutes using TBS. Fifteen microliters of substrate 
chromagen was placed on each of the sections for 10 minutes. The slides were then washed 
four times in distilled water. The slides were immersed into haematoxylin for 10 seconds and 
then placed into running tap water until the water ran clear. The slides were then dehydrated 
and mounted as described previously in Section 2.5.6. 
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2.7 Microscopy of cartilage specimens 
 
2.7.1 Environmental scanning electron microscopy 
Samples to be visualised using ESEM were placed onto the Peltier-cooled specimen stage in an 
FEI Quanta 200F environmental scanning electron microscope. Images of the cartilage surface 
were taken between 8 and 14 kV at 85-100% humidity. Environmental electron microscopy 
allowed the samples to remain hydrated. This was through manipulation of the dew point of 
water in the chamber via chamber pressure alterations and temperature acclimatisation, 
facilitated by the Peltier-cooled specimen stage. The chamber temperature ranged from 4-5°C 
with a chamber pressure of approximately 6.5 Torr. 
2.7.2 Transmission Electron Microscopy and Cupromeronic Blue Staining 
This method was adapted from a method in the series Methods In Cell Biology; Transmission 
Electron Microscopy of Cartilage and Bone (Keene and Tufa, 2010). This method used the 
cationic dye Cupromeronic blue to label proteoglycans and produced an image of the 
supramolecular complex formed by the proteoglycans. Cupromeronic blue was used at a 
critical electrolyte concentration which resulted in the staining of sulphated proteoglycans 
only. 
2.7.2.1 Monobasic sodium phosphate (0.2M) 
To 100 ml of deionised water 2.76 g of monobasic sodium phosphate (NaH2PO4H2O) was added 
and stirred using a magnetic stirrer. 
2.7.2.2 Dibasic sodium phosphate (0.2M) 
To 100 ml of deionised water, 2.839 g of Na2HPO4 was added and dissolved using a magnetic 
stirrer. 
2.7.2.3 Phosphate buffer (0.1M) 
To 39 ml of 0.2 M monobasic sodium phosphate, 61 ml of 0.2 M dibasic sodium phosphate was 
added and dissolved using a magnetic stirrer. The pH was adjusted to pH7 using either 
phosphoric acid or sodium hydroxide. The solution was increased to 200 ml with deionised 
water. 
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2.7.2.4 Magnesium chloride hexahydrate (3 M) 
To 25 ml of deionised water, 30.5 g of magnesium chloride hexahydrate was added. The 
solution was mixed using a magnetic stirrer and was finally increased to 50 ml with distilled 
water. 
2.7.2.5 Aqueous sodium tungstate 0.5% (w/v) 
To 99.5 ml of deionised water, 0.5 g of sodium tungstate was added. The solution was shaken 
by hand to dissolve the sodium tungstate. 
2.7.2.6 Aqueous sodium tungstate 0.5% (w/v) 
To 50 ml of deionised water 50 ml of 100% ethanol was added. Following this 0.5 g of sodium 
tungstate was added to 99.5 ml of the 50% ethanol solution. The solution was shaken by hand 
to dissolve the sodium tungstate. 
2.7.2.7 Cupromeronic blue dye solution 
To 20 ml of 0.1 M phosphate buffer, 5ml of 50% (v/v) gluteraldehyde was added. To the 
gluteraldehyde phosphate buffer solution, 10 ml of 3 M magnesium chloride hexahydrate was 
added. Sodium hydroxide or phosphoric acid was used to adjust the pH of the solution to pH 7. 
The solution was increased to 100 ml using distilled water. To this, 0.05 g of cupromeronic blue 
dye was added. The solution was mixed using a magnetic stirrer until the dye had dissolved. 
The solution was stored in the dark at 4°C. 
2.7.2.8 Araldite Resin 
The following steps were conducted in a fume hood. In a measuring cylinder, 27 ml of Araldite 
CY212 was added to 23 ml of dodecenyl succinic anhydride (DDSA). The solution was poured 
into a plastic cup. A clamp stand was used to grip the cylinder upside down over the cup to let 
any of the remaining resin solution drip into the cup. To the resin DDSA mixture, 1 ml of 
DMP30 was added. A glass rod was used to stir the mixture until the solution became an even 
golden tan colour. The resin was stored at 4°C for up to 24 hours. 
2.7.2.9 Saturated uranyl acetate solution 
To  92 ml of distilled water, 8 g of uranyl acetate powder was added. 
Cartilage tissue was dissected as previously described (Section 2.4). Cartilage disks were cut 
from the bone and dissected into blocks approximately 4 mm x 1.5 mm x 2 mm. The tissue was 
submerged in cupromeronic blue dye solution for 17 hours at 4°C. Specimens were rinsed in 
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0.02 M phosphate buffer then washed twice in 0.02 M phosphate buffer for 30 minutes. The 
specimens were placed into aqueous 0.5% (w/v) sodium tungstate for 15 minutes followed by 
a 15 minute incubation in 0.5% (w/v) sodium tungstate in 50% (v/v) ethanol. The specimens 
were passed through six ascending alcohol incubations of 20% (v/v), 40% (v/v), 60% (v/v), 80% 
(v/v) and 100% (v/v), with two 100% (v/v) steps for half an hour each. The samples were then 
placed into propylene oxide for 20 minutes, this step was repeated before specimens were 
transferred from the propylene oxide into a 1:1 solution of propylene oxide and Araldite resin 
solution respectively. The specimens remained in the 1:1 solution overnight before being 
transferred to a solution of 1:4 propylene oxide to Araldite resin solution for 3 hours. Finally 
specimens were immersed into 100% Araldite resin for 3 hours. Following this samples were 
baked in the oven overnight at 60°C. 
  Resin embedded cartilage specimens were sectioned using glass knives at 90-140 nm 
using a Reichert-Jung ultracut microtome. Sections were placed onto Formvar resin coated 
copper grids which were subsequently stained using saturated uranyl acetate for 2 hours. An 
FEI Spirit G2 12 BioTWIN transmission electron microscope was used to image the specimens 
at a voltage of 120 kV.  
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2.8 Biochemical assays for quantitative assessment 
of hydroxyproline and glycosaminoglycan content 
of cartilage tissues 
2.8.1 Hydroxyproline quantification assay for cartilage tissue 
This method was adapted from a method devised by Edwards & O’Brien (1980). In this assay 
acid hydrolysis was used to release hydroxyproline residues from collagen structures. The 
hydroxyproline content of a tissue can be used to determine the collagen content of a tissue 
by multiplying the hydroxyproline content by 7.14. This is possible as hydroxyproline makes up 
on average every 7.14th residue in collagen II fibrils. The chloramine T oxidised the free 
hydroxyproline residues inducing formation of pyrrole compounds. The addition of Ehrlich’s 
reagent (p-dimethylaminobenzaldehyde) caused the production of a red chromophore from 
the pyrrole compounds, which was measured at 570nm. 
2.8.1.1 Assay buffer 
To 13.3 g citric acid, 3.2 ml glacial acetic acid, 32 g sodium acetate (3 H2O), 9.1 g sodium 
hydroxide and 80 ml propan-1-ol (n-propanol) was added. The resulting solution was increased 
to 300 ml using distilled water and stirred using a magnetic stirrer. The pH of the solution was 
adjusted to pH 6.0 - 6.5 with 6 M sodium hydroxide, before adjusting the final volume to 400 
ml with distilled water. This solution remained stable for up to two months when kept in a 
dark bottle at 4°C. 
2.8.1.2 Chloramine T solution 
To 100 ml of water 1.41 g of chloramine T was added and stirred with a spatula until dissolved. 
This solution was used immediately. 
2.8.1.3 Ehrlich’s reagent 
In a measuring cylinder, 7 ml of distilled water was added to 30ml of propan-1-ol, 13 ml of 62% 
(v/v) perchloric acid and 7.5 g of p-dimethylaminobenzaldehyde. The cylinder was inverted 
until the solution was mixed. The solution was used within one hour. 
 
Cartilage was cut from bone plugs with a scalpel blade and weighed. Between 50 and 80 mg of 
wet tissue from each specimen was placed into glass test tubes and lyophilised to a constant 
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weight using a freeze dryer at -40°C. Lyophilised tissue was acid hydrolysed by the addition of 
5 ml of 6 M HCL to the tissue which was incubated at 120°C for four hours using a bench top 
autoclave. Once cooled, the hydrolysed samples were neutralised to pH 7 using a range of 
sodium hydroxide solutions from 12 M to 0.1 M.  After neutralisation the volume of the 
hydrolysed specimens was quantified. The hydroxyproline content of the hydrolysed cartilage 
tissue was determined using standards made from 4-hydroxy-L-proline in assay buffer that 
ranged between 1 and 30 µg.ml-1. Specimens and standards were assayed in triplicate, in a 
clear flat bottomed 96 well plate at a volume of 50 µl per well. A volume of 100 µl of 
Chloramine T solution was added to the wells and the plate was placed on a shaker for 5 
minutes.  Finally a volume of 100 µl of Ehrlich’s reagent was added to the wells and left to 
incubate in a water bath for 45 minutes at 60°C with the plate lid on. Parafilm was used to 
secure the plate lid and to prevent water entering the plate. The absorbance of the specimens 
was read at 570 nm using a microplate reader and the unknown values were interpolated from 
the standard curve and multiplied by 7.14 to determine total collagen content. 
 
2.8.2 Glycosaminoglycan quantification assay for tissue 
It is possible to use the cationic dye 1, 9-dimethylmethylene blue to stain sulphated 
proteoglycans.  The interaction between the dye and sulphated glycosaminoglycans in 
cartilage tissue can be measured colorimetrically using a spectrophotometer allowing 
quantification of the glycosaminoglycans.  
2.8.2.1 Assay buffer 
To 137 ml of 0.1 M sodium di-hydrogen orthophosphate, 63 ml of 0.1 M di-sodium hydrogen 
orthophosphate was added and stirred until dissolved using a magnetic stirrer.  
2.8.2.2 Digestion buffer 
To 900 ml of phosphate buffered saline containing calcium and magnesium 0.788 g of L-
cysteine hydrochloride and 1.8612 g disodium ethylenediaminetetraacetic acid were dissolved 
using a magnetic stirrer bar. The pH of the solution was adjusted to 6.0-6.1 using sodium 
hydroxide or hydrochloric acid and increased to one litre using phosphate buffered saline 
containing calcium and magnesium. 
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2.8.2.3 Crude papain solution for tissue digestion 
Fifty units of crude papain were added into each 1 ml of digestion buffer required and 
dissolved by gentle inversion. 
2.8.2.4 DMB dye solution 
To 5 ml of ethanol, 2 ml of formic acid and 16 mg of 1, 9- dimethylene blue were added. Two 
grams of sodium formate were added to the solution and the solution was adjusted to pH 3 
using formic acid and increased to 1 litre using distilled water.  
Cartilage was cut from bone plugs using a scalpel blade and weighed. Between 50 and 80 mg 
of wet tissue from each specimen was lyophilised in a plastic bijou to a constant weight using a 
freeze dryer at -40°C. Lyophilised tissue specimens were added to 5 ml of papain digestion 
solution and placed in a 60oC incubator for 36-48 hours. Specimens were centrifuged at 1360 g 
for 5 minutes to sediment the papain particulate. The remaining supernatant was transferred 
to new bijous. Undegraded control samples were diluted 1/50 with assay buffer. All 
mechanically and enzymatically degraded samples were diluted 1 in 20 with assay buffer. 
Standards made from chondroitin sulphate B were prepared in the assay buffer that ranged 
from 0 µg.ml to 25 µg.ml-1. Digested tissues and standards were pipetted into a 96 well flat 
bottomed microplate in triplicate at a volume of 40 µl per well. To each 40 µl, 250 µl of DMB 
dye was added and the plate was placed on a shaker for two minutes. After two minutes the 
absorbance was measured at 525 nm using a microplate reader. A graph of absorbance was 
plotted against the standard concentrations and linear regression analysis was used to 
interpolate the unknowns from the standard curve. 
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2.9 Statistical analysis 
All numerical data was anlaysed using Graphpad Prism software version 5. All numerical values 
were expressed as average values ± 95% confidence limits so P values below 0.05 were 
considered as statistically significant (Sokal & Rohlf, 3rd edition). All data sets with more than 
two groups were analysed using a one way ANOVA with a Tukey’s multiple comparison post-
test aside from the data in Sections 3.42 and 3.43 which were analysed using a repeated 
measures ANOVA with a Tukey’s multiple comparison post-test. Data sets with two groups 
were analysed using a Student’s t test. 
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Chapter 3 
 
Development and Characterisation of a 
Mechanical Model of Cartilage Degradation  
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3.1 Introduction 
The purpose of the study undertaken in this chapter was to investigate the biotribology of 
cartilage tissue through the development of mechanical degradation models. Previously, many 
mechanically induced models of cartilage degeneration have focused on examining the 
chondrocyte response after cyclic, compressive or impact loading regimes (Farquhar et al., 
1996 ; Chen et al., 1999 ; Patwari et al., 2001 ; Thibault et al., 2002; Patwari et al., 2003). In 
contrast, this work aimed to produce a degradation model in which physiological contact 
stresses were used to produce damage in osteochondral tissues undergoing cartilage on 
cartilage contact. The purpose of this was to investigate the biotribological changes associated 
with degraded cartilage tissue including effects of degradation on friction and wear of the 
cartilage surface.  
  In order to assess how mechanical degradation processes affected the cartilage tissue, 
it was necessary to comprehensively characterise the tissue before degradation. Established 
methods that have previously been used to characterise cartilage tissue include histological 
staining and biochemical assays to quantify the glycosaminoglycan (GAG) and collagen content 
of the tissue (Lufti, 1975 ; Tesche and Miosge, 2004 ; Hoemann, 2004).  These methods do not 
allow a full investigation of the changes that may occur in cartilage tissue due to degradation. 
This is because they are broad and include groups of cartilage components such as 
“proteoglycans” rather than individual components such as aggrecan and small leucine rich 
proteoglycans.  
  To obtain a greater understanding of the effects of a range of mechanical degradation 
protocols on the tissue, it was necessary to develop a comprehensive range of methods to 
allow thorough comparisons between degraded and native tissues. Quantitative surface 
profilometry was used to complement environmental scanning electron microscopy which 
allowed visualisation of the cartilage surface. Deformation and recovery measurements were 
obtained to determine the response of the cartilage to static loading and measurements were 
recorded during mechanical degradation testing to determine how friction changed during 
dynamic loading protocols. In addition to this, histological stains such as H & E and biochemical 
assays for determining collagen and GAG content were used. Transmission electron 
microscopy was used in conjunction with cupromeronic blue staining to examine the structure 
of both aggregating and small proteoglycans within the tissue. Alcian blue staining was used so 
that GAGs could be visually assessed; complementing the biochemical GAG assay and TEM 
analysis. Finally, antibodies to biglycan, cartilage oligomeric matrix protein and collagen VI 
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were used to label cartilage tissue sections to reveal how mechanical degradation may have 
affected these components of the tissue. 
3.1.1 Biglycan 
Biglycan is a small leucine rich proteoglycan. The absence of biglycan from cartilage is thought 
to increase the rate of cartilage degeneration as shown in a study by Furukawa et al. (2011) 
These authors showed that loss of the “BGN” gene caused significantly increased rates of 
degeneration of murine intervertebral discs. During osteoarthritic degeneration, biglycan has 
been shown to become fragmented. It has been suggested that this is caused by catabolic 
enzymes in the diseased tissue (Melrose et al., 2008). Hence, biglycan fragmentation may have 
potential as a biomarker for osteoarthritic disease.  
  Biglycan has been shown to play a role in collagen fibrillogenesis in the mammalian 
uterus. Here, biglycan has been shown to be associated with thick collagen fibres, while 
decorin is associated with thin fibres, indicating distinctive roles for these two small leucine 
rich proteoglycans (SLRP) which may also extend to musculoskeletal tissues such as cartilage.  
3.1.2 Cartilage Oligomeric Matrix Protein 
Cartilage oligomeric matrix protein (COMP) has been reported to play a role in extracellular 
matrix assembly and matrix–matrix protein interactions in addition to interaction with 
fibronectin (Di Cesare et al., 2002). COMP has been shown to be an effective marker for 
osteoarthritic degeneration in patient serum and synovial fluid making it an interesting subject 
for a tribological study (Clark et al., 1999; Song et al, 2012). It was of interest to assess whether 
COMP was affected by in vitro mechanical degradation. 
3.1.3 Collagen VI 
As well as fulfilling a major role as a mediator of cell-matrix interaction and anchoring 
chondrocytes to the pericellular matrix, collagen VI has also been shown to be involved in cell 
signalling (Keene et al., 1988; Pfaff et al., 1993; Marcelino and Mcdevitt, 1995; Rühl et al., 
1999a). Collagen VI, which is found in relatively small amounts in cartilage, does not 
participate in the process of fibril formation, associated for example with collagens II and XI. 
Rather, it is the major component of the beaded filaments which are found in the majority of 
connective tissues, and in cartilage, in the pericellular environment that surrounds the 
chondrocytes (Keene et al., 1988; Soder et al., 2002). 
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   Investigating the effects of in vitro degradation on collagen VI is important as this 
collagen is not distinguished from others by the hydroxyproline assay. Additionally, because of 
the structural differences between collagen II and collagen VI it was of interest to determine 
whether this collagen was affected in a similar way to collagen II. It would also give an 
indication of the changes in structure taking place directly adjacent to chondrocytes during 
degeneration, which could contribute to changes in the mechanical loading experienced by 
cells in vivo. 
3.1.4 Mechanical Degradation Methodologies 
In order to replicate the biotribological condition of degenerated cartilage tissue in vitro, 
mechanical degradation methodologies were developed. Two physiological contact stresses 
were chosen as part of the degradation conditions which were designated “mild” and 
“moderate”. These two conditions were chosen to provide an insight into the tribological 
condition of cartilage tissue under two distinct degradative conditions. Contact stresses in 
human cartilage tissues vary widely and under dynamic movement such as deep flexion, they 
can reach up to 25 MPa.  Damage to cartilage is not only observed at high contacts stresses for 
example, chondrocyte death has been measured in impact studies at contact stresses as low as 
4 – 4.5 MPa (Hodge et al.,1986; Duda et al., 2001; Loening et al.,2000). The mild condition 
contact stress chosen for this study was 3.1 MPa. The moderate condition contact stress 
chosen was 7.5MPa.  Multidirectional motion was chosen to reflect the motion experienced by 
tissues in an articulating knee joint which includes a small amount of rotation. Finally the 
sliding distance that was chosen avoided unloading of the tissues in the rig for an unnatural 
length of time, while the sliding speed was chosen to increase boundary lubrication between 
specimens. 
3.1.5 Lubricants 
Two lubricants were chosen for the degradation regimes to allow an investigation of the 
effects of different lubricants on the cartilage tribology. Ringer’s solution was chosen due to its 
ability to keep cartilage hydrated and partly due to its simplicity making it easier to analyse. 
Ringer’s solution was formulated by Sydney Ringer in the 19th century. It is isotonic with bodily 
fluids and came to recognition after its ability to increase survival times of excised tissues was 
discovered. Ringer’s solution is a weak buffer due to its bicarbonate content. 
  A second lubricant was used as part of the degradation methodologies. It was 
composed of new born calf serum in phosphate buffered saline (PBS). Calf serum is used 
frequently in cell culture and has a complex list of components including growth factors, amino 
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acids, hormones, phospholipids and globular proteins including bovine serum albumin. It is not 
possible to define the exact composition of calf serum comprehensively due to variability 
between donor animals, which is influenced by many factors including diet and gender (Bryan 
et al., 2010). This study hypothesised that use of a second lubricant that included calf serum 
may lead to an interesting variation in results from those observed with Ringer’s solution 
lubricant. This is because components of the serum such as phospholipids have the potential 
to alter the friction between specimens and therefore could reduce tissue degradation (Forsey 
et al., 2006).  Additionally, as the work completed in this study has the potential to be 
developed, eventually resulting in a natural whole joint simulator in which living tissues may 
be used, use of a serum solution to maintain cell viability would be necessary in the latter 
system. 
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3.2 Aims and objectives 
The overall aim of this part of the study was to develop and characterise a mechanical model 
of cartilage degradation that replicated the tribological condition of degenerated cartilage. 
Native bovine cartilage tissues were compared with bovine cartilage tissues that had been 
subjected to mechanical degradation. The tissues were compared comprehensively using 
quantitative and qualitative methods. 
Objectives: 
 To develop a mechanical degradation methodology for bovine cartilage tissue and to 
record friction during testing using a pin on plate friction rig. 
 
 To assess the deformation and recovery of undegraded control cartilage tissue using 
static loading methodologies to determine whether loss of tissue height occurs due to 
loading alone. 
 
 To characterise the changes to the surface roughness of the bovine cartilage tissues 
post mechanical degradation using contact profilometry. 
 
 To use histological staining to assess the normal histoarchitecture and staining 
patterns of glycosaminoglycans in undegraded bovine cartilage tissue and 
mechanically degraded bovine cartilage tissues using haemotoxylin and eosin staining 
and alcian blue staining, respectively.  
 
 To determine the distribution of biglycan, cartilage oligomeric matrix protein (COMP) 
and collagen VI qualitatively in undegraded and mechanically degraded bovine 
cartilage tissues  
 
 To use environmental scanning microscopy to observe the undegraded and 
mechanically degraded bovine cartilage surface in a hydrated state. 
 
 To use transmission electron microscopy with cupromeronic blue dye to examine the 
bovine cartilage ultrastructure and GAG interactions in mechanically degraded and 
undegraded tissue. 
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 To quantitatively determine the glycosaminoglycan and collagen content of healthy 
and mechanically degraded bovine cartilage tissue. 
 
 To develop methods for quantitatively analysing collagen and GAG content in the 
lubricants generated during friction testing. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
89 
 
3.3 Experimental approach 
The experimental approach that was taken during this study has been summarised in Figure 
3.1. A total of six repeats were conducted for each loading condition in the static loading 
experiments. After the final measurements were taken the tissue was stored in the freezer at -
20⁰C for future use. Six repeats per condition were also performed for the surface roughness 
measurements. Six repeats per condition were taken for all the histological and 
immunohistological analysis, each pin was cut in half with one half being used for histology 
and one half being used for immunohistochemistry. Three repeats were taken for both 
microscopy techniques with one half of each pin used for ESEM analysis and one half used for 
TEM analysis. Finally six repeats were conducted for each condition to provide enough tissue 
for biochemical analysis. Each pin was cut in half with one half being used for the collagen 
analysis and one half being used for glycosaminoglycan analysis. 
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Transmission 
Electron 
Microscopy
(N=3)
Quantitative 
Biochemical 
Assays
(N=6)
Immuno
histochemistry
(N=6)
ESEM
(N=3)
Static Loading
(N=6)
Osteochondral pins were dissected and stored for use in mechanical degradation protocols
Mechanical characterisation techniques Biological characterisation techniques
Histology
(N=6)
Osteochondral pins were
mechanically degraded under mild
and moderate conditions.
The cartilage was cut from the bone,
embedded and sectioned using a
cryotome.
Tissue was stained for biglycan,
COMP or collagen VI using
antibodies.
Osteochondral pins were
mechanically degraded under mild
and moderate conditions.
The cartilage tissue was cut from the
bone and dissected into a
rectangular shape. The tissue was
stained with cupromeronic blue and
sectioned. Undigested control tissue
was taken in chapter two.
The tissue was stained with
cupromeronic blue and sectioned.
Osteochondral pins were
mechanically degraded under
mild and moderate conditions
and the lubricant was collected .
Sections were stained with H & E
or alcian blue.
Osteochondral pins were
mechanically degraded under
mild and moderate conditions.
The pin was processed for
histological staining and was
bisected after decalcification then
sectioned.
The cartilage was cut from the
bone, lyophilised and processed
as required. The lubricant was
quantified and processed as
required.
Osteochondral pins were
mechanically degraded under
mild and moderate conditions.
Pins were viewed immediately 
using environmental scanning 
electron microscopy
Mechanical 
Degradation
Surface 
Roughness
(N=6)
After each mechanical protocol
degradation, silicone rubber
replicating compound was used to
take a mould of the cartilage surface.
Replicas were also taken after 24 and
48 hours of recovery.
The surface roughness of replicas was
determined using a surface
profilometer.
Osteochondral pin and plate
specimens were loaded statically for 6
hours using the loads used in the mild
and moderate degradation protocols.
Osteochondral pin and plate
specimens were dissected from the
medial condyles and medial patella
grooves of bovine femurs,
respectively.
The cartilage height of pins and the
plate heights were recorded.
The friction between osteochondral pin and plate was recorded
during the degradation protocol (N=6).
Osteochondral pin and plate specimens were
dissected from the medial condyles and medial
patella grooves of bovine femurs, respectively.
Osteochondral pin and plate from two different femurs
articulated for 6 hours in Ringer’s solution or serum lubricant
under mild or moderate conditions.
The cartilage height of pins and the
plate heights were recorded again.
Hydroxyproline or GAG assay
was conducted.
 
Figure 3.1. The experimental approach taken in the research described in chapter three, which focused on the effects of mechanical degradation on cartilage 
specimens.  The image includes characterisation techniques that were used to analyse specimens and the number of replicates. 
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3.4 Methods 
3.4.1 Lubricants for Mechanical Degradation Regimes 
Ringer’s solution and newborn calf serum 25% (v/v) in PBS (serum lubricant) were used as 
lubricants and for irrigation of osteochondral tissues during mechanical degradation. Ringer’s 
solution has previously been described (Section 2.2.1.5).  The formula of the Ringer’s solution 
used in this study is shown in Table 3.1. 
Table 3.1 The specific composition of the Ringer’s solution used in this study. 
Formula Grams Per Litre 
Sodium chloride 2.25 
Potassium chloride 0.105 
Calcium chloride (6H2O) 0.12 
Sodium bicarbonate 0.05 
pH 7  
 
3.4.1.1 Serum Lubricant 
To 25ml of new born calf serum, 50 ml of PBS (Section 2.2.4.4) was added and mixed by gentle 
inversion. The pH of the solution was adjusted to pH 7 using 1 M HCl or 1 M sodium hydroxide 
solution. The solution was topped up to 100 ml with PBS. 
3.4.2 Mechanical degradation of cartilage using a multidirectional pin on 
plate rig  
A single station multidirectional pin on plate friction rig was designed and manufactured in the 
School of Mechanical Engineering at the University of Leeds, UK (Figure 3.2). Osteochondral 
plates (Section 2.4) were clamped between two opposing stainless steel plates, one of which 
had a window cut into it in order that the cartilage face of the osteochondral plate was 
exposed. The opposing steel plates locked the osteochondral plate in place and were held 
together with plate screws. The plates were fixed into a bath using bath screws. The bath itself 
was attached securely to the reciprocating plate of the friction rig with clamp screws (Figure 
3.3). The various components and equipment required to set up the pin on plate rig are shown 
in Figure 3.4. A bath was attached to the reciprocating stage and 14ml of lubricant was added 
to the bath using a syringe. The osteochondral plug (Section 2.4) was placed into the collet 
with a stainless steel spacer (approximately 7 mm in height) behind it before being placed into 
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the pin holder and secured with a screw. Care was taken to ensure that at least 5 mm in total 
of cartilage and bone were left to protrude from the pin holder/collet to prevent the pin 
holder rubbing against the upper opposing plate during testing.   
 
 
 
 
 
 
 
 
 
 
 
The pin holder was slotted through the bridge of the rig so that the cartilage of the 
osteochondral pin was contacting the cartilage of the osteochondral plate. Bearings were 
placed on the top of the pin holder and the loading arm was lowered to contact the bearings. 
The spirit level was used to check that the loading arm was horizontal when contacting the pin 
holder (Figure 3.4). The motor and a charge amplifier were switched on. A weight was placed 
onto the loading arm as the test began. The stage reciprocated over a distance of 9 mm (stroke 
length) at 4 mm.s-1 for a total of 6 hours. Three different conditions were used, outlined in 
Table 3.2. Six repeats were conducted for each condition. 
  The piezoelectric sensor attached to the bridge of the rig detected the frictional force 
between the pin and plate which was converted to volts by a data aquisition unit. The voltage 
was relayed to the charge meter. The forces were recorded by a data acquisition unit and 
stored on the connected personal computer. The voltages were recorded using Labview 9 
software. The co-efficient of friction was calculated from the recorded voltages via a 
calibration curve. 
 
Loading arm
MotorReciprocating stage
Piezoelectric sensor
Weight
Charge meterBridge
 
Figure 3.2. The single station multidirectional pin on plate friction rig. 
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Bath
Opposing stainless 
Steel plates
Plate screw 
Bath screw Clamp screw
 
Figure 3.3. Friction rig components; plate clamp and bath. The components that were used 
to clamp the osteochondral plate in place on the friction rig. The bath was subsequently 
screwed to the reciprocating stage of the friction rig. 
 
Collet
Allen keys Spirit level Ball bearings
Screws
Bath
Pin holderOpposing platesSpacer
 
Figure 3.4. Equipment and components required for friction rig assembly. 
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Table 3.2 The different conditions used to generate mechanical degradation in cartilage 
specimens. 
 
3.4.2.1 Calibration 
Calibration was performed so that accurate friction values could be calculated from the 
recorded voltages taken from the pin on plate friction rig. To calibrate the rig, the pin holder 
was suspended in the bridge of the rig. A cotton thread with a loop on one end was looped 
around the base of the pin holder, laid around the wheel and hung vertically with the weight 
holder attached to the bottom of the thread (Figure 3.5). 
  Each weight used for the calibration was weighed three times and labelled before the 
calibration began and the charge meter was turned on. The mean value of the three weight 
measurements was used as the actual true weight of each weight. When the test had begun, 
one weight was added to the weight holder every 80 seconds up to a total of 8 weights. One 
weight was then removed again every 80 seconds until only the weight holder remained. The 
programme was set to take 4 measurements during the 80 second period. The calibration was 
repeated three times sequentially. As weights were added and removed, care was taken to 
keep the movement of the thread to a minimum during the reading to prevent inaccuracies in 
measurements. A calibration curve was produced from the readings of average voltage against 
weight in Newtons, which allowed the coefficient of friction to be calculated. 
 
 
 
 
Condition Load (N) Contact Stress (MPa) Lubricant 
Mild 200 3.1 Ringer’s solution 
Moderate 478 7.5 Ringer’s solution 
Moderate serum 478 7.5 25% (v/v) Calf serum in PBS 
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3.4.3 Static loading and deformation assessment of native cartilage 
A six station wear rig and single station multidirectional pin on plate friction rig was used to 
assess the permanent deformation of the cartilage tissue via static loading of the tissue. This 
was primarily carried out to determine whether any permanent deformation occurring during 
mechanical degradation was caused by loading rather than tissue loss. If no loss of height was 
observed after static loading, any post degradation loss of tissue height could be attributed to 
tissue degradation alone. A single station rig was used for moderate condition static loading 
since the six station rig was not able to take a load of 478 N. Details on the set up and use of 
the single station multidirectional have previously been described in Section 3.4.2. A six station 
wear rig was used for mild condition static loading, which allowed simultaneous loading of six 
pin and plate pairs. 
Thread Weights
Weight holder
Wheel
Clamp
Pin holder Metal ring
 
Figure 3.5. Calibration of the single station multidirectional pin on plate friction rig. A. The 
pin holder is suspended in the bridge using a metal ring. A wheel is clamped to the rig. B. A 
thread is looped around the base of the pin holder then around the groove of the wheel 
before being allowed to hang vertically with the weight holder at the bottom of it. 
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3.4.3.1 The six station multi-directional wear rig 
 The six station multidirectional pin on plate rig was designed and manufactured in the School 
of Mechanical Engineering at The University of Leeds, UK. The components required for setting 
up static loading of the six station rig are displayed in Figure 3.6. 
  To set up static loading conditions, bath inserts were placed into the bath wells and 
the CoCr plate was secured inside using screws. The well was placed onto the reciprocating 
stage and attached to the motor using the connecting rods to prevent movement of the stage 
(Figure 3.7A). An osteochondral plate was then placed onto the CoCr plate. The osteochondral 
pin was placed inside a small collet, which as then secured into the large collet. A spacer was 
placed behind the pin within the small collet (Figure 3.7B). A threaded nut was screwed into 
the large collet/ outer sleeve assembly to secure the pin in place. The bridge sections were 
placed onto the rig and the large collet/ outer sleeve assembly was slotted into the bridge. The 
setup was secured in place using clamps (Figure 3.8). Contact between the cartilage of the pin 
and plate was ensured by adjusting the plate position if necessary. A cantilever arm was placed 
into the bracket on the rig and secured with a pin. The ball bearings were placed onto the 
threaded nut. A spirit level was used to check that the lowered arm was horizontal and the 
weights (200 N) were placed onto the loading arms to produce a contact stress of 3.1 MPa 
between the pin and plate interface (Figure 3.9). The loading period was for 6 hours to 
replicate the loading time in the dynamic degradation protocol.  
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Figure 3.7. The plate set up and pin holding assembly. A. The bath well, bath insert and plate 
were assembled before being placed onto the reciprocating stage. The assembly was then 
secured with the connecting rod.  B. The osteochondral pin was placed inside the set up 
shown with the cartilage surface protruding. 
Lead weight Bridge
Screws
Bath well
Bath insert
CoCr plate
Connecting rod
Large collet Outer sleeve
Threaded nut Ball bearingsPinSmall collet & 
spacer 
 
Figure 3.6. One of six sets of small components for the six station multidirectional wear rig.  
A B 
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Figure 3.9. Complete assembly of the six station wear rig. 
Clamp
Bridge
 
Figure 3.8. Small component assembly on the rig. The bridges were put in place and secured 
using a clamp. The pin assembly was slotted through the bridge and the ball bearings were 
placed on top. 
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3.4.3.2 Deformation and Recovery Tests 
To assess changes to cartilage height, a Nikon profile projector was used to measure the 
cartilage height before loading, directly after loading, after 24 hours recovery from loading and 
after 48 hours of recovery from loading. The Nikon profile projector was to measure the 
cartilage height at six points around the circumference of the osteochondral pin. The pins were 
placed on the specimen platform of the profile projector. The image of the pins on the 
platform was projected onto a viewing screen which had a set of axis marked on it. The bone-
cartilage interface on the osteochondral pin was lined up with the y line on the axis, the 
specimen platform was then adjusted so that the Y axis line was lined up with the surface of 
the cartilage tissue. The movement of the platform from the base of the cartilage to the 
surface was measured by the profile projector in millimetres which allowed the height of the 
cartilage to be measured. To allow each pin to recover post loading, the pin was placed in a 5 
ml bijou containing tissue paper soaked in Ringer’s solution and stored 4°C. The measurements 
on the pin were taken at 6 points around the pin circumference that were approximately 
equidistant.   
  Plates were measured using a TRIMOS Vernier height gauge with a dial indicator 
attached purchased from Draper Expert Middlesex, UK. Three equidistant measurements were 
taken horizontally across the centre of the pin on plate contact area. The height gauge had a 
resolution of 1 µm and the dial indicator had a resolution of 10 µm.  
3.4.4 Silicon Mould Surface Replication for Surface Roughness 
Measurement 
3.4.4.1 Rationale 
Silicon rubber replicas were taken of cartilage specimens post mechanical degradation, after 
24 hours of recovery and then again after 48 hours of recovery. The moulds allowed the 
surface roughness (Ra) of the cartilage surface to be determined using surface profilometry. 
Replicas of the specimens were taken as a permanent record of the specimens’ features, which 
allowed the Ra to be determined at a later date. If measurements had been taken on the 
tissue specimens it would have resulted in specimens becoming extensively dried, rendering 
them useless for further analysis.  
  A 50 ml Microset system was used to produce the replicas (Figure 3.10). Synthetic 
rubber replicating compound 101Rf, was used to accurately replicate microstructures on the 
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cartilage surface. A Talysurf Ultra PGI800 from Taylor & Hobson, UK was used to take Ra 
measurements on the replicas.  
 The Ra is a surface roughness parameter that is defined as the arithmetic mean of 
absolute departures of the roughness profile from the mean line. After the trace had been 
taken the data was fitted to a line and a Gaussian filter was used to separate the waviness 
from the surface roughness. The use of this method allowed a quantitative value of roughness 
to be obtained to complement ESEM studies of the cartilage surface. 
 
 
 
 
 
 
 
 
 
 
 
3.4.4.2 Calibration 
The Talysurf calibration was completed at the beginning and the end of every session. A 
roughness standard was used to calibrate the machine (Figure 3.11). The stylus was positioned 
to measure the 0.8 µm line on the standard which resulted in a typical calibration trace and an 
Ra of approximately 0.8 µm if the tip was functioning correctly (Figure 3.12). Calibration 
analysis was completed with a least squares line fit, a Gaussian filter with an upper cut off of 
0.8 mm and lower cut off of 8 µm. 
 
 
Nozzle Plate Mould
Pin MouldCartridgeSilicone Gun
 
Figure 3.10.  Microset system equipment and replicas. A. The rubber replicating compound 
was applied to the cartilage surface from the cartridge in the dispensing gun with the nozzle 
attached. B. The pin and plate moulds after curing was complete. 
A B 
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Figure 3.11. The calibration standard for the Talysurf. Calibration of the machine with the 
right hand square is carried out before and after each session to confirm that no damage had 
taken place to the stylus ensuring correct results are recorded. 
 
Figure 3.12. A typical calibration trace. Aside from the requirement of an Ra of 0.8, the 
calibration trace pattern itself was required to appear as in the one shown above with the 
characteristic “left toe”, one of which is circled on the trace.  
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3.4.4.3 Method 
The specimens were removed from the friction rig and rinsed briefly in Ringer’s solution. 
Specimens were then allowed to air dry for two minutes before the liquid silicone rubber was 
applied to their surface using the dispensing gun and allowed to cure. Once the silicone rubber 
had set the moulds were peeled from the cartilage specimens and stored in individual plastic 
pots at room temperature. 
  Talysurf measurements were taken as follows; a diamond tip with a radius of 2.5µm 
was used to take traces across the replica surface at 5mm/sec with an applied force on the tip 
of 0.85 mN (Figure 3.13). As the stylus transversed the replica, vertical movements along the Z 
axis were recorded as electronic signals which were converted to digital measurements that 
were used to construct a roughness profile. Analysis of the traces was completed using a 
Taylor Hobson Ultra software package. Traces were fitted to a least squares line to remove 
underlying geometries and put through a Gaussian filter with an upper cut off of 0.25 mm and 
lower cut off of 2.5 µm. 
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3.4.5 Histological assessment of mechanically degraded cartilage tissues 
Specimens were visualised using H & E staining and alcian blue staining as described in sections 
2.6.1 and 2.6.2, respectively. 
3.4.6 Immunohistological assessment of mechanically degraded cartilage 
tissues 
Immunohistochemical staining for biglycan, collagen VI and cartilage oligomeric matrix protein 
was carried out as described in section 2.6.3. 
 
 
Figure 3.13. Trace map for cartilage pin and plate replicas. A. Arrows labelled in red indicate 
traces performed. The P1 trace was used as an undegraded control measurement. The blue 
line indicates the wear scar which was 18 mm by 9 mm. B. Pin traces are shown in red. Pin 
diameter was 9 mm. The traces are perpendicular to each other and are 8 mm in length. 
Diagram is not to scale. 
A 
B 
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3.4.7 Environmental scanning electron microscopy of the mechanically 
degraded cartilage surface 
Scanning electron microscopy was used to assess the alterations to the cartilage surface after 
mechanical degradation (Section 2.7.1)  
3.4.8 Transmission electron microscopy analysis of mechanically 
degraded cartilage tissue 
Ultrastructural changes to the cartilage tissue were assessed using cupromeronic blue staining 
with transmission electron microscopy previously described in section 2.7.2.  
3.4.9 Quantitative biochemical analysis of degraded cartilage tissue 
Quantitative biochemical assays for glycosaminoglycans (Section 2.8.2) and collagen (Section 
2.8.1) were carried out to assess whether loss of either of these components from the tissue 
had occurred during mechanical degradation. 
 
3.4.10 Quantitative analysis of collagen in lubricants recovered after 
mechanical degradation of cartilage specimens 
3.4.10.1 Rationale 
There is potential in the future for the mechanical model developed and characterised here to 
be developed into a more complex whole joint simulator model. In a more complex model 
with extended test times it would be useful to assess the damage to the tissues in the model 
by analysing the lubricating fluid. With this in mind, the hydroxyproline and glycosaminoglycan 
assays for tissue (Sections 2.8.1 and 2.8.2 respectively) were developed for use with the 
lubricants generated during mechanical degradation. Due to the low concentration of collagen 
and glycosaminoglycans in the lubricants taken from the bath post mechanical degradation 
(Section 3.4), both the hydroxyproline and glycosaminoglycan assays had to be developed for 
use with fluids containing small concentrations of these components. In recognition of the 
differences between the Ringer’s solution based lubricant and the serum based lubricant, the 
assays were optimised separately for each of the lubricants. 
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3.4.10.2 Quantitative analysis of collagen in Ringer’s solution based lubricants; development 
steps 
3.4.10.2.1 Sample concentration 
To concentrate the collagen in the Ringer’s solution lubricants, 1 ml of each mild and moderate 
lubricant (n=6 per condition) was pipetted into a sterile glass test tube and evaporated 
overnight in a dry heat block at 60°C. The dried lubricants were then placed upright in the 
freeze dryer to remove any remaining water.  
3.4.10.2.2 Determination of dilution factor  
Before samples were assayed they were diluted in assay buffer. The 1 in 50 dilution factor used 
for tissue specimens (Section 2.8.1) was too large for the lubricants as it would have resulted in 
over dilution. In order to prevent over dilution of the samples, a lower dilution factor was 
investigated. 
  A range of concentrations of hydroxyproline (standards) were diluted in Ringer’s 
solution then hydrolysed and neutralised to create replicas of lubricant samples with known 
hydroxyproline concentrations (Section 2.8.1). This range of standards was made so that the 
standards were double the concentration of the normal range of standards. This was so that 
when they were diluted in assay buffer they would become the same concentration as the 
standards in assay buffer alone. The hydrolysed standards in Ringer’s solution were diluted 1:1 
with assay buffer and the hydroxyproline assay was carried out as in Section 2.8.1. The 
absorbance readings for both sets of standards were similar and it was concluded that a one to 
one dilution of specimens with assay buffer could be used in future experiments (Figure 3.14). 
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3.4.10.2.3 Determination of acid volume 
In the hydroxyproline assay for tissue 5 ml of 6 M HCl was used to hydrolyse each 15 mg of 
tissue (dry weight) therefore it was reasoned that 2.5ml of 6 M HCL would be suitable for 
hydrolysing tissue volumes that were less than 7 mg. Six 1 ml samples of lubricant and five 1 ml 
samples of Ringer’s solution were dried and lyophilised. It was found that the major proportion 
of the dry weight of the lubricants, was made up of the salts from the Ringer’s solution (Table 
3.3) and on average, less than 0.3 mg of tissue was present in each millilitre of the lubricant. 
Therefore 2.5 ml of 6 M HCL would be suitable for effective hydrolysis of 1 ml of Ringer’s 
solution lubricant.   
  After the Ringer’s solution lubricant samples had been assayed for collagen, it was 
found that the mild condition Ringer’s solution lubricants required further concentration as 
the absorbances were close to the lowest standard on the standard curve. To further reduce 
the dilution of the mild lubricants use of a lower volume of acid could be used to hydrolyse the 
mild specimens was assessed.  
 
Figure 3.14. Standards diluted in assay buffer and standards diluted one to one with assay 
buffer and neutralised hydrolysed Ringer’s solution. Black circles represent standards 
diluted in assay buffer. Green triangles represent known concentrations of hydroxyproline in 
neutralised hydrolysed Ringer’s solution diluted one to one with assay buffer.  Data is 
presented as the mean (n=3) ±95% confidence limits. 
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 Mild Ringer’s solution lubricant samples (n=3) were dried, and lyophilised. The samples were 
then hydrolysed with either 0.5 ml 6 M HCL or 2.5 ml of 6 M HCL. The hydroxyproline assay 
was then carried out on the samples as described in Section 2.8.1. There was no difference in 
collagen content of the lubricants indicating that 0.5 ml of 6 M HCL was sufficient to hydrolyse 
the mild Ringer’s lubricants as effectively as 2.5 ml of 6 M HCl (Figure 3.15). 
Table 3.3 The post lyophilisation weights of 1ml of moderate Ringer’s solution lubricant and 
Ringer’s solution. 
Sample Lyophilised moderate condition 
Ringer’s lubricant (mg). 
Lyophilised Ringer’s solution  
(mg). 
1 9.9 10.7 
2 9.2 9.6 
3 10.6 9.9 
4 11.2 8.8 
5 9.1 9.6 
Average 10.0 9.72 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.15. Effect of acid volume on mild lubricant hydrolysis prior to using the 
hydroxyproline assay. The results indicated that 0.5ml of 6M hydrochloric acid was suitable 
for digestion of 1ml of lyophilised mild Ringer’s solution lubricant. Data is presented as the 
mean (n=3) ± 95% confidence limits. 
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3.4.10.3 Quantitative analysis of collagen in Ringer’s solution based lubricants generated 
during mechanical degradation regimes 
All reagents used in the assay have been previously described in Chapter 2, Section 2.8.1. Post 
mechanical degradation, the lubricant bathing the cartilage specimens in the bath was 
collected and quantified. The lubricant was aliquoted into 1 ml fractions and stored at -25°C 
until use. To determine the collagen content of the lubricant, 1 ml of each lubricant was 
pipetted into a test tube and evaporated overnight in a dry heat bath at 60°C. The specimens 
were then lyophilised using a freeze dryer until specimen weights stabilised. To the moderate 
condition Ringer’s solution lubricants, 2.5 ml of 6 M hydrochloric acid was added. To the mild 
condition Ringer’s solution lubricants, 0.5 ml of 6 M hydrochloric acid was added. The samples 
were hydrolysed for 4 hours in a bench top autoclave at 121°C, followed by neutralisation with 
sodium hydroxide solutions that ranged between 12 M and 0.1M. The volume of each sample 
after neutralisation was quantified and recorded. The neutralised samples were diluted 1 in 2 
with assay buffer and 50 µl of each sample, along with a range of hydroxyproline standards, 
was pipetted into a 96 well flat bottomed microplate in triplicate. Standards were composed of 
trans-4-hydroxy-L-proline in assay buffer at a range of 0-15 µg.ml-1. Chloramine T solution (100 
µl) was added to each of the standards and specimens and the plate was placed on a shaker 
for 5 minutes. Ehrlich’s reagent (100 µl) was then added to the wells and incubated for 45 
minutes at 60°C in a waterbath with the plate lid on. Parafilm was used to secure the lid onto 
the plate and to prevent water entering the plate. The absorbance was read at 570 nm using a 
plate reader and the unknown values were interpolated from the standard curve. 
3.4.10.4 Collagen quantification assay for serum lubricants 
Lubricant specimens containing serum were found to undergo caramalisation during acid 
hydrolysis. It was postulated that the caramelisation was caused by a chemical reaction known 
as the Maillard reaction between sugars and proteins in both the degradation products and 
serum. Various methodologies were examined before guanidine extraction was considered 
including pepsin digestion of cartilage tissues followed by a colorimetric assay using a Sircol kit. 
Guanidine extraction has been used previously for proteoglycan extraction in many studies 
(Stanton and Fosang, 2002; Bateman et al, 2010). The theory behind the decision to trial this 
technique lay in the principle that removal of sugars from the lubricants through removal of 
glycosaminoglycans would prevent the caramelisation reaction occurring. During this study 
there was insufficient time to complete the development of the hydroxyproline assay for 
serum lubricants. However it was determined that if cartilage was guanidine extracted for 48 
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hours before the acid hydrolysis step of the hydroxyproline assay, caramelisation was 
prevented. 
3.4.11 Quantitative analysis of glycosaminoglycans in lubricants 
recovered after mechanical degradation of cartilage specimens 
 
3.4.11.1 Quantitative analysis of glycosaminoglycans in Ringer’s solution based lubricants; 
development steps 
Several development steps were necessary to allow the GAG content of lubricants to be 
quantified. This was partly due to their low concentration, in addition to other factors 
including impurities in the papain used for digestion that caused problems with the 
absorbance readings during the assay. 
3.4.11.1.1 Sample concentration 
To concentrate the glycosaminoglycan content in the Ringer’s solution lubricants, 1 ml of each 
lubricant was pipetted into a 2 ml eppendorf and then evaporated overnight in a dry heat 
block at 60°C. The dried lubricants were then placed in the freeze dryer for approximately 24 
hours to remove any remaining water content. When the weights of the samples remained 
stable they were removed from the freeze dryer and digested using papain as described in 
Chapter 2 Section 2.8.2. 
3.4.11.1.2  Papain source  
When tissues were analysed using the GAG assay, crude papain was used during the digestion 
step (Section 2.8.2). The papain enzyme is extracted from papaya fruit and in its crude version 
contains contaminants and fibrous material that is not removed during its preparation. When 
lubricants that had been digested with crude papain were assayed with the dimethylene blue 
dye, the dye turned a yellow/ green colour rather than blue/ pink which resulted in abnormal 
absorbance readings. This was due to the presence of contaminants in the crude papain used 
for digestion. To reduce contamination pure papain was used. Pure papain has contaminating 
particulate matter removed from it resulting in a pure powder with a high concentration of 
enzyme. This resulted in cleaner digests that did not contain a large amount of particulate 
contamination. As a result of this, digested lubricant solutions could be diluted less prior to 
being assayed using DMB.  
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3.4.11.1.3 Dilution factor investigation 
Before the digested samples were assayed in a 96 well plate, they were diluted with assay 
buffer. Reduced dilution factor volumes were investigated to prevent unnecessary dilution of 
the lubricants that contained low concentrations of GAGs.  A range of concentrations of 
chondroitin sulphate were diluted in Ringer’s solution then digested using 50 U.ml-1 pure 
papain, to create replicas of lubricant samples with known glycosaminoglycan concentrations. 
These samples were then assayed as described in Section 2.8.2 against standards diluted in 
assay buffer alone. The absorbances for the samples that had not been diluted with assay 
buffer were significantly lower than those in assay buffer. This indicated that dilution in assay 
buffer was required for samples to allow accurate absorbance readings to be recorded (Figure 
3.16).  
    
 
 
 
 
 
 
 
 
 
 
Following this the chondroitin sulphate samples that had been digested with pure papain in 
digestion buffer were diluted one to one in assay buffer and compared to standards in assay 
buffer alone (Figure 3.17). The samples diluted one to one with assay buffer did not have a 
statistically different absorbance to the standards of the same concentration in assay buffer 
alone. This showed that dilution of digested lubricants one to one with assay buffer before 
assaying was acceptable as it allowed the standard absorbances and the sample absorbances 
to be comparable.  
 
Figure 3.16. The absorbance profile of standards diluted in assay buffer and chondroitin 
sulphate in Ringer’s solution that has been digested with 50 U.ml of pure papain. Green 
triangles represent digested standards in Ringer’s solution that were not diluted in assay 
buffer. Black circles represent standards in assay buffer. Data is presented as the mean (n=3) 
± 95% confidence limits. 
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3.4.11.1.3 Optimising pure papain concentration for lubricant digestion 
To determine whether the concentration of papain used to digest lubricant samples could be 
reduced, moderate lubricant samples (n=6) were digested with 30, 40 or 50 U.ml-1 of pure 
papain and assayed using the DMB assay. The GAG content of the lubricants did not differ for 
samples digested with the different concentrations of papain (Figure 3.18). In light of this 
40µg.ml-1 concentration was chosen for future studies. 
 
 
 
 
 
 
 
 
 
Figure 3.17. The absorbance profile of standards diluted in assay buffer and digested 
standards in Ringer’s solution diluted one to one with assay buffer. Green triangles represent 
digested standards diluted one to one with assay buffer. Black circles represent standards in 
assay buffer. Data is presented as the mean (n=3) ± 95% confidence limits. 
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3.4.11.1.4 Digestion buffer volume  
In the final development step, a smaller volume of digestion fluid was investigated for 
digestion of lubricant samples. One millilitre aliquots of moderate condition Ringer’s solution 
lubricant were digested with 0.5 ml, 1 ml, 2 ml or 3 ml of 40 U.ml-1 pure papain digestion 
solution (Figure 3.19).  
  There was no significant difference between the GAG content of lubricant digested 
with 0.5 ml, 1 ml and 2 ml of 40 U.ml-1 digestion solution. However, a significantly lower GAG 
concentration was recorded when a 3ml digestion solution volume was used. Therefore, it was 
determined that 0.5 ml of 40 U.ml-1 pure papain digestion solution was sufficient to digest 1 ml 
of lyophilised moderate Ringer’s solution lubricant so 0.5ml of digestion solution was used for 
future experiments.  
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Figure 3.18. Effect of papain concentration on lubricant digestion. There was no significant 
difference found in the GAG concentration of specimens digested with the different papain 
concentrations (One way ANOVA, P > 0.05). Data is presented as the mean (n=6) ± 95% 
confidence limits. 
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The changes described above resulted in the successful quantitation of low GAG 
concentrations in the mild and moderate condition Ringer’s solution lubricants.  
3.4.11.2 Quantitative analysis of glycosaminoglycan in Ringer’s solution based lubricants 
generated during mechanical degradation regimes 
3.4.11.2.1 Pure papain digestion solution  
To each 1 ml of digestion buffer, 40 units of pure papain were added and dissolved using 
gentle inversion by hand. The remaining solutions used in this protocol have previously been 
described in Chapter 2, Section 2.8.2. 
After mechanical degradation was complete, the lubricant bathing the cartilage specimens was 
collected and the total volume was quantified before being aliquoted into 1 ml fractions and 
frozen at 25°C. Before use, the lubricant aliquots were defrosted at room temperature. To 
assay, the Ringer’s lubricants were aliquoted into 2 ml eppendorfs at a volume of 1 ml and 
placed into a dry heat bath at 60°C overnight to evaporate. Specimens were then lyophilised 
**
**
**
 
 
Figure 3.19. Effect of digestion buffer volume for lubricant digestion. It was determined that 
0.5 ml of 40 µg.ml of pure papain in digestion buffer was sufficient for complete digestion of 
moderate Ringer’s solution lubricant. Asterisks represent a P value of P ≤ 0.01 determined by 
one way ANOVA. Data is presented as the mean (n=3) ± 95% confidence limits. 
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until they reached a stable weight.  To each of the samples, 0.5 ml of 40 U.ml pure papain 
solution was added. The specimens were incubated at 60°C for 36 hours then centrifuged for 
40 seconds at 1360 G in a minifuge. The supernatant was removed into a clean eppendorf. A 
range of standards (3.125 to 25 µg.ml-1) were made up using chondroitin sulphate B in assay 
buffer. Standards below 3.125 µg.ml-1 were not suitable for this assay due to non-linearity in 
the standard curve below this concentration.  Before assaying, the mild condition samples 
were diluted 1 in 2 with assay buffer. The moderate samples were diluted 1 in 7 with assay 
buffer and 40 µl of each specimen and standard was pipetted into a 96 well flat bottomed 
microplate in triplicate.  To each specimen and standard, 250 µl of DMB dye was added using 
an automatic pipette and the plate was placed on a shaker at 100 rpm. After two minutes the 
absorbance was determined using a microplate spectrophotometer at 525 nm. A graph of 
absorbance was plotted against the standard concentrations allowing linear regression analysis 
to be used to interpolate the unknowns from the standard curve. 
3.4.11.3 Quantitative analysis of glycosaminoglycan in serum based lubricants generated 
during mechanical degradation regimes 
Not all of the development steps that were suitable for assaying glycosaminoglycans in the 
Ringer’s solution lubricants were  suitable for the serum based lubricant. Unlike Ringer’s 
solution lubricant, serum lubricant was not evaporated and lyophilised prior to digestion. This 
was due to the formation of an unsoluble film around the inside of the eppendorf after 
evaporation of serum lubricant. The film prevented complete digestion of the lubricant 
because large particles of the film were still visible after digestion.  
3.4.11.3.1 Dilution Factor Investigation 
As with the Ringer’s solution lubricants, dilution experiments were conducted with the serum 
lubricants to determine the effects of low dilutions on absorbance readings.   A set of 
chondroitin sulphate concentrations in 25% (v/v) serum in PBS were digested using 60 U.ml-1 
pure papain in digestion buffer: 1 ml of each concentration was added to 1ml of pure papain in 
digestion buffer. The final concentration of the pure papain in the digestion was therefore 30 
U.ml-1. The samples were then diluted one in five in assay buffer and compared to standards in 
assay buffer. There was no difference in absorbance of the standards so it was concluded that 
a one in ten dilution of digested serum lubricant samples with assay buffer before assaying 
was appropriate (Figure 3.20).  
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3.4.11.3.2 Papain concentration optimisation  
Finally, it was determined whether a lower concentration of papain could be used to digest 
serum lubricant samples. The starting concentration for the previous serum lubricant digests 
had been 60 U.ml-1 so 60 U.ml-1 was compared with 40 U.ml-1. Serum lubricants were digested 
with either 60 U.ml-1 or 40 U.ml-1 pure papain in digestion buffer and the total GAG content of 
the lubricants was compared (Figure 3.21). As there was no significant difference between the 
two values, 40 U.ml-1 of pure papain was used for subsequent assays. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.20. The absorbance profile of standards diluted in assay buffer and standards diluted 
one in five with assay buffer. Black circles represent standards diluted in assay buffer. Green 
triangles represent standards in digested lubricant diluted one in five with assay buffer. Data is 
presented as the mean (n=3) ± 95% confidence limits. 
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3.4.11.4 Quantitative analysis of glycosaminoglycan in serum based lubricants generated 
during mechanical degradation regimes. 
To 1 ml of each serum lubricant sample, 1ml of 40 U.ml pure papain solution was added. The 
specimens were incubated at 60°C for 36 hours then centrifuged for 40 seconds at 1360 G in a 
minifuge. The supernatant was removed into a clean eppendorf. The supernatant was diluted 
1 in 5 with assay buffer. A 40 µl volume of each sample and standard were pipetted into a 96 
well flat bottomed microplate in triplicate. To each 40µl in the plate, 250 µl of DMB dye was 
added and the plate was placed on a shaker at 100 rpm. After two minutes the absorbance 
was determined using a microplate spectrophotometer at 525nm. A graph of absorbance was 
plotted against the standard concentrations allowing linear regression analysis to be used to 
interpolate the unknowns from the standard curve. 
 
 
  
 
Figure 3.21. Effect of pure papain concentration for serum lubricant digestion. It was 
concluded that a 40 µg.ml-1 pure papain concentration was suitable for serum lubricant 
digestion. Data is presented as the mean (n=4) ± 95% confidence limits. 
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3.5 Results 
3.5.1 Macroscopic evaluation of dynamically mechanically degraded 
cartilage  
Osteochondral pins and plates were degraded using a single station friction rig under varying 
load and lubricant conditions. The two conditions were classed as mild (3.1 MPa/ 200 N) and 
moderate (7.5 MPa/ 478 N) which represented two different loading conditions in the knee 
that have been previously detailed (Table 3.2). A Ringer’s based lubricant was used for mild 
and moderate loading condition, a serum based lubricant was also used with the moderate 
loading condition. During mechanical degradation osteochondral pins and plates were 
articulated against each other under load for 6 hours (described in Section 3.4.2). Photographs 
were taken of specimens allowing assessment of macroscopic damage (Figures 3.22-3.24). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mild condition specimens articulated in Ringer’s solution demonstrated the least damage of all 
the conditions and tissue loss was not observed at a macroscopic level (Figure 3.22). The most 
severe form of macroscopic degradation observed under mild degradation conditions was 
 
Figure 3.22. Osteochondral pin specimens after mild condition degradation in Ringer’s 
solution. The pins shown represent the typical damage patterns seen on osteochondral pins 
after degradation. The third pin has been bisected in preparation for histological analysis. A. 
Specimen A did not appear to have any obvious damage to the surface, however the cartilage 
did appear swollen. B. This pin had a small crack across the surface of the tissue (arrow). The 
remaining tissue did not appear damaged however the surface did appear to be duller than 
control specimens. C. This pin which has been bisected, shows the most severe type of 
damage that was observed after mild condition degradation. Several cracks can be seen on the 
surface of the swollen cartilage (arrow). 
 
A B C 
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cracking at the cartilage surface, four of the specimens had cracks. Two mild condition 
specimens retained a smooth appearance, however swelling of the tissue was observed. Three 
specimens had a single fine crack on the surface while one specimen showed several 
intersecting cracks across its surface (Figure 3.22C). 
  Moderate condition specimens tested under a 478 N load in Ringer’s solution lubricant 
were highly variable in their macroscopic appearance. Four specimens did not show a large 
loss of tissue whereas two specimens appeared to have a significant loss of tissue resulting in a 
loss of over 50% of the cartilage height (Figure 3.23C). Cracking was the most common form of 
damage under moderate loading conditions in Ringer’s lubricant; all of the specimens 
demonstrated cracking to some degree across the surface.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Specimens degraded under moderate conditions with serum lubricant demonstrated similar 
damage to that observed in the moderate condition specimens in which Ringer’s solution 
lubricant was used (Figure 3.24). Tissue loss that was equivalent to over 50% of the cartilage 
height was observed in addition to extensive cracking on two specimens. However some 
 
Figure 3.23. Osteochondral pin specimens after moderate condition degradation in Ringer’s 
solution. The pins shown are representative of the typical damage patterns observed on 
osteochondral pins under the moderate degradation conditions. A. This specimen was 
damaged primarily around the circumference of the pin (arrow) which was unusual as the 
remaining specimens primarily lost tissue from the central region of the pin rather than the 
edges. The surface of the tissue appeared dull and scratched. B. Apart from two cracks across 
the pin surface (arrows), this pin was not heavily damaged and represented the lower end of 
the damage scale seen on specimens that underwent moderate condition degradation with 
Ringer’s solution lubricant. C. This specimen was heavily damaged and represented the most 
severe end of the scale of damage seen on moderate condition pins in Ringer’s solution 
lubricant. A large volume of cartilage tissue was lost from the pin leaving less than one half of 
the pin depth remaining. 
 
A B C 
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specimens, as was seen with moderate specimens in Ringer’s solution, showed only fine 
superficial cracks. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.5.2 Height loss and recovery of statically loaded cartilage specimens 
To confirm that tissue loss from the osteochondral specimens was due to articulation during 
degradation rather than permanent deformation and to determine the recovery time of the 
tissue post degradation, static loading assessments were conducted. The loading protocol and 
the equipment used to assess the height of the specimens have previously been described 
(Section 3.4.3). In brief, the  osteochondral pins and plates were loaded statically using either a 
six station wear rig or single station multidirectional friction rig to determine how loading 
affected cartilage height via permanent deformation. Changes to the height of the cartilage on 
osteochondral pins was measured using a Nikon profile projector, while changes in the height 
of the cartilage on the osteochondral plates was measured using a Vernier height gauge. The 
 
Figure 3.24. Osteochondral pin specimens after moderate condition degradation with serum 
lubricant. The pins shown here represent the typical damage patterns observed 
macroscopically on osteochondral pins under the specified loading conditions. The pin to the 
left of the image had lost a large volume of tissue. The middle pin and right hand pin showed 
cracks in the surface (arrows).  
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tests were conducted in Ringer’s solution. A repeated measures ANOVA was used to 
statistically analyse the static loading data followed by a Tukey’s multiple comparison post 
test.  
  For the pins loaded statically under mild conditions (3.1MPa) the post loaded cartilage 
height was significantly lower than the pre loading cartilage height. After 48 hours of recovery, 
the cartilage height was significantly higher than the post loading height, indicating that 
recovery had taken place (Figure 3.25). Pins loaded statically under moderate loading 
conditions had a significant drop in cartilage height directly after loading compared with pre-
loading height. A significant difference was also observed between cartilage height prior to 
loading and heights after 48 hours of recovery (Figure 3.26). 
  The cartilage height of the plates loaded statically under mild loading conditions 
dropped significantly between pre and post loading (Figure 3.27). A significant difference was 
also seen between post loading heights and both the 24 hour and 48 hour recovery specimens, 
indicating that cartilage recovery was complete within 24 hours.  
  The cartilage height of plates loaded statically under moderate loading conditions 
dropped significantly between pre and post loading time points. A significant difference was 
also observed between post loading heights and both the 24 hour and 48 hour recovery 
heights, indicating cartilage recovery had taken place by 24 hours (Figure 3.28). 
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Figure 3.25. Osteochondral pin cartilage height recovery post static loading under mild 
conditions (200 N load applied for 6 hours). Data is presented as the mean (n=6) ± 95% 
confidence intervals. The data was analysed by repeated measures analysis of variance 
followed by determination of significant differences between groups using a Tukey post 
test; ** equates to P ≤ 0.01 ; *** equates to P ≤ 0.001. 
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Figure 3.26. Osteochondral pin cartilage height recovery post static loading under 
moderate conditions (478 N load applied for 6 hours). Data is presented as the mean (n=6) 
± 95% confidence intervals. The data was analysed by repeated measures analysis of 
variance followed by determination of significant differences between groups using a Tukey 
post test; * equates to P ≤ 0.05 ; *** equates to P ≤ 0.001. 
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Figure 3.27. Osteochondral plate cartilage recovery post static loading under mild 
conditions (200 N load applied for 6 hours). Data is presented as the mean (n=6) ± 95% 
confidence intervals. The data was analysed by repeated measures analysis of variance 
followed by determination of significant differences between groups using a Tukey post 
test; * equates to P ≤ 0.05 ; **** equates to P ≤ 0.0001. 
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Figure 3.28. Osteochondral plate cartilage recovery post static loading under moderate 
conditions (478 N load applied for 6 hours). Data is presented as the mean (n=6) ± 95% 
confidence intervals. The data was analysed by repeated measures analysis of variance 
followed by determination of significant differences between groups using a Tukey post 
test; * equates to P ≤ 0.05.  
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These results indicated that the cartilage on the osteochondral plates loaded under either the 
mild or moderate conditions was completely recovered to its original height after 24 hours. 
The cartilage of the pins that underwent mild condition static loading was recovered after 24 
hours. The cartilage of the pins that underwent moderate condition static loading appeared to 
have recovered at 24 hours as there was no significant difference between the pre loading and 
24 hour recovery heights. However, at 48 hours the difference in heights became significant 
implying that the tissue was not recovered. Due to the conflicting nature of this result, all 
tissues were allowed to recover for 48 hours after mechanical degradation, before further 
analysis or freezing was carried out. 
 
3.5.3 Assessment of cartilage height post dynamic mechanical 
degradation 
 
To assess if tissue loss was occurring during dynamic mechanical degradation, the height of 
osteochondral plates and the height of the cartilage of the osteochondral pins was recorded 
using a vernier height gauge and Nikon shadowgraph, respectively. Three measurements were 
taken equidistantly across the deformed area of the plate using the height gauge (Section 
3.4.3.2). Six measurements were taken around the circumference of the pin using the 
profilometer (Section 3.4.3.2). 
  The height of the cartilage on the pins that underwent mild condition dynamic loading 
with Ringer’s solution were not significantly different from each other (Figure 3.29). There was 
a significant difference in the cartilage height of the pins loaded dynamically under moderate 
conditions in Ringer’s solution at the pre-loading and post loading time points (Figure 3.30). 
There was no significant difference between the cartilage heights of the pins loaded under 
moderate dynamic conditions with serum based lubricants at any time point (Figure 3.31). 
There was no significant difference between any of the heights recorded at the different time 
points, for the plates under mild or moderate conditions with Ringer’s solution lubricants 
(Figures 3.32 and 3.33). There was a significant drop in cartilage height of the plates loaded 
dynamically under moderate conditions with serum based lubricant at the pre-loading and 
post loading time points but no difference was seen between the 24 and 48 hour times points 
(Figure 3.34). 
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Figure 3.29. Cartilage height of osteochondral pins following mild condition dynamic 
mechanical degradation in Ringer’s solution lubricant.  Data is presented as the mean (n=6) ± 
95% confidence intervals. The data was analysed by repeated measures analysis of variance, 
no significant differences were found. 
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Figure 3.30. Cartilage height of osteochondral pins following moderate condition 
dynamic mechanical degradation with Ringer’s solution lubricant.  Data is presented as 
the mean (n=6) ± 95% confidence intervals. The data was analysed by repeated measures 
analysis of variance followed by determination of significant differences between groups 
using a Tukey post test; * equates to P ≤ 0.05. 
 
 
* 
125 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C
a
r
ti
la
g
e
 H
e
ig
h
t 
(m
m
)
P
re
-L
o
a
d
in
g
P
o
s
t 
L
o
a
d
in
g
2
4
h
r  
R
e
c
o
v
e
ry
4
8
h
r  
R
e
c
o
v
e
ry
0 .0
0 .5
1 .0
1 .5
 
Figure 3.31. Cartilage height of osteochondral pins following moderate condition dynamic 
mechanical degradation with serum lubricant.  Data is presented as the mean (n=6) ± 95% 
confidence intervals. The data was analysed by repeated measures analysis of variance, no 
significant differences were found. 
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Figure 3.32. Height of osteochondral plates following mild condition dynamic mechanical 
degradation with Ringer’s solution lubricant.  Data is presented as the mean (n=6) ± 95% 
confidence intervals. The data was analysed by repeated measures analysis of variance, no 
significant differences were found. 
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Figure 3.33. Cartilage height of osteochondral plates following moderate condition dynamic 
mechanical degradation with Ringer’s solution lubricant.  Data is presented as the mean 
(n=6) ± 95% confidence intervals. The data was analysed by repeated measures analysis of 
variance, no significant differences were found. 
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Figure 3.34. Cartilage height of osteochondral plates following moderate condition dynamic 
mechanical degradation with serum lubricant.  Data is presented as the mean (n=6) ± 95% 
confidence intervals. The data was analysed by repeated measures analysis of variance 
followed by determination of significant differences between groups using a Tukey post test; * 
equates to P ≤ 0.05. 
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It was concluded from these results that tissues were recovered after 48 hours and that there 
was no significant loss of tissue from the osteochondral pins and plates due to mechanical 
degradation. 
3.5.4 Surface roughness measurement of mechanically degraded cartilage replicas 
To allow quantitative evaluation of the roughness of the cartilage tissue after mechanical 
degradation had taken place, Ra values were determined using surface profilometery of 
silicone replicas of the cartilage surface (Section 3.4.4). A Talysurf PGI 800 profilometer was 
used to perform the measurements. The silicone replicas of the mechanically degraded pin and 
plate surfaces were taken immediately after mechanical degradation, after 24 hours of 
recovery and after 48 hours of recovery. 
  No significant differences in surface roughness was found between the control pin 
tissue replicas and the replicas of the mild degradation condition pin tissue in Ringer’s solution 
lubricant and the moderate condition pin tissue replicas in serum lubricant (Figure 3.35 / Table 
3.4). The surface roughness of the control pin replicas was significantly lower than the replicas 
of the moderate degradation condition pin tissue in Ringer’s solution at the 24 and 48 hour 
recovery time points.  The surface roughness of the pins subjected to moderate degradation 
conditions in Ringer’s solution was significantly higher at the 24 hour and 48 hour recovery 
time points compared to the surface roughness of the pins subjected to mild degradation 
conditions in Ringer’s solution at all three time points tested (Figure 3.35 / Table 3.4). It was 
observed that both the pin and plate specimens that underwent moderate degradation 
conditions had a greater variability in their surface roughness values than the control tissue 
and the tissues that underwent mild degradation conditions. In addition to this, it was clear 
that pin specimens that underwent moderate degradation with serum lubricant had greater 
variability than pins that underwent mild or moderate degradation protocols with Ringer’s 
solution lubricant (Figure 3.35B/C/D.) 
   The surface roughness of the control plate replicas was significantly lower than 
the surface roughness of the replicas from plates tested under moderate conditions using 
Ringer’s solution lubricant at all of the time points. A significant increase in surface roughness 
was also seen between the control plate replicas and the moderate plate replicas with serum 
lubricant at the 24 hour and 48 hour recovery time points (Figure 3.36 / Table 3.5). A 
significant increase in Ra was found between the mild condition replica plates at the post, 24 
hour recovery and 48 hour recovery time points and the moderate condition plate replicas 
articulated with Ringer’s solution lubricant at the post, 24 hour and 48 hour recovery time 
points (Figure 3.36 / Table 3.5). 
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  These results indicated that the roughness of mild condition pin and plate tissue did 
not increase during mechanical degradation as the tissue on both pins and plates that 
underwent mild condition degradation showed no change in surface roughness compared to 
the undegraded control. Degradation of pins and plates under moderate conditions in Ringer’s 
solution lubricant increased the surface roughness of the tissue. The results also indicated that 
the surface roughness of plates increased when they were articulated under moderate 
conditions with serum lubricant however, the surface roughness of the pins did not. 
  The moderately degraded pin specimens that were articulated in Ringer’s solution 
were the roughest specimens of the three conditions. The moderate condition pin specimens 
articulated in serum based lubricant also became rough. However, high variability was 
observed under this condition, as some specimens became very rough while some remained 
smooth.  The results indicated that a higher load and therefore an elevated contact stress was 
more likely to produce a rougher surface on the cartilage tissue. The roughness of the pins was 
more variable than the roughness of the plates, implying that the use of specimens with a 
smaller surface area led to an increase of variability in the experimental conditions. 
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Figure 3.35. The mean surface roughness of pin replicas directly after degradation and 
after 24 and 48 hours of recovery. A. Post refers to post degradation, 24 denotes 24 hours 
of recovery, 48 denotes 48 hours of recovery. Data is presented as the mean (n=6) ± 95% 
confidence intervals. The data was analysed by repeated measures analysis of variance 
followed by determination of significant differences between groups using a Tukey post 
test. B. The individual Ra measurements for the pins degraded under moderate conditions 
in serum lubricant immediately after loading, after 2 hours of recovery (C) and after 48 
hours of recovery (D).  
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Control - ns ns ns ns ** ** ns ns ns 
Mild post ns - ns ns ns * * ns ns ns 
Mild 24 ns ns - ns ns ** * ns ns ns 
Mild 48 ns ns ns - ns * * ns ns ns 
Mod post ns ns ns ns - ns ns ns ns ns 
Mod 24 ** * ** * ns - ns ns ns ns 
Mod 48 ** * * * ns ns - ns ns ns 
Mod serum post ns ns ns ns ns ns ns - ns ns 
Mod serum 24 ns ns ns ns ns ns ns ns - ns 
Mod serum 48 ns ns ns ns ns ns ns ns ns - 
Table 3.4 The significant differences between the surface roughness (Ra) values of pin replicas taken of mechanically degraded and undegraded control 
specimens. Asterisk represents level of significance: one asterisk equates to P ≤ 0.05, two asterisks equate to P ≤ 0.01, three asterisks equate to P ≤0.001, four 
asterisks equate to P ≤ 0.0001. 
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Figure 3.36. The surface roughness of plate replicas directly after degradation and after 24 
and 48 hours of recovery. Post refers to post degradation, 24 denotes 24 hours of recovery, 
48 denotes 48 hours of recovery. Data is presented as the mean (n=6) ± 95% confidence 
intervals. The data was analysed by repeated measures analysis of variance followed by 
determination of significant differences between groups using a Tukey post test.  
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Control - ns ns ns **** **** ** ns * **** 
Mild post ns - ns ns **** **** *** ns ** **** 
Mild 24 ns ns - ns **** **** ** ns * **** 
Mild 48 ns ns ns - **** **** *** ns ** **** 
Mod post **** **** **** **** - ns ns ns ns ns 
Mod 24 **** **** **** **** ns - ns ns ns ns 
Mod 48 ** *** ** *** ns ns - ns ns ns 
Mod serum post ns ns ns ns ns ns ns - ns ns 
Mod serum 24 * ** * ** ns ns ns ns - ns 
Mod serum 48 **** **** **** **** ns ns ns ns ns - 
Table 3.5 The significant differences between the surface roughness (Ra) values of plate replicas taken of mechanically degraded and undegraded control 
specimens. Asterisk represents level of significance: one asterisk equates to P ≤ 0.05, two asterisks equate to P ≤ 0.01, three asterisks equate to P ≤0.001, four 
asterisks equate to P ≤ 0.0001. 
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3.5.5 Friction between pins and plates during mechanical degradation 
 
The friction that occurred between the osteochondral pins and plates during the mechanical 
degradation regimes was recorded via a piezoelectric sensor (Section 3.4.2). Six repeats were 
taken for each condition. Data was recorded every 15 seconds for five minutes, subsequently a 
measurement was taken every 5 minutes for up to 6 hours. There was no significant difference 
between the co-efficient of friction measurements recorded for any of the degradation 
conditions, which were taken at each time point up to the 5 minute point and then each hour 
up to 6 hours, (determined by one way ANOVA; Figure 3.37A).  
  The co-efficient of friction recorded for the mild conditions was 0.051 at the start of 
the test which dropped to 0.042 within 3 minutes. From the 3 minute point the friction co-
efficient gradually increased for the first hour and plateaued at approximately 0.05 for the 
remaining five hours of the test. The co-efficient of friction recorded for the moderate 
condition with Ringer’s solution at the start of the test was 0.04, the friction then immediately 
dropped to 0.038 after the first 15 seconds then increased to 0.041 after the first five minutes. 
The friction then dropped resulting in a co-efficient of 0.036 at the 20 minute point. From here 
the friction gradually increased to 0.048 over the remainder of the test (Figure 3.37B). 
  The co-efficient of friction recorded for the moderate degradation condition with 
serum lubricant was initially 0.04. The co-efficient dropped to 0.034 by two minutes and 
fifteen seconds, rose to 0.037 by three minutes and thirty seconds then dropped again to 
0.033 at four and a half minutes. By the ten minute time point the friction had increased to 
0.037, it then dropped to 0.034 again by the fifteen point minute. From this point the friction 
gradually increased to 0.048 by the 6 hour time point of the test (Figure 3.37B). 
 
 
 
 
 
 
 
 
 
134 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
T im e  (M in u te s )
C
o
-e
ff
ic
ie
n
t 
o
f 
fr
ic
it
o
n
0 6 0 1 2 0 1 8 0 2 4 0 3 0 0 3 6 0
0 .0 0
0 .0 2
0 .0 4
0 .0 6
0 .0 8
M ild  c o n d itio n  -  R in g e r 's  s o lu tio n
M o d e ra te  c o n d itio n  -  R in g e r 's  lu b r ic a n t
M o d e ra te  c o n d itio n  -  s e ru m  lu b r ic a n t
 
T im e  (M in u te s )
C
o
-e
ff
ic
ie
n
t 
o
f 
fr
ic
it
o
n
0 6 0 1 2 0 1 8 0 2 4 0 3 0 0 3 6 0
0 .0 0
0 .0 1
0 .0 2
0 .0 3
0 .0 4
0 .0 5
0 .0 6
M ild  D e g ra d a tio n  F r ic tio n
M o d e ra te  D e g ra d a tio n  F r ic tio n
M o d e ra te  S e ru m  D e g ra d a tio n  F r ic tio n
 
Figure 3.37. The co-efficent of friction recorded between osteochondral pins and plates 
during mechanical degradation protocols (N=6). A. The friction data recorded for all 
mechanical degradation conditions including error bars. Data is presented as the mean 
friction coefficient (n=6) ± 95% confidence intervals. The data was analysed by one way 
analysis of variance which revealed no significant difference in the friction levels at any time 
point between the three conditions B. The friction data recorded for all mechanical 
degradation conditions excluding error bars 
 
B. The friction data recorded for all mechanical degradation conditions without error bars 
shown.  
A 
B 
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3.5.6 Histological evaluation of mechanically degraded cartilage 
specimens 
The histo-architecture of the mechanically degraded cartilage tissue was assessed using H & E 
staining (Section 2.61) This was carried out on six specimens from each condition. The 
morphology of chondrocytes varied throughout the superficial, medial and deep zones of the 
undegraded control tissue (Figure 3.38). In the superficial zone chondrocytes contained dark 
purple stained nuclei, the lacunae containing the chondrocytes were flattened compared with 
the rounded lacunae observed in the medial zone (Figure 3.39A/B). In the deep zone the 
lacunae did not have a fixed shape and ranged from circular to elongated and angular shapes. 
The distribution of chondrocytes varied throughout the tissue; chondrocytes in the superficial 
zone were not grouped together. In the middle zone it was common to see groups of three or 
four chondrocytes forming columns (Figure 3.39B). In the deep zone the linear grouping of 
chondrocytes was again evident as in the middle zone, however some chondrocytes lay next to 
each other within columns resulting in a less regimented appearance and some of the lacunae 
appeared to be larger than those in the superficial and middle zones (Figure 3.39C). Some 
lacunae did not contain chondrocytes. The surface of the cartilage was very smooth. Eosin 
staining was stronger in the deep zone of the tissue. The images shown (Figure 3.38-3.39) are 
representative of the six control specimens. 
  Four of the six specimens that had undergone mild mechanical degradation in Ringer’s 
solution lubricant were observed to have a smooth surface (examples shown in Figures 
3.40A/B). Two of the six specimens had obvious tissue damage (Figure 3.40C/D). One of the 
damaged specimens had a tear through the middle zone that did not extend to the superficial 
zone. The other damaged specimen had a fissure in the cartilage that extended from the 
surface into the middle zone of the tissue. No fibrillation was seen on any of the specimens 
however, small fissures in the superficial zone were observed in the specimen that had internal 
tearing (Figure 3.40C). 
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Figure 3.38. Haematoxylin and eosin stained section of undegraded bovine articular 
cartilage pin control tissue. The complete tissue section showing the superficial, middle and 
deep zones of the tissue. 
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Figure 3.39. Haematoxylin and eosin stained section of bovine articular cartilage pins. A. 
The superficial zone of the cartilage tissue showing chondrocytes at the surface in flattened 
lacunae (arrows). B. The middle zone of the tissue showing chondrocytes in rough columns. C. 
The deep zone of articular cartilage showing chondrocytes in columnar forms within large 
irregularly shaped lacunae (arrows).   
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Various grades of degradation were observed in tissues degraded under moderate mechanical 
degradation conditions in Ringer’s solution lubricant.  One of the six specimens had a relatively 
smooth surface, however the tissue appeared to be becoming detached from the bone at the 
deep / calcified zone (Figure 3.41A). Four of the remaining specimens showed focal areas of 
tissue loss and one specimen had a large volume of tissue loss across a large area of the pin 
(Figure 3.41C). Fibrillation of the cartilage surface was often observed adjacent to and within 
areas of tissue loss (Figure 3.41D). Some specimens showed tissue loss that extended deeper 
than 50% of the tissue height, with one specimen showing extensive tissue loss into the deep 
zone. 
 
 
 
Figure 3.40. Haematoxylin and eosin stained section of cartilage pin specimens following 
mild degradation in Ringer’s solution.  Both images A and B show specimens without visible 
degradation to the tissue. C. This specimen was one of two specimens showing damage to the 
tissue (arrow). D. This specimen contained a fissure in the surface that extended less than 
50% of the cartilage height (arrow). Scale bars represent 500 µm. 
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The cracks seen at the surface of some tissue specimens that had undergone moderate 
mechanical degeneration in serum lubricant did not extend beyond 50% of the tissue height 
(Figure 3.42B/D). Away from the areas of focal damage observed, the surfaces of specimens 
remained smooth. One specimen did not appear to have any signs of degradation (Figure 
3.42A). The most severe volume of tissue loss observed in the specimens articulated in serum 
was similar to that seen in the most severe loss in moderately degraded specimens in Ringer’s 
lubricant. Fibrillation was not typically observed at the surface of the tissues with the serum 
based lubricant, however it was observed in one specimen in which the superficial zone had 
been lost (Figure 3.42C). 
 
Figure 3.41. Haematoxylin and eosin stained section of cartilage pin specimens following 
moderate degradation in Ringer’s solution. A. This specimen had a relatively smooth 
superficial zone however the tissue appeared to have become detached at the calcified zone 
(arrow). B. Away from the fissure in the cartilage surface the surface of the tissue remained 
smooth. C. A large volume of tissue loss was observed from this specimen in which the tissue 
had been lost progressively across the pin resulting in less than 50% of tissue height 
remaining at the pin edge.  D. Tissue loss and fibrillation was observed in this specimen 
(arrows).  Scale bars represent 500 µm. 
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Overall the specimens subjected to mild degradation conditions showed the lowest amount of 
damage and the majority of the surfaces remained smooth. The specimens that were 
degraded under moderate conditions in Ringer’s solution had the greatest amount of damage. 
The specimens degraded under moderate conditions in serum lubricant had the highest 
variability of damage with some specimens exhibiting signs of severe damage and some 
specimens retaining a smooth undamaged surface. Therefore a higher contact stress led to an 
increase in damage to the tissue and the serum lubricant in some cases appeared to protect 
the surface of the cartilage tissue from the severe damage observed in the specimens 
degraded in Ringer’s solution under moderate conditions. 
 
 
Figure 3.42. Haematoxylin and eosin stained sections of cartilage pin specimens following 
moderate degradation with serum lubricant. A-B. The cartilage surface away from the 
obvious areas of tissue damage remained smooth. C. Severe tissue damage was seen in one 
specimen in which tissue loss was observed. D. Fissures in the tissue were a typical form of 
damage (arrow). Scale bars represent 500 µm. 
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3.5.7 Qualitative evaluation of GAGs in mechanically degraded cartilage 
specimens 
Alcian blue was used to stain the glycosaminoglycans (GAGs) in sections of the mechanically 
degraded specimens. The stain was chosen as the GAGs in the cartilage tissue are integral to 
its function. The staining procedure has been described previously (Section 2.6.2). Six samples 
of cartilage were evaluated. Staining in the superficial and upper middle zone of undegraded 
specimens was even and an intense blue. A patchy reduction in staining was observed from 
the deep zone to the calcified zone resulting in purple areas where the alcian blue had not 
been taken up. The areas surrounding these patches showed alcian blue staining that 
appeared darker than in the middle and superficial zones (Figure 3.43).  Patchy alcian blue 
staining was observed in the transitional zone from cartilage to bone. The subchondral bone 
did not stain heavily for alcian blue, haematoxylin staining was observed with patches of alcian 
blue. In general there was high repeatability of staining for the six tissue samples, however in 
two of the specimens, haematoxylin staining in the mid-deep zones was less visible. Staining in 
the calcified and subchondral bone was similar across all specimens. 
 
                   
 
Figure 3.43. Alcian blue stained control cartilage pin section. Image shows an undegraded 
control pin section with superficial, middle, deep and calcified zones. 
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Alcian blue staining intensity was reduced in mild mechanically degraded specimens 
articulated in Ringer’s solution. At the superficial zone, the alcian blue was not taken up 
resulting in a pink region approximately 12 µm deep and a light blue region approximately 50-
100 µm thick. The stain was also not taken up as strongly adjacent to some areas of tissue 
damage, for example torn regions within the tissue (Figure 3.44B). Half of the mechanically 
degraded mild condition specimens had a significant reduction in alcian blue staining in the 
deep zone of the tissue, resulting in increased pink staining in this region (Figure 3.44C).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A large reduction in alcian blue staining intensity was observed in moderate mechanically 
degraded specimens articulated in Ringer’s solution resulting in sections that appeared to be 
washed out (Figure 3.45). As with mild condition specimens, alcian blue was not taken up at 
the superficial zone, there was also a lack of alcian blue staining in areas of tissue damage 
(Figure 3.45B). The alcian blue was especially reduced in areas where tissue had become torn 
during the degradation protocol (Figure 3.45C). 
 
Figure 3.44. Alcian blue stained cartilage pin specimens following mild degradation using 
Ringer’s solution lubricant. A, C. A reduction in staining was observed in the deep zone of 
some specimens (arrows). B. Around areas of tissue damage a reduction in alcian blue staining 
was seen (arrow head). D. An overall loss of staining intensity compared with the undegraded 
control tissue was evident. Scale bars represent 500 µm. 
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  Moderate condition specimens articulated in serum lubricant showed similar staining 
patterns to the moderate condition specimens articulated in Ringer’s solution lubricant. 
Specimens appeared washed out and had reduced alcian blue staining intensity. Overall 
staining was heterogeneous and specimens showed a net loss of colour across different 
regions of the tissue (Figure 3.46). 
  It appeared that the moderate degradation condition led to the largest loss of GAGs as 
a lower intensity of alcian blue staining was observed in these specimens compared to the 
undegraded control tissues and the tissue treated under mild mechanical degradation 
conditions. The largest loss of alcian blue staining intensity was observed in the moderately 
degraded specimens in serum lubricant. 
 
Figure 3.45. Alcian blue stained cartilage pin specimens following moderate mechanical 
degradation in Ringer’s solution (N=6). A. Specimens appeared washed out due to a severe 
reduction in alcian blue staining. In this specimen the majority of GAG loss appeared to be in 
the middle to deep zone. B, C, D. Specimens with torn or fibrillated areas showed a greater 
reduction in focal alcian blue staining than areas with a clean fissure as was observed in A 
(arrows).  Scale bars represent 500 µm. 
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3.5.8 Quantitative evaluation of biglycan in mechanically degraded 
cartilage specimens 
A biglycan antibody was used to identify changes in the presence of this proteoglycan due to 
mechanical degradation (Section 2.6.3). In undegraded control specimens, biglycan was 
present in the superficial and middle zones of the cartilage tissue and was not present in the 
deep zone of the tissue (Figure 3.47). Biglycan was expressed in the calcified region of the 
tissue. Antibody labelling of biglycan in control tissues was highly repeatable.  
  A heterogeneous presence of biglycan was observed in the specimens that had been 
degraded under mild conditions in Ringer’s solution lubricant. One specimen had retained  
 
Figure 3.46. Alcian blue stained cartilage specimens following moderate degradation with 
serum lubricant (N=6). A. An overall reduction in alcian blue staining intensity was observed, 
however it was particularly evident in the superficial zone and in a band through the mid zone. 
B. Specimens showed a reduction in alcian blue uptake across the whole tissue. C. A reduction 
in alcian blue uptake was observed around areas of tissue damage (arrow). D. Tissue was seen 
breaking away from the bone (arrow). Scale bars represent 500 µm. 
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biglycan in the deep/calcified zone deep/calcified zone and had light staining in the upper 
middle zone but no staining was seen in the superficial zone (Figure 3.48A). One specimen 
retained biglycan in the superficial/ upper middle zone and staining in the calcified zone was 
only visible in the pericellular region (Figure 3.48B) Two specimens appeared to have lost 
biglycan from the calcified zone and retained it in the superficial and upper middle zone 
(Figure 3.48C/D). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.47. Biglycan distribution in control cartilage pin specimens. A. Image shows an 
undegraded control pin section. B. Image shows the isotype control, which was negative. 
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Figure 3.48. A-D. Biglycan distribution in pin specimens degraded under mild mechanical 
conditions in Ringer’s solution. Staining was reduced in the calcified zone of two specimens 
(B, C). Scale bars represent 500 µm. 
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Figure 3.49. Biglycan distribution in pin specimens degraded under moderate mechanical 
conditions in Ringer’s solution. Scale bars represent 500 µm. Stronger staining was observed 
in the upper-middle to superficial zone (arrows). 
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Decreased staining for biglycan was seen in the specimens degraded under moderate 
conditions with Ringer’s solution lubricant, when compared with the undegraded control 
tissue (Figure 3.47). None of the specimens retained the stain in the deep/calcified zone as was 
observed with the undegraded controls. Strong staining for biglycan was observed in the 
superficial/upper middle zone (Figure 3.49A). 
  As with many of the results for the specimens degraded under moderate conditions in 
serum lubricants, there was a large amount of variation in the biglycan staining observed, 
however, overall there did appear to be a loss of biglycan in the tissues caused by the 
mechanical degradation protocol. Two specimens retained light staining in the superficial zone 
of the tissue (Figure 3.50A/B). One specimen was observed to have light staining in the deep 
and middle zones but had lost staining intensity at the superficial zone (Figure 3.50C). Two of 
the specimens were void of any particular staining pattern and showed very little biglycan 
presence overall (example specimen shown in Figure 3.50D).    
 
 
 
 
 
 
 
 
 
 
 
 
Overall, despite the heterogeneity of the results, mechanical degradation was observed to 
have an effect on biglycan distribution and presence leading to a reduction in staining and also 
changes in the location of biglycan throughout the tissue. 
 
Figure 3.50. Biglycan distribution in cartilage pin specimens degraded under moderate 
mechanical conditions in serum based lubricant. Light staining was observed in the superficial 
zones of two specimens (arrows). Scale bars represent 500 µm. 
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3.5.9 Quantitative evaluation of COMP in mechanically degraded 
cartilage specimens  
Undegraded control specimens assessed using immunohistochemical staining for cartilage 
oligomeric matrix protein (COMP) showed uniform staining across the superficial and middle 
zones (Figure 3.51). Lighter staining was observed in the deep to calcified zone. A dark band of 
staining was seen at the superficial zone. The staining pattern was repeatable across all six 
specimens assessed however, occasionally staining appeared less intense in colour. 
  Specimens degraded under mild mechanical conditions did not have any reduction in 
COMP staining intensity or any changes to the staining pattern when compared with 
undegraded controls (Figure 3.52). Specimens degraded under moderate conditions in either 
the Ringer’s solution or serum based lubricant did not appear to have a reduction in COMP 
staining intensity or any changes to the staining pattern (Figure 3.53 and 3.54). Overall the 
staining intensity and the pattern of COMP staining was not affected by any of the mechanical 
degradation regimes or variations in lubricants.  
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Figure 3.51. A. Characterisation of undegraded pin control tissue using a cartilage oligomeric 
matrix protein antibody. B.  Image shows the isotype control, which was negative.   
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Figure 3.52. COMP distribution in cartilage pin specimens degraded mechanically under 
mild condition with Ringer’s solution lubricant. 
 
Figure 3.53. COMP distribution in cartilage pin specimens degraded mechanically under 
moderate conditions with Ringer’s solution lubricant. Scale bars represent 500 µm. 
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Figure 3.52. COMP distribution in cartilage pin specimens degraded mechanically under 
mild conditions with Ringer’s solution lubricant. Scale bars represent 500 µm. 
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3.5.10 Qualitative evaluation of collagen VI in mechanically degraded 
cartilage specimens 
Heavy staining for collagen VI was observed in the pericelluar regions of the cartilage tissue.  
Interterritorial and territorial staining was also observed in the superficial to mid zones of the 
tissue (Figure 3.55). Some light staining was observed in the deep-calcified zone. Collagen VI 
staining was highly repeatable in the six control specimens. 
  Specimens that were degraded under mild mechanical degradation conditions did not 
show any reduction in staining intensity for collagen VI or changes to staining pattern when 
compared to the staining observed in undegraded control specimens (Figure 3.56). Staining 
was observed in the pericellular regions of chondrocytes in all zones in addition to the 
territorial and interterritorial regions of the upper middle zone and superficial zones. The same 
trend was also seen in specimens degraded under moderate mechanical degradation 
conditions in Ringer’s solution lubricant, where the collagen VI staining remained similar to the 
staining seen in the undegraded tissues (Figure 3.57). 
 
Figure 3.54. COMP distribution in cartilage pin specimens degraded mechanically under 
moderate conditions with serum lubricant. Scale bars represent 500 µm. 
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The results for specimens degraded under moderate mechanical degradation conditions in 
serum were heterogeneous (Figure 3.58). Many of the specimens appeared to have lighter 
staining in the upper mid and superficial zones, however one specimen had staining similar to 
that of the controls (Figure 3.58B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.55. Collagen VI distribution in control cartilage pin specimens. A. Image shows an 
undegraded control pin section. B. Image shows the isotype control, which was negative. 
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have lighter staining in the upper mid and superficial zones, however one specimen had 
staining similar to that of the controls (Figure 3.57B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.56. Collagen VI distribution in cartilage pin specimens degraded mechanically under 
mild conditions in Ringer’s solution lubricant (N=6). Scale bars represent 500 µm. 
 
Figure 3.57. Collagen VI distribution in cartilage pin specimens degraded mechanically under 
moderate conditions in Ringer’s solution lubricant. Scale bars represent 500 µm. 
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The mechanical degradation protocols did not overtly deplete the collagen VI in the tissue 
specimens. In both the mild and moderate degradation condition specimens articulated in 
Ringer’s solution, the collagen VI was retained within the pericellular environment of the 
chondrocytes and in interterritorial regions of the upper middle to superficial zones of the 
tissue.  In the moderately degraded specimens articulated in serum lubricant, the collagen VI 
was retained in the pericellular environment, however, in one specimen collagen VI appeared 
to stain more lightly within the interterritorial regions of the superficial and upper middle 
zones of the tissue (Figure 3.58A). 
3.5.11 Evaluation of mechanically degraded cartilage tissues using 
electron microscopy 
3.5.11.1 Evaluation of the cartilage surface by environmental electron scanning microscopy 
of the cartilage surface. 
Environmental scanning electron microscopy (ESEM) was used to image the surfaces of the 
undegraded pin control tissues and the mechanically degraded pin tissues in a hydrated 
natural state. Three specimens were analysed using ESEM per condition. The qualitative results 
gained from the ESEM imaging complemented quantative surface roughness measurements of 
 
Figure 3.58. Collagen VI distribution in cartilage pin specimens degraded mechanically under 
moderate conditions in serum lubricant. Scale bars represent 500 µm. 
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the cartilage tissue taken using a surface profilometer. The methods of imaging the cartilage 
surfaces have been previously described (Section 2.7.1).  
  The control cartilage was free from fissuring. Some small particles were seen on the 
cartilage surface (Figure 3.59A).  Overall the surface was observed to be smooth and 
undulating with some light creasing. The creasing of the surface increased in the mechanically 
degraded mild condition specimens (Figure 3.59B). Creasing of the tissue was most severe in 
the moderately degraded specimens that were articulated in Ringer’s solution lubricant (Figure 
3.59C).  The moderate specimens that were articulated in serum lubricant remained relatively 
smooth and were similar in appearance to the undegraded controls. (Figure 3.59D) 
  Other interesting features were observed on the surfaces of the degraded cartilage 
specimens (Figure 3.60). These included fissures in the surface and wear particles. In the 
moderate mechanically degraded specimens, deep fissures were observed with extensions of 
cartilage crossing over the fissure remaining attached at each side (Figure 3.60B). A commonly 
observed macroscopic feature on the degraded cartilage plates was a fibrous gelatinous mass 
around the edge of the wear scar. In some cases wear particles could be observed 
accumulating in the fissures in the cartilage surface (Figure 3.60D). 
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Figure 3.59. Characterisation of undegraded control cartilage pins and mechanically 
degraded articular cartilage pin surfaces using environmental scanning electron microscopy 
(ESEM). A. The undegraded control cartilage surface. B. The cartilage surface after mild 
mechanical degradation. C. The moderately mechanically degraded surface articulated in 
Ringer’s solution. D.  The moderate mechanically degraded surface articulated in serum 
lubricant. 
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3.5.12 Qualitative evaluation of proteoglycans in cartilage tissues stained 
with cupromeronic blue dye by transmission electron microscopy 
Transmission electron microscopy of ultrathin sections following treatment with cupromeronic 
blue dye which stains glycosaminoglycans was used to investigate the ultrastructural changes 
that took place in the cartilage tissue due to mechanical degradation. Three specimens were 
examined per condition. Three sections were taken from each specimen; one in the superficial 
 
Figure 3.60.Features of degraded cartilage pin surfaces observed by ESEM. A. The mild surface 
showing a crack in the surface and increased creasing of the cartilage surface (arrows). B. The 
moderate condition surface articulated in Ringer’s solution showing a deep crack in the surface 
containing protrusions. C. The moderate condition surface articulated in Ringer’s solution 
showing a torn area of the cartilage surface (arrow). D. The moderate condition surface 
articulated in serum lubricant showing wear particles accumulating in the edge of a crack in the 
surface. 
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zone, one in the middle zone and one in the deep zone so that changes throughout the zones 
of the tissue could be observed. The procedure for preparing and imaging specimens has been 
described previously (Section 2.7.2). 
3.5.12.1 Control cartilage tissue 
At the superficial zone of the cartilage tissue there was a region approximately 500 nm thick 
that was characterised by an absence of collagen fibrils (Figure 3.61A). Below this band was 
another distinctive region which contained a small number of fine collagen fibrils. There was a 
small amount of staining for GAGs in this region. Below this region fine collagen fibres 
approximately 21 nm thick formed a thick band approximately 3 µm in width which could be 
seen crossing the tissue in parallel to the tissue surface. Below this band, the densely packed 
collagen fibres were randomly organised. Small proteoglycans could be seen interacting with 
collagen fibrils in some parts of this zone (Figure 3.61B/C).  
  Collagen fibrils in the middle section of the tissue had no fixed orientation and were 
highly visible. The fibres were observed crossing through the tissue without any dominating 
direction. Round features were observed in the tissue sections, where collagen fibres had been 
cut transversely, in addition to long fibres where the fibre had been sectioned through the 
sagittal plane. The distinctive D-band pattern associated with collagen could be seen along the 
sagittally sectioned fibres (Figure 3.62). Collagen fibres in the middle zone were approximately 
52 nm in diameter. Aggrecan was present throughout the middle zone as small black flecks 
(Figure 3.62). In some areas of the tissue, aggrecan could be seen connecting where it formed 
a loose honeycomb like structure (Figure 3.62). The aggrecan could also be seen interacting 
with collagen fibres and spanning gaps between collagen fibres (Figure 3.62).  
  Collagen fibrils were less visible in the deep zone of the cartilage tissue. Collagen fibres 
that were thicker than the fibres seen in both the superficial and middle zones of the tissue 
were observed in the deep zone however some fibrils that were similar in diameter to the 
middle zone were observed. This resulted in a mixture of fibres ranging from approximately 
50-100 nm. Collagen fibres appeared to be loosely aligned in one direction however it was 
sometimes possible to see collagen fibres in alternative directions to the general direction 
(Figure 3.63). The aggrecan staining was increased in the deep areas of the tissue and sections 
appeared darker with amorphous clouds of patchy dark staining. The aggrecan network also 
appeared to become more densely packed (Figure 3.63). The structure of the tissue changed in 
the proximity of chondrocytes. Collagen fibres were thinner than those in the interterritorial 
and territorial regions. The collagen fibres were also arranged in a roughly parallel manner that 
created a ring around the chondrocyte which can partially be seen in Figure 3.64. 
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Figure 3.61. Transmission electron microscopy images of the superficial zone of undegraded 
control cartilage pin tissue stained with cupromeronic blue. A. The superficial zone of the 
tissue including the surface amorphous layer and a horizontal collagen band (bracket). B. Part 
of the band of fine collagen fibres running parallel to the cartilage surface where small leucine 
rich proteoglycans were observed (arrows). C. The cartilage tissue towards the middle zone of 
the tissue. 
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Figure 3.62. Transmission electron microscopy images of the middle zone of undegraded 
control cartilage tissue at 11,000 times magnification. A. Aggrecan was observed forming a 
network within the middle zone of the tissue (arrows). B. Proteoglycans were observed 
interacting with the surface of collagen fibrils (arrow).   
  
 
 
Figure 3.63. Transmission electron microscopy of the deep zone of undegraded control 
cartilage tissue at 11,000 times magnification (N=3). A. Thick collagen fibrils were observed 
behind the dense aggrecan network (arrow). B. Patchy dark areas of staining were observed 
where dense areas of aggrecan appeared (circle). 
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3.5.12.2 Mild condition degradation with Ringer’s solution lubricant.  
The tissue that had been degraded under mild mechanical conditions appeared lighter in 
colour than the undegraded control tissue. The horizontal collagen fibres in the superficial 
zone were not as tightly packed as they were in the control tissue which meant that many of 
the fibres did not lie in the same straight and horizontal manner.  
  The structure of the cartilage at the tissue surface did not appear to be different to the 
undegraded tissue however the sections appeared lighter and there was a light band that 
extended approximately 2 µm into the tissue from the surface (Figure 3.65A). In the middle 
zone of the tissue degraded under mild degradation conditions, collagen fibres were not 
observed to be different to those in the undegraded control tissues. However, the overall 
staining intensity of the section was lower and the aggrecan network was fragmented (Figure 
3.65B). In the deep zone of the tissue the sections were stained at a lower intensity than those 
in the undegraded control tissue sections however, a large volume of aggrecan was observed 
in the tissue.  The aggrecan network was more fragmented than the network observed in the 
undegraded control tissue (Figure 3.65C). 
 
Figure 3.64. Transmission electron microscopy of the deep zone in undegraded control 
cartilage. A. The image shows the changes in the ultrastructure of the cartilage in the deep 
zone in close proximity to a chondrocyte (nucleus not visible). To the right hand side of the 
dashed line the fine parallel collagen fibres that line the perimeter of chondrocytes can be 
seen   B. The structure begins to resemble the tissue in the territorial and interterritorial zones 
as the image is captured further away from the chondrocyte. 
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Figure 3.65. Tissues following mild condition mechanical degradation with Ringer’s solution 
lubricant stained with Cupromeronic blue dye for proteoglycans. A. The superficial zone of 
the tissue; the surface of the tissue is shown in the bottom left hand corner of the image. B. 
The middle zone of the tissue. C. The deep zone of the tissue. 
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3.5.12.3 Moderate condition degradation with Ringer’s solution lubricant 
In the specimens that had undergone moderate degradation in Ringer’s solution, it was not 
possible to image the superficial zone, as it had been removed during mechanical degradation.  
It was possible to image the transitional zone between the superficial zone and the upper 
middle zone in which aggrecan staining was extremely fragmented, with only some small parts 
of the network remaining. There was also a clear network of what was assumed to be 
hyaluronan as the reduction in GAG staining intensity allowed other ultrastructural 
components to be visualised more easily (Figure 3.66A).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.66. Tissues having undergone moderate condition mechanical degradation with 
Ringer’s solution lubricant stained with cupromeronic blue dye for proteoglycans (N=3). A. 
The surface of the degraded tissue specimen possibly showing the hyaluronan network 
(arrows). B. The middle zone of the tissue. C. The deep zone of the tissue. 
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The collagen fibres in the middle zone of the tissue degraded under moderate conditions in 
Ringer’s solution lubricant were less tightly packed than the fibres in the undegraded control 
tissue (Figure 3.66B).  There was a reduction in aggrecan staining in both the middle and deep 
zones and the aggrecan network had been destroyed leaving some fragments within the tissue 
(Figure 3.66B/C). 
  It was possible to observe the ultrastructure of the tissue surrounding the 
chondrocytes in the superficial and deep zones of the cartilage tissue that had undergone 
moderate condition degradation in Ringer’s solution lubricant (Figure 3.67). As with the 
undegraded control tissue, fine collagen fibres lined the perimeter of the chondrocyte then 
became more randomly orientated as their distance from the chondrocyte increased (Figure 
3.67A/C). It was possible to see the chondrocyte nucleus in addition to short fibres which may 
have been hyaluronan or collagen VI (Figure 3.67B). 
3.5.12.4 Moderate condition degradation with serum based lubricant  
All of the tissues that were degraded under moderate conditions with serum lubricant showed 
large gaps in the collagen fibre network in the superficial zone (Figure 3.68A). The middle zone 
of the tissue had lost a large amount of aggrecan, however some fragments were still visible 
(Figure 3.68B). The collagen network through the middle zone of the tissue was looser in some 
areas however in other regions of the tissue a close network of collagen fibres was observed, 
similar to that seen in undegraded control tissue. In the deep zone of the tissue that had 
undergone moderate condition mechanical degradation in serum lubricant, there were a 
variety of changes to the cartilage ultrastructure. Two specimens appeared to have lost their 
aggrecan network and there was very minimal staining of the fragments that remained (Figure 
3.68C). One specimen however, retained more aggrecan despite the fact that the aggrecan 
network was extremely fractured. 
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Figure 3.67. Chondrocyte ultrastructure in the superficial and deep zones of cartilage 
following moderate mechanical degradation in Ringer’s solution lubricant. Stained with 
Cupromeronic blue A. A chondrocyte in the superficial zone of the tissue.  B. A chondrocyte 
and its nucleus (partially shown ; asterisk) in the deep zone of the tissue. C. The transitional 
zone between the chondrocyte environment and the territorial region of the tissue in the 
deep zone. 
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3.5.13 Quantitative assessment of collagen and glycosaminoglycan 
content of cartilage tissues 
3.5.13.1 Collagen content of undegraded and mechanically degraded cartilage tissues. 
The hydroxyproline assay was used to provide a measure of the collagen content of specimens. 
Six specimens were analysed for each condition. Standard concentrations were used allowing 
the hydroxyproline content of specimens to be interpolated from a standard curve (Figure 
 
Figure 3.68. Tissues following moderate condition mechanical degradation with serum 
solution lubricant stained with Cupromeronic blue dye for proteoglycans. A. The superficial 
zone of the tissue showing gaps in the collagen network (arrow). B. The middle zone of the 
tissue. C. The deep zone of the tissue. 
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3.69). Results for the hydroxyproline assay were calculated using the dry weight of the tissue. 
The collagen content of the undegraded control cartilage was approximately 621 µg.mg (Figure 
3.70). The tissue treated under mild mechanical degradation conditions had a collagen content 
of 591 µg.mg-1. Moderately mechanically degraded specimens treated with Ringer’s solution 
and serum lubricant had collagen contents of 688 µg.mg-1 and 797 µg.mg-1 respectively (Figure 
3.70). There was no significant difference in the collagen content between any of the degraded 
tissues and the undegraded control tissues. However, the collagen content of the tissue 
degraded under mild conditions in Ringer’s solution was significantly lower than the tissue 
degraded under moderate conditions in serum based lubricant (Figure 3.70).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.69. The relationship between absorbance at 570nm and the concentration of trans-4-
hydroxy-L-proline (mg.ml-1). Data is presented as the mean (n=3) ±95% confidence limits. 
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3.5.13.2 Glycosaminoglycan content of undegraded and mechanically degraded cartilage 
tissues. 
The glycosaminoglycan (GAG) assay was used to assess the GAG content of the cartilage tissue. 
Standard chondroitin sulphate concentrations were used allowing the GAG content of 
specimens to be interpolated from the standard curve (Figure 3.71). The GAG content of the 
undegraded tissue was 334 µg.mg-1 of the dry weight of the tissue. The tissue degraded under 
mild mechanical degradation conditions contained a GAG content of 145.6 µg.mg-1, while 
tissues degraded under moderate mechanical conditions in Ringers’s solution and serum 
lubricants contained 125 µg.mg-1 and 111 µg.mg-1, respectively. The GAG content of 
undegraded control tissues was significantly greater than the GAG content of the mechanically 
degraded tissues (Figure 3.72) 
 
 
 
 
 
Figure 3.70.  The collagen content of control cartilage and mechanically degraded cartilage. 
Data is presented as the mean (n=6) ±95% confidence limits. The data was analysed using one 
way analysis of variance followed by determination of significant differences between  groups 
using a Tukey post test; * equates P ≤ 0.05. 
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Figure 3.71. The relationship between absorbance at 525nm and the concentration of 
chondroitin sulphate B (mg.ml-1). Data is presented as the mean (n=3) ±95% confidence limits. 
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Figure 3.72. The GAG content of control cartilage and mechanically degraded cartilage. Data 
is presented as the mean (n=6) ±95% confidence limits. The data was analysed using one way 
analysis of variance followed by determination of significant differences between  groups 
using a Tukey post test; *** equates P ≤ 0.001.   
*** 
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3.5.14 Quantitative assessment of collagen and glycosaminoglycan 
content of lubricants recovered from mechanical degradation protocols 
3.5.14.1 Collagen content of lubricant recovered from mechanical degradation protocols 
The hydroxyproline assay was used to provide a measure of the collagen content of the 
lubricants recovered after mechanical degradation testing had been completed. The original 
protocol for detecting collagen in tissue specimens was adapted for lubricants (Section 3.4.10). 
The mean hydroxyproline concentration detected in the mild lubricant was 6.6 µg.ml-1 or 47 
µg.ml-1 collagen, whereas the moderate lubricant contained 12.9 µg.ml-1 of hydroxyproline or 
92 µg.ml-1 of collagen. The average hydroxyproline concentration in the Ringer’s solution 
control was 1.4 µg.ml-1 or 10 µg.ml-1 of collagen (Figure 3.73).  The collagen content of the 
Ringer’s solution control was significantly lower than the collagen content of the lubricant 
recovered from the moderate condition degradation protocol. 
 
 
 
 
 
 
 
 
 
 
 
 
 
*  
 
Figure 3.73. The collagen content of lubricants recovered after mechanical degradation 
protocols. Data is presented as the mean (n=6) ±95% confidence limits. The data was analysed 
using one way analysis of variance followed by determination of significant differences 
between  groups using a Tukey post test; * equates P ≤ 0.05.  
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3.5.14.2 Glycosaminoglycan content of lubricant recovered from mechanical degradation 
protocols 
The glycosaminoglycan (GAG) assay was used to provide a measure of the GAG content of the 
lubricants recovered after mechanical degradation testing had been completed. The original 
protocol for detecting GAGs in tissue specimens was adapted for lubricants (Section 3.4.11). 
The concentration of GAGs in the mild lubricant was 11.9 µg.ml-1, while the concentration of 
GAGs in the moderate condition lubricant in Ringers solution and the moderate condition 
lubricant in serum lubricant was 39.2 µg.ml-1 and 45 µg.ml-1, respectively. There was a 
significant difference between the Ringer’s solution control and both Ringer’s solution and 
serum lubricants under the moderate condition (Figure 3.74). The results showed that 
mechanical degradation increased the GAG concentration in the lubricants. 
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Figure 3.74. The GAG content of lubricants recovered from mechanical degradation 
protocols. Data is presented as the mean (n=6) ±95% confidence limits. The data was analysed 
using one way analysis of variance followed by determination of significant differences 
between  groups uinsg a Tukey post test; * equates P ≤ 0.05. 
* 
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3.6 Summary of results 
The following table provides a summary of the results that were obtained during analysis of the cartilage specimens that underwent mechanical degradation 
conditions.   
 
 
 
 
 
 
Friction
Surface 
Roughness
Height loss
Histo-
architecture
Qualitative
GAG analysis
Minor component presence
Surface
morphology
Ultrastructural analysis
HXP
Tissue
(µg.mg-1)
GAG
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(µg.mg-1)
HXP 
Lubricant
(µg.ml-1)
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Biglycan COMP Collagen VI
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network 
disruption
Aggrecan
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control
N/A Smooth N/A Smooth
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+++ +++ +++ +++ Smoothest - - - - - - 87 334 1.4 1.1
Mild 
degradation 
with ringer's 
solution
Low Smooth No
Smooth/ 
cracks/ 
internal tear
++ +++ +++ +++ Rough + + 82.8 145.6 6.6 11.9
Moderate 
degradation 
with Ringer's 
solution
Low Rough No
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tissue loss/ 
cartilage 
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- + +++ +++ Roughest ++ ++ 96.4 125 12.9 39.2
Moderate 
degradation 
with serum 
lubricant
Low
Smooth/ 
Rough
No
Cracks/
tissue loss
- - + +++ ++ Smooth ++ ++ 111 111 N/A 45.0
 
Figure 3.75. A summary of the results obtained using a range of methods to characterise cartilage mechanical degradation models. Key: *** indicates strong 
presence of the feature, ** indicates Presence, * indicates slight presence, - indicates reduction in presence of feature, -- indicates strong reduction, --- indicates 
complete absence of a feature. 
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In summary, the surface roughness of cartilage specimens was increased in specimens as the 
load on the tissue was increased. However, some of the specimens articulated in serum 
lubricant retained a smooth surface. The surface roughness results correlated with the 
degradative changes that were observed in the cartilage histoarchitecture. The GAG content of 
the specimens that were mechanically degraded was reduced when compared with the control 
tissue. The collagen content of specimens was not altered significantly by the mechanical 
degradation. The collagen VI content did not appear to be altered in the specimens articulated 
in Ringer’s solution, however, a reduction was observed in specimens degraded in serum 
lubricant. Biglycan staining was reduced in specimens degraded under moderate conditions. 
COMP staining was not altered by mechanical degradation. 
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3.7 Discussion 
The aim of this study was to develop and characterise mechanical degradation models that 
replicated the tribological conditions of degenerate cartilage tissue. Three degradation models 
were developed using Ringer’s solution and serum in PBS as lubricants.  
  Two models of degradation were chosen to investigate the effect of contact stress on 
tissues. The contact stresses that were chosen reflected physiological values and produced 
tissues with some features that were similar to degraded cartilage tissue as seen in the 
Modified International Cartilage Repair Society Chondral Injury Classification System and the 
microscopic histologic histochemical grading system developed by Mankin et al (1971).  
  Ringer’s solution was chosen as a lubricant because of its osmotic properties which 
allowed the cartilage tissue to remain hydrated during mechanical degradation. Ringer’s 
solution was also chosen for its simplicity, which facilitated the analysis of cartilage 
components released into the lubricant during testing. Calf serum was used as an alternative 
to synovial fluid as a lubricant. The calf serum lubricant contained glycoproteins and lipids 
which are important molecules implicated in boundary lubrication between cartilage tissues.  
  An extensive range of complementary qualitative and quantitative methods were used 
to thoroughly characterise the degraded cartilage tissues. The methods were chosen so that 
the scope of changes to the tissue that were anticipated would be detectable. For example, 
established methods such as alcian blue staining and a glycosaminoglycan assay were used in 
conjunction with cupromeronic blue staining. This allowed detailed information about the 
macroscopic and ultrastructural condition of GAGs and proteoglycans in the tissue to be 
determined which was reinforced with quantitative data.  
  The major findings of this chapter were that lubricant and contact stress had a 
profound effect on the degradation of tissue specimens during mechanical degradation. As 
contact stress was increased in the moderate condition, a large volume of GAGs were lost from 
the tissue and the collagen and aggrecan networks were disrupted. Tissue was lost from the 
surface of the specimens and the surface became rougher. However under “mild” conditions a 
large proportion of GAGs remained in the tissue and there was a reduction in tissue loss from 
the specimen surface. The surfaces of the mild specimens also remained relatively smooth. 
Collagen VI and COMP remained relatively unchanged in the degraded tissues under both mild 
and moderate conditions, whereas biglycan was reduced under both conditions. However, in 
some cases the results were largely variable. 
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  From the results that were obtained it was clear that both the contact stress and the 
lubricant chosen for the mechanical degradation protocol had an effect on the changes that 
occurred in the cartilage tissue. The increasing contact stress from the mild to moderate 
condition led to a significant increase in tissue loss, damage to the cartilage surface,  
destruction of the aggrecan network,  loss of GAGs and collagen fibre networks.  
  It was evident that the type of lubrication employed during mechanical degradation 
had an effect on extent of damage that was observed in the cartilage specimens. Ringer’s 
solution offered lower protection from damage at the higher contact stress used in the 
moderate condition, but was sufficient for the mild loading condition, as the data showed that 
in the mild condition the cartilage was similar in comparison to the undegraded control tissue, 
aside from a loss of GAGs. The data from the moderate condition tests in serum lubricant had 
the largest level of variance, with some specimens having little damage to their ultrastructure 
and a smooth superficial layer, whereas other specimens were severely damaged in a manner 
that replicated the moderate condition specimens that were articulated in Ringer’s solution. 
This may have been because of the pin geometry. The serum may have been able to prevent 
severe damage to pins that were congruent with the plate surface via boundary lubrication. 
However, if the pin and plate were not congruent the serum may not have been able to 
prevent damage occurring that was similar to that seen in some of the specimens degraded 
under moderate conditions in Ringer’s solution. The serum also seemed to exacerbate GAG 
loss from the cartilage tissue. This may have been due to the electrochemical characteristics of 
the lubricant which was not isotonic with the tissue as the Ringer’s solution was, possibly 
causing GAGs to leach out. 
  The changes in cartilage height measured using the shadowgraph showed that there 
was no loss of cartilage height during any of the degradation protocols. However, the method 
that was used successfully to measure statically loaded pins may not have been appropriate 
for pins following dynamic loading conditions since the macroscopic images of the tissues 
showed that the edges of the pin remained the same height despite tissue loss within the 
central region of the pin. In future a vernier height gauge should be used to take readings in 
the centre of the pin which would allow height changes in this region to be recorded. The loss 
of height in the centre of the pin that was observed macroscopically may not have correlated 
with loss of height on the edge of the cartilage pins due to an edge effect. Edge effects are 
caused by the different response of tissue that is unrestrained at the circumference of the pin 
to those in the central region of the pin which are restrained by the surrounding tissue. The 
large load on the cartilage pin may have resulted in the edges of the pin spreading outwards 
during loading which may have resulted in a lower exposure of the pin edge to abrasion 
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against the opposing plate. This result showed that it would be better to use large tissue 
specimens because this may reduce the influence of edge effects on tissue specimens. A 
reduction in edge effects is desirable because edge effects equate to an occurance of non-
physiological conditions. 
  The H & E images of the specimens reflected the extent of changes that were seen 
with the other characterisation techniques. When the load was increased there was an 
increase in cracking of the tissue which may have been due to the contact stress on the tissue. 
There was also a tissue loss from the cartilage surface which would have been exacerbated by 
the multidirectional motion used during the degradation protocol. 
  The ESEM images of the cartilage surface and the surface roughness data were used in 
a complementary manner. The results showed that the surface of the tissue became rougher 
as an increased load was applied when specimens were articulated in Ringer’s solution. 
However the surface roughness of the tissue articulated with serum solution was variable, with 
some specimens remaining fairly smooth while others became very rough. The results from 
the two techniques were found to be in agreement for all specimens.  One of the drawbacks of 
using the surface profilometry method for assessing cartilage surface roughness was that the 
surface roughness readings did not take into account the whole tissue surface. Traces were 
taken across the surface and an average roughness was calculated, however it would have 
been more accurate if the surface roughness of the whole surface could have been 
determined. 
 The biggest ultrastructural change brought about by the mechanical degradation 
regimes was the loss of aggrecan from the tissue, shown in the TEM images. This was 
interesting because there appeared to be a significant amount of biglycan remaining in the 
tissue after mechanical degradation had occurred, shown by the immunohistochemistry 
results. This may be due to differences in the way that these two different types of 
proteoglycan are anchored into the matrix. Biglycan is associated with collagen II and collagen 
VI in the ECM, whereas the large aggrecan core is attached to hyaluronan via one link protein, 
which may make aggrecan easier to disrupt (Watanabe et al., 1997 ; Wiberg et al, 2003). The 
results showed that loss of aggrecan in the cartilage tissue in patients with degenerative 
diseases such as osteoarthritis may also be lost through kinematic degradation rather than 
enzymatic digestion alone. It would be interesting to conduct further experiments on the 
aggrecan fragments in the lubricant collected after mechanical degradation using atomic force 
microscopy. This is because the atomic force microscoy would make it possible to visually 
determine the changes that may have occurred to aggrecan. The collagen network was 
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disrupted by the mechanical degradation especially in the superficial zone of the tissue. The 
deep zone of the tissue in the specimens examined appeared to remain in a tight network. 
  A limitation of the TEM technique was that imaging of cartilage zones was 
inconsistent. This was due to the small size of the specimen which meant it was not possible to 
take sections in precise areas of the tissue.  This may have led to some middle zone sections 
being taken in closer proximity to either the superficial or deep zones which may have had an 
effect on the structure of the tissue that was observed. Some of the deep zone sections may 
have also been closer to the calcified zone which could have had an effect on the tissue 
structure seen in the images. This could also explain why in some repeats, collagen fibres were 
not identical in size despite being from the same zone in the tissue.  
  The largest loss of aggrecan was seen in tissues degraded under moderate loading 
conditions. These results correlated with the alcian blue staining in which specimens loaded 
under moderate conditions with either lubricant showed the largest amount of GAG loss. 
  The antibody labelling of cartilage oligomeric protein (COMP) and collagen VI showed 
that these two components were not significantly depleted by the mechanical degradation 
regimes. COMP is found in the synovial fluid and serum of osteoarthritis patients. Therefore 
these results imply that during cartilage degeneration, COMP is lost from the tissue via 
biological means (Clark et al., 1999 ; Song et al, 2012). Similar staining to that seen in this study 
for collagen VI has been observed previously in human tissues (Pullig et al., 1999). However in 
the tissues observed in the Pullig study, collagen VI staining was increased within the tissue. It 
was also observed in the deep zone of the tissue as tissue became increasingly degraded, 
which was not observed during this study. This infers that collagen VI is altered through 
biological processes during in vivo cartilage degeneration. 
  The concentration of collagen and GAG in cartilage have been determined in human 
tissues, where approximately 64% of the dry weight of cartilage is collagen, while 21% of the 
dry weight is proteoglycan, leaving approximately 15% of the tissue remaining, which is taken 
up by cells and other minor cartilage components (Maroudas et al., 1980).   In this study the 
collagen content and GAG content were 621 µg.mg-1 and 334 µg.mg-1 respectively. Therefore 
these two components account for approximately 95.5% of the bovine cartilage composition. 
The slight differences seen in comparison in the results of the human study may be due to 
inter-species variation and may also be due to the different locations from which the tissue 
was taken.  
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 The collagen content of the tissues did not change due to mechanical degradation 
when compared to the undegraded tissue. However, there was an apparent increase in the 
collagen content of the tissue degraded under moderate conditions with serum lubricant. This 
may have been due to the large loss of GAGs from the tissue which would effectively increase 
the collagen content of the tissue. Despite there being no apparent loss in collagen from the 
tissue, hydroxyproline residues were detected in the lubricants. This implied that there were 
cartilage wear particles being removed from the bulk of the tissue, but that collagen was not 
leaching from the tissue. One limitation was that the hydroxyproline assay is optimised to 
detect total collagen levels, therefore it was not possible to say whether other collagen types, 
such as collagen IX, were leaching from the tissue. 
  Unfortunately it was not possible to determine the collagen content of the serum 
lubricant due to time constraints. However when observing the results for the hydroxyproline 
assay on tissues and lubricants with Ringer’s solution it could be predicted that collagen was 
not lost from the tissue mass but that it may been present in the lubricant due to cartilage 
wear particles that had been worn from some of the rougher specimens.  
  There was a significant loss of GAGs from the tissue under all of the mechanical 
degradation conditions however the highest loss was in the tissue that was more heavily 
loaded. In line with this, higher GAG concentrations were found in the lubricants that were 
taken from the specimens degraded under moderate conditions. 
  Despite the differences seen in the specimens that were degraded under the varying 
conditions, there was no significant difference between the friction values taken for any of the 
conditions. The friction coefficient measured during all of the conditions was at a relatively low 
level and rose slightly. The only slight difference that was seen was between the friction values 
of the mild and moderate conditions. The mild specimen eventually reached a plateau where 
friction remained relatively constant whereas the friction between the specimens under the 
moderate conditions continued to rise throughout the test.  This may have been because the 
specimens under mild loading conditions reached an equilibrium, while the friction between 
the specimens under moderate conditions may have continued to increase as the GAGs were 
removed from the specimens. 
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3.8 Conclusion 
Both the mild and moderate mechanical degradation protocols resulted in degeneration of 
cartilage specimens. Loading was the most important factor in terms of causing the most 
damage to the cartilage tissue. The tissues loaded under moderate conditions became 
rougher, they had increased damage to the cartilage surface, increased GAG loss, and greater 
wear. The lubricant type also had an effect on specimens. Ringer’s solution lubricant was 
suitable for maintaining the tissue at mild level of loading but did not protect the tissue from 
severe degradation at moderate loading levels. The serum lubricant appeared to protect some 
specimens from severe degradation however other specimens appeared as damaged as those 
under moderate loading conditions with Ringer’s solution, which produced a large variability in 
the results for this lubricant. 
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Chapter 4 
 
Development and Characterisation of an 
Enzymatic Model of Cartilage Degradation  
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4.1 Introduction 
During degeneration, cartilage tissue is degraded through mechanical and biological means. 
Matrix metalloproteases (MMPs) produced by chondrocytes are found in healthy cartilage 
tissue and help to maintain cartilage homeostasis (Aigner and Stove, 2003). Cartilage 
degeneration of a biological nature, rather than a mechanical nature, begins to occur when the 
rate of extracellular matrix degradation by catabolic enzymes in the tissue is greater than the 
rate of anabolic activity (Mueller and Tuan, 2011). One of the main components of the 
cartilage tissue that are lost during enzymatic digestion are the proteoglycans and their 
associated glycosaminoglycans (Thompson and Oegema, 1979).  
  Proteoglycans with their associated GAGs are integral for optimal cartilage function 
because GAGs attract water into the tissue, which causes the cartilage to swell (Mow and 
Huiskes, 2005). Swelling caused by interstitial fluid pressurisation in the cartilage is 
fundamental for maintaining low friction in joints. Therefore when GAGs are depleted from the 
tissue it has a major effect on the biotribological properties of the tissue (Katta et al., 2007). A 
reduction in GAGs has been shown to reduce the ability of cartilage to resist loading on the 
solid phase of the tissue which can lead to cartilage damage (Mow and Huiskes, 2005). 
Therefore it was hypothesised that enzymatic treatment of cartilage tissue to remove GAGs 
would provide a model of cartilage degradation representative of the biotribological state of 
cartilage tissue following biological degradation as compared to the previous model of 
mechanical degradation.  
  A variety of enzymes have been used to investigate changes to cartilage tissue 
structure and properties caused by biological degradation. Previous studies have included the 
use of collagenases, hyaluronidase and chondroitinase ABC (Katta et al., 2007; Park et al., 
2008; June and Fyhrie, 2009; Lee et al., 2013). All of these studies aimed to determine the 
effects of removal or alteration of the individual components on the cartilage tissue, to 
increase knowledge of the relationship between the structure and function of cartilage tissue 
in more detail.  
  June and Fyhrie, (2009) used collagenase and hyaluronidase to digest bovine cartilage 
samples. The study investigated the ability of models of polymer dynamics to predict the 
contributions of matrix components to the flow independent viscoelastic properties of 
cartilage tissue. The theory of polymer dynamics is used to describe the motions and 
interactions of polymeric molecules in a quantitative manner. In cartilage this includes the 
collagen network and the aggrecan network. Flow independent viscoelastic properties are 
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caused by the interactions between the solid components of the tissue and cannot be 
distinguished from fluid dependent viscoelastic properties experimentally, hence the 
assessment of polymer dynamics in this study for use in distinguishing these two factors. Since 
polymer dynamics are affected by the length of the polymers in the tissue, collagenase and 
hyaluronidase were used to decrease the length of the polymers in the tissue. The use of 
collagenase and hyaluronidase allowed the authors to determine how collagen and 
hyaluronidase networks contributed to a faster stress-relaxation rate in the tissue. The authors 
also confirmed their hypothesis; that polymer dynamics are able to give a greater 
understanding of how individual cartilage components contribute to the properties of cartilage 
tissue. 
  Chondroitinase ABC, collagenase and hyaluronidase have been used to investigate the 
effects of degradation of the specific matrix components on the friction of porcine cartilage 
tissues (Lee et al., 2013). Each enzyme was used to treat cartilage samples followed by 
reciprocation of the treated samples against each other in a rig under variable loads and sliding 
speeds. In this study the cartilage was cut from the bone and glued to glass slides before 
articulation. Removing the cartilage from the bone was likely to have had an effect on the 
results and the glue used may have leached into the tissue, which was only approximately 
3mm thick. The removal of bone or use of glue could have affected the deformation properties 
of the tissue or altered fluid flow through the tissue, which is also likely to have affected 
friction readings. The authors reported that treatment with any of the enzymes increased the 
friction between specimens, with chondroitinase ABC treatment causing the greatest increase. 
Treatment with chondroitinase ABC and hyaluronidase also modified the stick slip conditions 
recorded during articulation, which were related to increased wear of the cartilage surface.  
  Katta et al. (2007) investigated the effects of chondroitinase ABC treatment on the 
friction and deformation characteristics of cartilage tissue. The rationale for conducting this 
study was that contradictory results had been found in relation to the link between GAG loss 
and an increase in friction between cartilage tissues. This study found via indentation testing 
that depletion of GAGs from the cartilage resulted in a loss in compressive stiffness in the 
cartilage. The elastic modulus of the cartilage was decreased by the enzyme treatment and 
permeability was increased. An increase in friction was seen in treated specimens under 
dynamic loading conditions. The study confirmed GAG loss using a quantitative biochemical 
assay and the surface was examined using surface profilometry and scanning electron 
microscopy. Further characterisation of the tissues was, however, not conducted. Histological 
analysis would have allowed the changes to the tissue architecture and components of the 
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tissue to be qualitatively analysed. Transmission electron microscopy of the tissue may also 
have given an insight into any ultrastructural changes in the tissues. 
  The studies described above indicate that selective digestion of cartilage components 
can be useful for revealing how the different components of the cartilage tissue influence the 
cartilage properties. Chondroitinase ABC is a particularly interesting enzyme due to its 
substantial effect on the GAGs in the cartilage tissue, which are responsible for the ability of 
the cartilage to resist loading, and prevent damage to the tissue during articulation via biphasic 
lubrication.  
  The enzyme chosen in the present study to digest GAGs in the cartilage tissue, was 
chondroitinase ABC. Chondroitinase ABC carries out an elimination reaction with chondroitin-
4-sulphate (chondroitin sulphate A), chondroitin-6-sulphate (chondroitin sulphate C) and 
dermatan sulphate (formerly known as chondroitin sulphate B) which yields 4,5-unsaturated 
disaccharides. As a result the GAGs are removed from the aggrecan core protein to which they 
are attached. After chondroitinase ABC treatment has occurred other components of the 
tissue such as collagen remain intact (Yamagata et al., 1968; Lyyra et al., 1999).  
  As described in Chapter 3, in which mechanical degradation of cartilage was 
investigated, in this part of the study histological techniques were used to assess changes to 
the tissue structure and alterations in the components of the tissue after chondroitinase ABC 
treatment. GAG and hydroxyproline assays were used to determine changes in the amount of 
the two major components of the cartilage tissue, GAGs and collagen, respectively. 
Transmission electron microscopy was used to determine how the removal of GAGs from the 
tissue changed the appearance of the tissue on an ultrastructural scale. The GAG content of 
cartilage tissue has been reported to be related to the compressive resistance of the tissue 
(Mow and Huiskes, 2005). To investigate these changes indentation testing was performed 
before and after chondroitinase ABC treatment. Indentation analysis of chondroitinase ABC 
treated cartilage tissue has been conducted in previous studies and is an established method 
for investigating changes to cartilage stiffness properties caused by enzymatic treatment (Stolz 
et al., 2004; Katta et al., 2007; Hall et al., 2009). 
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4.2 Aims and objectives 
The aim of the studies described in this chapter was to compare native bovine control cartilage 
tissue to bovine cartilage tissues that had undergone treatment with chondroitinase ABC. The 
tissues were compared comprehensively using quantitative and qualitative methods. 
 
Objectives: 
 To develop an enzymatic degradation method for bovine cartilage tissue using 
chondroitinase ABC to remove glycosaminoglycans from the cartilage tissue.  
 
 To use histological staining to assess the normal histoarchitecture and staining 
patterns of glycosaminoglycans in chondroitinase ABC treated bovine cartilage tissue 
using haematoxylin and eosin staining and alcian blue staining, respectively.  
 
 To determine the distribution of biglycan, cartilage oligomeric matrix protein (COMP) 
and collagen VI qualitatively in chondroitinase ABC treated bovine cartilage tissues 
using immunohistochemistry. 
 
 To determine the deformation properties of the cartilage tissue before and after 
chondroitinase ABC treatment using indentation testing. 
 
 To use transmission electron microscopy with cupromeronic blue dye to examine the 
bovine cartilage ultrastructure and GAG interactions in enzymatically degraded a 
tissue. 
 
 To quantitatively determine the glycosaminoglycan and collagen content of 
chondroitinase ABC treated bovine cartilage tissue. 
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4.3 Experimental approach 
The experimental approach taken during this part of the study is shown in Figure 4.1.  The 
diagram shows the various steps that were undertaken in the enzyme treatment of the 
cartilage specimens and the subsequent steps taken to characterise the treated tissues, 
including sample numbers. 
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Transmission 
Electron 
Microscopy
(N=3)
Quantitative 
Biochemical 
Assays
(N=6)
Immuno
histochemistry
(N=6)
Osteochondral pins were dissected and treated using chondroitinase ABC
Mechanical characterisation Biological characterisation
Histology
(N=6)
Digested osteochondral cartilage
was dissected from the bone.
The cartilage was embedded
and sectioned using a cryotome.
Tissue was stained for biglycan,
COMP or collagen VI using
antibodies.
Digested cartilage was cut from the
bone and dissected into a small
rectangle.
The tissue was stained with
cupromeronic blue. Undigested
control tissue was taken in chapter
two.
The tissue was sectioned and
visialised using TEM.
Digested cartilage was cut from
the bone and macerated.
Sections are stained with H & E
or alcian blue.
Digested osteochondral pins
were decalcified and bisected.
Pins were processed for
histological staining and
sectioned.
The cartilage was lyophilised and
processed as required.
Enzymatic 
Treatment 
Protocol
Indentation
(N=6)
Osteochondral pin specimens were
soaked in antibiotic antifungal
solution and then digested using
chondroitinase ABC.
Specimens were indented. 
The osteochondral pins were incubated
in chondroitinase ABC solution for 16
hours at 37⁰C (N=6).
Osteochondral pin specimens were
dissected from the medial condyles of
bovine femurs.
Osteochondral pins were incubated in an
antibiotic antifungal solution at 4⁰C for
24 hours.
Either the hydroxyproline or GAG
assay was conducted.
 
Figure 4.1. The experimental approach taken in the research described in chapter 4 in which specimens were treated with chondroitinase ABC. The image 
includes the characterisation techniques that were used to analyse specimens and the number of replicates. 
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4.4 Methods 
A number of the methods that were used in this chapter have been described previously in 
Chapter 2. These methods include histological staining using haematoxylin and eosin (Section 
2.6.1) and alcian blue staining (Section 2.6.2), immunohistochemical analysis of biglycan, 
COMP and collagen VI (Section 2.6.3), TEM with cupromeronic blue dye to examine cartilage 
ultrastructure (Section 2.7.2) and quantitative biochemical assays for GAGs and collagen 
(Sections 2.8.1 and 2.8.2).  
4.4.1 Chondroitinase ABC treatment of cartilage tissue  
Chondroitinase ABC was used to deplete GAGs from the cartilage tissue. The chondroitinase 
ABC was suspended in a buffer solution at pH 8, as recommended by the supplier. The enzyme 
solution, which also contained bovine serum albumin (BSA), was incubated at 37°C during 
treatment of the cartilage. The temperature conditions and addition of BSA put the solution at 
risk of bacterial growth. Therefore the cartilage pin specimens were soaked in a solution of 
antibiotics in PBS for 24 h before enzymatic treatment. Antibiotics were also added to the 
chondroitinase ABC treatment solution.  
4.4.1.1 Extensive chondroitinase ABC treatment of cartilage tissue 
The protocol described below was also used to create positive control tissues for the 
cupromeronic blue staining protocol (described in section 2.7.2). However, rather than one 16 
hour incubation, specimens were incubated extensively for two consecutive 24 hour periods in 
the chondroitinase ABC solution with the solution being refreshed at the 24 hour time point. 
4.4.1.2 Antibiotic solution 
The antibiotic solution was prepared by adding one PBS tablet and the antibiotics listed in 
Table 4.1 to 30 ml of distilled water. The solution was stirred using a magnetic stirrer bar until 
all of the antibiotics were dissolved. The pH of the solution was adjusted to pH 7 using sodium 
hydroxide solution (1 M) or hydrochloric acid (1 M). The volume of the solution was increased 
to 100 ml using distilled water 
4.4.1.3 Chondroitinase ABC treatment solution 
Tris (0.605 g), 0.82 g of sodium acetate and 0.02 g of BSA were added to 10 ml of distilled 
water. The antibiotics listed in Table 4.1 were also added to the solution. The solution was 
adjusted to pH 8 using sodium hydroxide solution (1 M) and chondroitinase ABC was added to 
187 
 
the solution to produce a final concentration of 0.1U.ml-1. The solution volume was increased 
to 100 ml using distilled water.  For chondroitinase ABC treatment, osteochondral pins were 
dissected (Section 2.4) and each pin was placed into 5 ml of antibiotic solution for 24 h at 4°C 
on a shaker at 100 rpm. The osteochondral pins were then placed into 5 ml of the 
chondroitinase ABC treatment solution for 16 hours at 37°C. 
Table 4.1 Antibiotic concentrations in the antibiotic solution. 
Component Description 
Final 
concentration 
Nystatin Antifungal 2500 U.ml-1 
Gentamicin 
Broad spectrum aminoglycoside 
antibiotic 
20 µg.ml-1 
Polymixin B 
Antibiotic active against Gram 
negative rod bacteria 
200 µg.ml-1 
Vancomycin 
Antibiotic active against Gram 
positive bacteria 
50 µg.ml-1 
Imipenem 
Broad spectrum beta lactam 
antibacterial 
0.2 mg.ml-1 
Amphoteracin B Antifungal 25 µg.ml-1 
Aprotonin Protease inhibitor 10 KIU.ml-1 
 
After 16 h incubation, the specimens were removed from the chondroitinase ABC treatment 
solution and rinsed in PBS to remove the enzyme. Specimens that were chosen for histological 
assessment were placed into 10% (v/v) NBF and processed accordingly (Section 2.5.3). For the 
specimens chosen for immunohistochemical analysis, the cartilage disk was cut from the bone 
and processed as described in Section 2.6.3. Cartilage specimens for TEM were removed from 
the bone and processed as detailed in Section 2.7.2. Specimens used for indentation testing 
were stored at -20°C for a maximum of 31 days in a sterile bijou containing tissue paper soaked 
in Ringer’s solution before being defrosted overnight at 4°C. 
4.4.2 Histological assessment of chondroitinase ABC treated cartilage 
tissues 
Sections were stained using H & E and alcian blue as described in Sections 2.6.1 and 2.6.2, 
respectively. 
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4.4.3 Immunohistological assessment of chondroitinase ABC treated 
cartilage tissues 
Immunohistochemical staining for biglycan, collagen VI and cartilage oligomeric matrix protein 
was carried out as described in Section 2.6.3. 
4.4.4 Transmission electron microscopy analysis of chondroitinase ABC 
treated  cartilage tissue 
Ultrastructural changes to the cartilage tissue were assessed using cupromeronic blue staining 
with transmission electron microscopy previously described in Section 2.7.2.  
4.4.5 Quantitative biochemical analysis of chondroitinase ABC treated  
cartilage tissue 
Quantitative biochemical assays for glycosaminoglycans (Section 2.8.2) and collagen (Section 
2.8.1) were carried out to assess whether loss of either of these components from the tissue 
had occurred during enzyme treatment. 
4.4.6 Indentation testing of chondroitinase ABC treated cartilage tissues 
to derive cartilage deformation properties 
To investigate the changes to the deformation properties of the cartilage after treatment with 
chondroitinase ABC, an indentation rig was used (Figure 4.2). The rig was manufactured in 
house, in the School of Mechanical Engineering, University of Leeds. Before indentation 
testing, cartilage specimens were defrosted overnight at 4°C. Specimens that were used for 
indentation testing were not kept frozen for more than 28 days after dissection. This was 
because it was not known if freezing specimens for over one month had an effect on the 
biomechanical properties of the tissue.     
  Each osteochondral specimen was fastened into a collet using an allan key. The collet 
was slotted into the specimen cup which was filled with Ringer’s solution. A 3 mm diameter 
flat bottomed indenter tip was screwed into the tip holder. The specimen cup, which was 
screwed into the base of the indenter was adjusted vertically via screwing and unscrewing of 
the cup so that the cartilage surface was approximately 1 mm from the indenter tip. The 
indenter was allowed to indent the tissue surface continuously for 60 min.  
  A linear variable differential transformer (LVDT) was attached to the shaft at the top of 
the indenter to measure displacement of the shaft. A piezoelectric force transducer was fitted 
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to the rig above the indenter attachment. The data from the LVDT and the force sensor was 
relayed to a computer via an analogue to digital converter.  Labview 9 software was used to 
automatically record data and to specify test conditions.  
  Weights were not added to the rig during indentation, as a result a total of 70 g was 
loaded onto pin specimens through the weight of the rig components. The sampling frequency 
of the digital measurements was 5 Hertz. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Specimen cup
Indentation tip
Collet
Tip holder
 
Figure 4.2. The indentation apparatus used to indent untreated control and chondroitinase 
ABC treated cartilage specimens. Image shows the indenter rig and components of the rig 
required for indentation testing. 
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4.5 Results 
Histological staining was used to examine the architecture of the tissue (H&E) and the 
distribution of GAGs (alcian blue) after chondroitinase ABC treatment. 
4.5.1 Histological evaluation of chondroitinase ABC treated cartilage 
specimens  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The enzymatic treatment  of the cartilage specimens with chondroitinase ABC did not have a 
significant effect on the tissue structure (Figure 4.3). The appearance of the tissue was very 
similar to the untreated control specimens, however there was a band of pale staining in the 
superficial to upper middle zone in which eosin staining was lighter due possibly due to the 
removal of GAGs from the tissue by the chondroitinase ABC (Figure 4.3B, C and D). 
 
Figure 4.3. Representative images of haematoxylin and eosin stained sections of cartilage pin 
tissue treated with chondroitinase ABC. A. The untreated control. B,C,D. The chondroitinase 
ABC treated specimens. The pale band of staining has been highlighted (Braces ; N=6). 
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4.5.2 Qualitative evaluation of GAGs in chondroitinase ABC treated 
cartilage 
Alcian blue was used to stain for GAGs in the tissue. This stain was of particular interest in this 
part of the study because the purpose of the chondroitinase ABC treatment was to deplete 
GAGs in the tissue. Therefore alcian blue staining provided qualitative assessment of the 
changes to the GAG staining pattern caused by the chondroitinase ABC treatment (Figure 4.4). 
  Following chondroitinase ABC treatment  there was a distinctive pale band in the 
superficial and upper middle zones of the sections of the  specimens where a large amount of 
GAGs had been lost from the tissue (Figure 4.4B, and D).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Alcian blue staining at the cartilage surface was weak, which led to the appearance of a thin 
purple band. Staining in the lower middle and deep zones of the treated tissue remained as 
intense as the untreated control specimens (Figure 4.4A). 
 
Figure 4.4. Representative images of alcian blue stained sections of cartilage pin specimens 
treated with chondroitinase ABC. A. The untreated control B,C,D. The chondroitinase ABC 
treated specimens. The pale band of staining has been highlighted (Braces ; N=6). 
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4.5.3 Qualitative evaluation of biglycan in chondroitinase ABC treated 
cartilage specimens  
Biglycan staining was used to assess the effects of chondroitinase ABC treatment on this small 
proteoglycan. A representative image of a section of the untreated control tissue is shown in 
Figure 4.5A. After the chondroitinase ABC treatment there was a reduction in biglycan staining 
in the superficial zone of the tissue, despite some artifactual staining, observed in some 
specimens, such as a strong band of staining in the superficial zone (Figure 4.5B). There was a 
reduction in haematoxylin staining in the sections in the superficial to upper middle zones of 
the tissue (Figure 4.5B and C). All specimens also had a reduction in staining in the middle and 
deep zones of the tissue. However, staining was still visible in the deep zone of the tissue 
(Figure 4.5D and E).  
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Figure 4.5. Representative images of chondroitinase ABC treated cartilage pin sections 
labelled with a biglycan antibody (N=6). A. Untreated control tissue B. The surface and 
upper middle zone of the treated tissue. The arrow shows artifactual staining. C.  The 
surface and upper middle zone of the treated tissue, which showed a reduction in 
haematoxylin staining (brace). D. The middle to deep zones of the tissue. E. The middle to 
deep zones of the treated tissue in which some staining was observed (arrows).    
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4.5.4 Qualitative evaluation of cartilage oligomeric matrix protein in 
chondroitinase ABC treated cartilage tissue  
 
Six specimens were prepared for staining with COMP. The COMP staining that was observed in 
the chondroitinase treated specimens was much paler than in the control tissue, however on 
closer inspection it was observed that staining was present across the superficial and middle 
zones of the tissue, as it was in untreated control tissues (Figure 4.6A). In areas of COMP 
staining, the stain was evenly distributed. Two of the six specimens had COMP staining in the 
calcified zones, however, the staining was likely to be artifactual (Figure 4.6D and E). 
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4.5.5 Qualitative evaluation of collagen VI in chondroitinase ABC treated 
cartilage tissue 
 
Chondroitinase ABC treated specimens stained for collagen VI had the same staining pattern 
and intensity as the untreated controls (Figure 4.7A). Staining was strong in the pericellular 
 
Figure 4.6. Chondroitinase ABC treated cartilage pin sections stained with a cartilage 
oligomeric matrix protein antibody A. The untreated control tissue. B-E. Chondroitinase ABC 
treated specimens with arrows highlighting artefact staining in the calcified zone of specimens 
D and E (N=6).   
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regions of chondrocytes. Some specimens showed a more intense band of staining in the 
middle zone of the tissue (Figure 4.7C).There was also visible staining of collagen VI in the 
interterritorial regions of the tissue (Figure 4.7E).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7. Chondroitinase ABC treated cartilage sections labelled with a collagen VI 
antibody (N=6). A. The untreated control tissue. B-E. The chondroitinase ABC treated 
specimens (N=6).  Interterritorial staining is highlighted (arrow). 
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4.5.6 Qualitative evaluation of proteoglycans in cartilage tissues stained 
with cupromeronic blue dye  
Transmission electron microscopy in combination with Cupromeronic blue stain was used to 
investigate the ultrastructural changes to the cartilage tissue with a focus on the GAGs, which 
were stained using Cupromeronic blue. In addition to this, a positive control was developed 
through extensive treatment of cartilage tissues with chondroitinase ABC (Section 4.4.1.1).  
  At the surface of the chondroitinase ABC treated tissue, there was an obvious change 
in the cartilage appearance (Figure 4.8A). The surface of the tissue was no longer smooth and 
defined. The structure of the tissue was also less defined and had a cloudy amorphous 
appearance, collagen fibres were not clearly visible, as they were in the untreated negative 
control (Figure 4.8B). In the middle zone of one of the three chondroitinase ABC treated tissue 
specimens, the aggrecan network was disrupted and there was a reduction in aggrecan 
staining (Figure 4.9A). In two of the specimens the links between the aggrecan were disrupted, 
however there was visible GAG staining. The structure of the chondroitinase ABC treated 
tissues was less clearly defined than the untreated negative control tissues. In the deep zone 
of the treated tissue a dark amorphous cloud of staining was observed in the treated specimen 
inferring that GAGs were still present (4.10A), as was seen in the deep zone of untreated 
negative control tissue (4.10B). The aggrecan network was similar to the network seen in the 
untreated control suggesting that the GAG aggrecan complex was intact. However, the 
ultrastructure of the tissue in the treated specimens was less well defined. 
  These results inferred that the chondroitinase ABC enzyme cleaved the chondroitin 
sulphate in the superficial zone and the chondroitin sulphate subsequently leached out of the 
tissue. The chondroitinase ABC also reached the middle zone of the tissue and partially 
depleted the GAGs in this zone however, the GAGs did not completely leach out. From the 
analysis it appeared that the chondroitinase ABC did not penetrate into the deep zone, as 
GAGs remained present and the aggrecan network remained intact. 
  In order to confirm that the cupromeronic blue dye was specifically staining GAGs in 
the tissue, positive control cartilage tissue created through extensive chondroitinase ABC 
treatment, was analysed (Section 4.4.1.1; Figure 4.11).  The superficial zone was free from GAG 
staining and appeared lighter than the control images (Figure 4.11A). In the upper middle zone 
of the tissue, no small proteoglycans or aggrecan were visible. The extensive chondroitinase 
treatment protocol increased collagen fibre visibility in the sections and allowed another 
component of the tissue, which was assumed to be hyaluronan to become more easily 
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observed (Figure 4.11B). The extensive chondroitinase ABC treatment completely removed the 
aggrecan network from the deep and middle zones of the tissue (Figure 4.11C/D). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9. Chondroitinase ABC treated and untreated control cartilage specimens stained 
with Cupromeronic blue dye viewed with TEM. A. The middle zone of the chondroitinase ABC 
treated tissue where the aggrecan network has been disrupted (circle). B. The middle zone of 
the untreated negative control cartilage tissue with examples of intact areas of the aggrecan 
network (circles). 
 
A B 
 
Figure 4.8. Chondroitinase ABC treated and untreated control cartilage specimens stained 
with Cupromeronic blue dye viewed with TEM. A. The superficial zone of the chondroitinase 
ABC treated tissue showing the cartilage surface in the top left corner. B. The superficial zone 
of the untreated negative control cartilage tissue showing the cartilage surface in the top left 
corner. 
 
A B 
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Figure 4.10. Chondroitinase ABC treated and untreated control cartilage specimens stained 
with Cupromeronic blue dye viewed with TEM. A. The deep zone of the chondroitinase ABC 
treated tissue. B. The deep zone of the untreated negative control cartilage tissue. 
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4.5.7 Quantitative assessment of the collagen and glycosaminoglycan 
content of untreated control tissue and chondroitinase ABC treated 
cartilage tissue 
 
The collagen and glycosaminoglycan (GAG) content of the chondroitinase treated cartilage 
tissues was quantified using colorimetric assays. These two assays have been previously used 
 
Figure 4.11. TEM images of cartilage tissue treated with chondroitinase ABC and stained 
with Cupromeronic blue dye to act as negative control images. A. The superficial zone of the 
tissue; the surface of the tissue is visible in the top right hand side of the image. B. The upper 
middle zone of the tissue. Hyaluronan was observed in the extensively treated specimens 
(arrow) C. The middle zone of the tissue. D.  The deep zone of the tissue. 
A B 
C D 
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in this study to investigate the changes in collagen and GAG content of mechanically degraded 
tissues (Section 3.5.13). Six chondroitinase ABC treated specimens were assessed for collagen 
and GAG content.  
 
4.5.7.1 Collagen content of chondroitinase ABC treated cartilage tissues 
 
The unknown concentrations of collagen in the chondroitinase ABC treated cartilage tissues 
were determined using standards read from a standard curve. The average collagen content of 
untreated control cartilage tissue was 618 µg.mg-1 of the dry weight of the tissue. The average 
collagen content of the chondroitinase ABC treated tissue was 706 µg.mg-1. There was no 
significant difference between the collagen contents of the treated tissue and the untreated 
control tissue (p> 0.05; Student`s t-test; Figure 4.12). It was concluded that the chondroitinase 
ABC treatment did not reduce the collagen content of the tissue. 
 
  
 
 
 
 
 
 
 
 
 
 
 
4.5.7.2 Glycosaminoglycan content of chondroitinase ABC treated cartilage tissues 
Six specimens were analysed for GAG content. The assay quantified the concentration of GAGs 
lost during the chondroitinase ABC treatement. Unknown concentrations of GAGs were 
 
Figure 4.12. The collagen content of untreated control cartilage and cartilage treated using 
chondroitinase ABC at a concentration of 0.1U.ml-1 for 16 hours. No significant difference 
was found between the two values. Data is presented as the mean (n=6) ±95% confidence 
limits.  
C
o
ll
a
g
e
n
 C
o
n
te
n
t

g
.m
g
-1
C
o
n
tr
o
l 
T
is
s
u
e
D
ig
e
s
te
d
 T
is
u
e
0
2 0 0
4 0 0
6 0 0
8 0 0
1 0 0 0
202 
 
determined using standards read from a standard curve. The untreated control tissue had a 
GAG content of 328 µg.mg-1, whereas the chondroitinase ABC treated tissue had a GAG 
content of 108.4 µg.mg-1 (Figure 4.13). There was a highly significant difference between the 
two values (P<0.0001; Student`s t-test). The chondroitinase ABC treatment removed GAGs 
from the tissue resulting in a significantly lower concentration of GAGs post treatment. 
 
 
 
 
 
 
 
 
 
 
 
 
4.5.8 Indentation analysis of chondroitinase ABC treated cartilage 
specimens 
Six chondroitinase ABC treated specimens were indented in addition to six unntreated 
controls. The specimens were indented while submerged in Ringer’s solution, as previously 
described in Section 4.4.6. 
  There was no significant difference between the displacement of the non-treated and 
treated tissues at the early time points ranging from time point zero up to one minute (Figure 
4.14B ;P> 0.05; Student`s t-test). At the two minute time point and at all of the time points 
subsequent to this, there was a significant difference between the non-treated control tissue 
and the chondroitinase ABC treated tissue (P< 0.05; Student`s t-test; Figure 4.14A). These 
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Figure 4.13. The glycosaminoglycan content of untreated control cartilage and cartilage 
treated using chondroitinase ABC. A significant difference was found between the two 
values. Data is presented as the mean (n=6) ±95% confidence limits. The data was analysed 
using a Student’s t-test; **** equates P ≤ 0.0001. 
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results implied that chondroitinase ABC treatment affected the displacement of the cartilage, 
resulting in an increase in the displacement of the tissue and a reduction in stiffness.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A
B
 
Figure 4.14. The displacement of untreated control tissue and chondroitinase ABC treated 
cartilage tissue during a 60 minute indentation test. A The purple line marks the deformation 
of the chondroitinase ABC treated tissue. The orange line marks the deformation of the 
untreated control tissue. A significant difference was found between the values at several time 
points. Data is presented as the mean (n=6) ±95% confidence limits. The data was analysed 
using a Student’s t-test; * P ≤ 0.05, ** P ≤ 0.01. B. The early elastic response region which 
showed no significant differences between displacement of control and digested tissues. 
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4.6 Discussion 
The purpose of this part of the study was to treat cartilage tissue using chondroitinase ABC to 
remove GAGs and to investigate  the changes caused by GAG removal from the tissues using a 
variety of techniques; histological, antibody labelling, TEM, quantitative assays and indentation 
analysis. This was in order to determine the effects that treatment had on the tissue structure, 
ultrastructure, properties and matrix components, to provide insight into the biotribological 
performance of the tissues. 
 The H & E staining of the chondroitinase ABC cartilage specimens showed that there 
was no significant difference between the appearance of the treated and untreated tissues. 
However, there was a clear difference in the images stained with alcian blue. The treated 
tissues showed a pale band in the superficial and upper middle zones of the tissue caused by 
the removal of GAGs by the chondroitinase ABC. This result correlated with the significant loss 
of GAGs, detected using the quantitative GAG assay. The GAG assay showed that 
chondroitinase ABC treatment reduced the GAG content of the tissue from 328.2 µg.mg-1 to 
108.4 µg.mg-1. The results obtained agree with previous studies in which chondroitinase ABC 
has been used to remove GAGs from cartilage tissues (Katta et al., 2007). Treating the cartilage 
tissue with chondroitinase ABC did not have an effect on the collagen content of the tissue, 
which can be explained by the fact that chondroitinase ABC does not interact with collagen. 
  The major change seen in the immunohistochemical analysis of the treated and 
untreated control tissues, was in the distribution of biglycan. Staining for biglycan was lighter 
in the treated tissues. This was most likely due to the fact that the antibody stained for a 
specific region on the two chondroitin sulphate chains of biglycan, which were removed via 
chondroitinase ABC treatment (Iozzo, 1999). The results were in line with the hypothesis that 
chondroitinase ABC would reduce the biglycan staining in the tissues. Collagen VI was of 
interest because it resides in the pericellular environment of cartilage tissues. Therefore the 
loss of this component may have given an indication about the changes that occur in the 
environment immediately adjacent to the chondrocyte. It also gave more information about an 
alternative collagen to type II collagen. The collagen VI distribution was not affected by the 
chondroitinase ABC treatment, however COMP staining appeared to be lighter. It is not clear 
why COMP staining would be lighter as COMP does not contain any GAG chains. The changes 
in staining may have been due to a technical error or could be down to an increase in the 
permeability of the cartilage, which may have led to an indirect effect on COMP loss. 
  In the previous chapter it was shown that mechanical degradation of the tissue altered 
both the GAG concentration and the aggrecan network in the tissue. It was hypothesised that 
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chondroitinase ABC would deplete the GAGs from the tissue which would disrupt the aggrecan 
network and deplete the GAGs attached to the small leucine rich proteoglycans from the 
tissue.  The results of the Cupromeronic blue staining visualised using TEM showed that 
chondroitinase ABC had removed GAGs from the superficial zone of the cartilage tissue and 
had led to the partial digestion and removal of GAGs from the middle zone of the tissue. The 
aggrecan network in the middle zone of the tissue appeared disrupted due to GAG removal. 
The deep zone was minimally affected, which may have been due to the short amount of time 
that the tissues were exposed to chondroitinase ABC.  The results suggest that the enzyme did 
not penetrate the deep zone of the tissue. The structure of the chondroitinase ABC treated 
tissue was less well defined than that of the untreated control. This may be due to a decrease 
in the stiffness of the tissue, making it more difficult to section. The cartilage tissue that was 
treated extensively with chondroitinase ABC, which acted as a positive control, did not show 
evidence of GAG staining. This implied that the cupromeronic blue staining was specific for 
GAGS. 
  Indentation analysis can be used to determine the displacement of a material such as 
cartilage. Displacement analysis was used because GAGs are known to increase the stiffness of 
cartilage, therefore it was proposed that GAG removal with chondroitinase ABC treatment 
would reduce the compressive stiffness of the tissue, resulting in increased displacement. A 
significant difference was seen between the indentation profile of the untreated control and 
chondroitinase ABC treated cartilage tissue after several minutes of indentation. The 
untreated control tissue reached a plateau of deformation that remained at a constant level 
after 10 minutes, whereas the treated tissue continued to deform throughout the test. There 
was no significant difference between the displacement values measured on the early region 
of the curve. The early region of the curve represents the elastic stage of the viscoelastic 
response of cartilage, which is observed when cartilage tissue is under deformation. This result 
suggests that the elastic properties of the tissue were not affected by chondroitinase ABC 
digestion. The results of this study agree with the results in a similar study (Katta et al., 2007). 
It is likely that the increased deformation of the tissue is linked to the loss of GAGs from the 
surface and middle zones of the tissue. It can be postulated that the loss of GAGs reduced the 
interstitial fluid pressurisation in the tissue reducing the ability of the tissue to resist 
compressive forces. If more time was available, it would have been possible to use the 
indentation data with a finite element model to derive further information about the treated 
tissues, such as permeability and elastic modulus (Pawaskar et al., 2010). 
 During cartilage degradation a spectrum of changes take place and the degradation 
observed in the model presented in this work represents one part of that spectrum. 
Chondroitinase ABC is suitable for use in creating degradation models because GAG loss is a 
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major part of cartilage degradation. However, it would improve the model if the model 
complexity was increased. For example, it could be useful to use additional enzymes such as a 
collagenase to break down the collagen matrix, which would further replicate cartilage in a 
degenerated state. Further work could include digestion of tissue components with alternative 
enzymes alongside articulation in a friction rig to assess the changes to the tribological 
properties of the tissues after digestion. In future the model could be used to investigate the 
biotribology of degenerated cartilage via friction rig testing under various conditions such as 
variable loads or sliding speeds.  
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4.7 Conclusion 
The chondroitinase ABC removed GAGs from the cartilage tissue. This was demonstrated both 
qualitatively and quantitatively using histology, TEM and biochemical assays. The treated 
cartilage tissue showed an increase in deformation under load compared to untreated tissue. 
The chondroitinase ABC treated tissue may be used as a model  for investigation of novel 
cartilage substitution materials or biomaterials. Because the model did not have an altered 
structure or loss of any of the components besides GAGs it may be useful for investigating 
methodologies that aim to re-incorporate GAGs back into the matrix.  
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Chapter 5 
 
Characterisation of cartilage wear particles 
generated during mechanical degradation 
protocols.   
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5.1 Introduction 
Wear is used to describe the damage, erosion or destruction of a material as a result of friction 
or motion. As with surfaces in engines for example, the surfaces of joints in the body also 
experience friction and wear which causes damage to the surface of cartilage tissue. The 
damage can be in the form of wear particles which are a result of tissue loss from the surface 
of the tissue. Wear particles have predominantly been studied in relation to joint replacement 
materials, such as ultra high molecular weight polyethylene (UHMWPE), ceramics, and cobalt 
chrome (Catelas et al., 2003; Tipper et al., 2006; Brown et al., 2007; Richards et al., 2008; 
Dressler et al., 2011; Ellison et al., 2012; Behl et al., 2013). It has been recognised that wear of 
these materials may  be the cause of osteolytic loosening of implants, as it has been 
determined that particles of a certain size range can be phagocytosed by macrophages which 
causes inflammation and bone resorption around the implant (Beck et al., 2012).  
  Cartilage wear particles have been observed in the synovial fluid of patients with 
osteoarthritis (Kuster et al., 1998). More recently, interest in cartilage wear particles has 
increased which is due in part to advances in technology that have made isolation and analysis 
of the particles more feasible. One of the earliest studies on cartilage wear particles was 
conducted using sheep joints. Synovial fluid containing wear particles was extracted from the 
cavity in the joint, separated using ferrography and analysed using SEM (Stachowiak and 
Podsiadlo, 1997). The problem with imaging cartilage particles using SEM, is that the 
techniques used in the preparation of the particles for SEM imaging may have altered the 
features of the particles such as the size or surface topography. Following on from the initial 
study, human cartilage wear particles were obtained and analysed using numerical particle 
shape predictors. The study concluded that the shape of cartilage wear particles from 
osteoarthritic joints was altered in comparison to wear particles extracted from healthy knees 
(Podisadlo et al., 1997; Kuster et al., 1998).  
  Following these early studies, Peng (2007) used a mechanical rig to generate cartilage 
wear particles in sheep joints, to investigate the 2D and 3D parameters of wear particles. This 
study also aimed to correlate particle features with the worn surfaces of the cartilage in the 
joint which was done succesfully.  The study stated that in future, this type of analysis may 
lead to an alternative method for diagnosis of degenerative diseases such as osteoarthritis as 
the particles may be linked to degradative stages of the disease. However, the study 
disregarded particles under 5 μm in size, which may have had important implications. In 
addition to this, particles were treated with chemicals such as gluteraldehyde which may have 
affected the features of the particles, such as size.  
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  Mendel et al. (2010) adapted a technique known as ferrography, to allow them to 
isolate cartilage wear particles from human synovial fluid by labelling cartilage particles with 
nanometric paramagnetic beads. One of the issues with the method used in this study was 
that the synovial fluid was mixed with saline solution and centrifuged. This was performed to 
make the synovial fluid suitable for use with the ferrographer. However, the diluted synovial 
fluid was removed after centrifugation which may have resulted in the loss of some wear 
particles from the solution. In addition to this, the particles were coated in a layer of copper 
approximately 15–20 nm thick before visualisation, which may have altered the surface 
topography features of the particles; this could be particularly problematic in future studies in 
which the surface topography of particles is to be investigated. The use of ferrography is also 
associated with overlapping of particles during detection by the ferrographer. The 
bioferrography technique was used in a follow up study that investigated the effects of 
hyaluronan injections on the characteristics of cartilage wear particles (Hakshur et al., 2011). 
The study found that while hyaluronan injections appeared to slow the rate of wear, they did 
not prevent joint degradation overall.  
  Most recently Tian et al. (2012) used feature parameters such as “hill and valley 
recognition” and field parameters defined in ISO standard ISO/FDIS 25178-2 alongside laser 
scanning confocal microscopy to study the surface topography of ovine cartilage wear particles 
for the first time. The particles were isolated using filtration. The results may have the 
potential to complement current diagnostic procedures for osteoarthritis. The same group also 
used atomic force microscopy to study the nanomechanical properties of human cartilage 
wear particles (Wang et al., 2013). An issue with the methodology used in the study, was that 
particles were imaged in either air or water. The authors postulated that the particles imaged 
in air may have lost moisture by evaporation and which may have affected their size giving rise 
to an underestimation of particle size. To overcome this, particles were imaged in water. 
However, the water used may have caused the cartilage particles to swell artificially, increasing 
particle size and masking surface features. Both the dry and hydrated environments may have 
had an effect on the surface topography, size and mechanical properties of the particles that 
were being assessed.  
  It is clear therefore that further investigation of cartilage wear particles is important 
because the investigation of changes in particles during degenerative diseases, which include 
changes in size distribution and mechanical properties, may help to provide a deeper 
understanding of degenerative diseases such as osteoarthritis. It is also clear that despite some 
early studies that showed interesting results, the field of cartilage wear particles is still in its 
infancy and that the quality of the methodologies used to isolate and characterise wear 
particles must be improved if physiologically relevant results are to be obtained. 
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5.1.1 Rationale 
 The wear particle isolation procedures developed within the IMBE have been successfully 
optimised for UHMWPE and metal particles. The processes rely on recovery of particles by 
filtration, involve several steps that are not suitable for cartilage particle analysis, including 
digestion of particles with enzymes or strong alkali for several days (Tipper et al., 2000; Brown 
et al., 2007). Therefore a new isolation method suitable for cartilage wear particles was 
developed. To observe the particles in their natural state, environmental electron scanning 
microscopy (ESEM) was used to visualise the particles. The use of ESEM allowed the direct 
visualisation of untreated, hydrated cartilage wear particles for the first time, to the author’s 
knowledge. Mendel et al. (2010)  previously used ESEM coupled with energy dispersive X-ray 
spectroscopy to characterise the chemical composition of cartilage wear particles,  but did not 
publish images of the cartilage particles taken using ESEM. Imaging of the cartilage wear 
particles with ESEM presented several problems, which included difficulty observing cartilage 
particles at high magnifications. Therefore the procedure for imaging particles developed in 
the IMBE was adapted for the cartilage particles.  
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5.2 Aims and Objectives 
The aim of this chapter was to isolate and characterise the cartilage wear particles that were 
generated during mechanical degradation protocols described previously in Chapter 3.   
Objectives 
 To develop a method for isolation of cartilage wear particles from Ringer’s solution 
lubricants recovered from mechanical degradation tests. 
 
 To use environmental scanning electron microscopy to take images of cartilage wear 
particles in a natural hydrated state. 
 
 To develop a method for identifying the differences in the quantity and features of 
cartilage wear particles generated from the mild and moderate mechanical 
degradation regimes. 
 
 
 
 
 
 
 
 
 
212 
 
5.3 Methods  
Cartilage wear particles were generated under mild (3.1 MPa/ 200 N) and moderate (7.5 MPa/ 
478 N) mechanical degradation regimes, described previously in Chapter three (Section 3.4.2). 
During the mechanical degradation protocols, an osteochondral pin was articulated against an 
osteochondral plate for six hours in Ringer’s solution lubricant. At the end of the test the 
lubricant was collected, the total volume was quantified and then aliquoted into 2 ml 
eppendorfs. The eppendorfs were stored at -20°C. To create a control for this part of the 
study, three repeats of the mechanical degradation protocol were conducted without cartilage 
tissue in the rig. This helped to determine whether particles in the lubricant had come from 
the tissue or the surrounding environment during the test. 
5.3.1 Particle Isolation 
Before the particles were isolated from the lubricant, the lubricant was defrosted at room 
temperature for 10 minutes. A 15 ml vacuum filter (Millipore) was clamped onto a 125 ml filter 
flask (Millipore; Figure 5.1A). A 10 µm pore sized filter was carefully placed into the vacuum 
filter using tweezers, so as not to damage the filter (Figure 5.1B). The filter flask was attached 
to an electric pump (Figure 5.1C). 
  The following procedure was performed in a class I laminar flow cabinet to minimise 
airborne contamination of filters. When the lubricant had defrosted the eppendorf was shaken 
by hand to redistribute the particles. A syringe was used to remove 1 ml of lubricant from the 
eppendorf. The lubricant was added onto the filter. The syringe was then refilled with Ringer’s 
solution twice which was used to flush any particles from the inside of the syringe. A volume of 
15 ml of Ringer’s solution was then added into the measuring cylinder clamped to the filtration 
flask and allowed to run through. The electric pump was set to the lowest setting and attached 
to the filter flask to speed up the filtration process when necessary. Following this, a further 15 
ml of Ringer’s solution was added to the measuring cylinder and allowed to run through the 
filter into the filtration flask. As soon as the lubricant had passed through the filter, the filter 
was then placed onto Ringer’s solution soaked tissue paper in a petri dish for transport to the 
environmental electron microscope. 
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5.3.2. Investigation into the effects of humidity on particle appearance  
To determine how a decrease in humidity affected the appearance of the cartilage particles, an 
area of the filter with several particles was selected. An image of the particles was captured at 
96% humidity. From there, the humidity was decreased in 9 to 10 % increments down to 46 % 
and an image was captured of the particles at each humidity.  
5.3.3 Imaging of cartilage wear particles using environmental scanning 
electron microscopy (ESEM) 
A section of each filter was taken just within the perimeter of the area covered in particles 
using a 6 mm biopsy punch (Figure 5.2). The filter sample was placed onto the Peltier-cooled 
specimen stage in an FEI Quanta 200F environmental scanning electron microscope as 
previously described (Section 2.7.1).  
  Images of the particles on the filter were captured between 8 and 14 kV at 87-90% 
humidity.  To prevent particles being sampled more than once, images were taken at specific 
 
Figure 5.1. Apparatus for cartilage wear particle isolation. A. The vacuum filter holder 
(composed of a measuring cylinder and filter holder with bung), and filter flask components. 
The measuring cylinder and filter holder were held together with a clamp. B. The case 
containing 45 mm diameter 10 µm pore filters and the petri dish. C. The electric pump. 
A B 
C 
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co-ordinates which were selected via the ESEM computer programme (Table 5.1). This resulted 
in 49 images being captured from each filter. The magnification used to image the particles 
was 1500x. If a particle was only partially visible at any of the selected co-ordinates, the co-
ordinate was slightly altered so that the particle could be included. This was done as long as 
the change in-co-ordinates did not result in an intrusion of the surrounding co-ordinate points. 
If a particle was too large to fit the screen it was not included in the particle count. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Image Pro-plus 6 imaging software was used to manually draw around and record the number 
of particles that were observed at each co-ordinate on the filter. The total percentage area of 
the filter that was observed was determined (Figure 5.3). This allowed the total number of 
particles on the filter to be estimated by extrapolating to estimate the number of particles on 
the unobserved area of the filter. The number of particles was also normalised to account for 
the variation in the volumes of lubricant that were retrieved from the bath after mechanical 
testing had been conducted. 
 
 
6 mm
Biopsy punch
area
Filter rim
Area of filter
where particles
were deposited
11 mm
 
Figure 5.2. A schematic of the filter post filtration, including the area of the filter which was 
removed using a 6mm diameter biopsy punch for imaging using ESEM. 
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Table 5.1. The Co-ordinates used when taking images of particles on the filter. 
X-axis co-ordinate Y-axis co-ordinate 
-1.8 -1.8, -1.2, -0.6, 0, 0.6, 1.2, 1.8 
-1.2 -1.8, -1.2, -0.6, 0, 0.6, 1.2, 1.8 
-0.6 -1.8, -1.2, -0.6, 0, 0.6, 1.2, 1.8 
0 -1.8, -1.2, -0.6, 0, 0.6, 1.2, 1.8 
0.6 -1.8, -1.2, -0.6, 0, 0.6, 1.2, 1.8 
1.2 -1.8, -1.2, -0.6, 0, 0.6, 1.2, 1.8 
1.8 -1.8, -1.2, -0.6, 0, 0.6, 1.2, 1.8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total area of the filter observed during imaging
The average area of the filter that was observed per image taken was 0.034 mm2 and the number of
images taken for each filter was 49.
Therefore the total area observed during imaging of each filter
= 1.69 mm2 (49 x 0.034 mm2)
Calculation of the total filter size
The diameter of the total filtration area, not including the filter rim was 11 mm. The equation for
determining the area of a circle is:
(radius2) π
Therefore the total filtration area  where particles could have been captured on the filter
= 95.03 mm2
Percentage of the filter observed during particle imaging
The area actually imaged was 1.69 mm2 while the total filter area was 95.03 mm2. 
Therefore the percentage of filter that was imaged
= (1.69/95.03) x 100 = 1.77 %
 
Figure 5.3. Calculation of the percentage area of the filter observed during imaging. 
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5.4 Results 
A total of five lubricant specimens from each loading condition were filtered and analysed by 
ESEM imaging.  
5.4.1 Study into the effect of humidity on particle appearance 
To determine how changes to the humidity in the ESEM chamber affected the appearance of 
the cartilage particles, a short investigation was completed. As the humidity in the ESEM 
chamber was reduced, the appearance of the particles was altered (Figure 5.4). The surface of 
the cartilage particles was featureless at the highest humidity (96%). As the humidity was 
reduced more features became visible on the surface of the particles and Ringer’s salts were 
seen to be precipitating on the surface of the particles. When comparing the image captured 
at 96% humidity to the image captured at 46% humidity, it was observed that all of the major 
features visible on the image at low humidity could also be observed at the highest humidity, 
with the exception of one feature (Figure 5.4). It was concluded that cartilage particles should 
be imaged at a humidity of approximately 87 to 90 %. This was to maximise the information 
that could be obtained from the images, while maintaining a high humidity in the chamber to 
prevent alterations in particle appearance, caused by drying.   
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A greater number of particles were released into the lubricant during the moderate 
mechanical degradation regime as compared to the mild degradation regime. On average 5581 
particles were released into each ml of the lubricant during the mild degradation regime, 
whereas 8886 were released during the moderate degradation regime.  The control, which did 
not include osteochondral tissue was found to contain 301 particles per ml of lubricant. The 
number of particles in the mild condition lubricant was significantly higher than the number 
detected in the control lubricant (Figure 5.5). The number of particles in the moderate 
lubricant was also significantly higher than the number in the control lubricant (Figure 5.5). 
 
 
 
86% humidity96% humidity 75% humidity
46% humidity55% humidity65% humidity
 
Figure 5.4. The appearances of the cartilage wear particles at a range of humidities. As the 
humidity dropped the clarity of the images was improved. Precipitated salt crystals from the 
Ringer’s solution could be seen clearly on the surface of the largest particle in the images 
taken at 55 and 45 % humidity. There was only one feature that was visible on the lowest 
humidity image that was not also clearly visible on the highest humidity image (circled). 
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5.4.2 Imaging of cartilage wear particles from lubricants using ESEM 
Examples of the particles observed in the Ringer’s solution lubricants after mild and moderate 
mechanical degradation protocols are shown in Figures 5.6 and 5.7, respectively. Many of the 
particles that were observed were clearly defined, however some particles were semi-
amorphous (Figure 5.6G-I). The particles generated under both degradation conditions did not 
appear to have a dominant size or shape. A range of particle shapes were seen in both of the 
lubricants and it was possible to observe different types of particle in the same image. Four 
different types of particle, fibrous, spherical, granular and smooth flake are shown in Figure 
5.6A. Fibrillar particles were observed in the images shown in Figures 5.6B and 5.6C. In Figure 
5.6D a smooth flake like particle could be observed in the image while in Figure 5.6E a particle 
that appeared to have a cross between a granular and globular appearance was observed. 
Globular particles with an irregular shape and smooth edges were observed (Figure 5.6F). 
Finally, the amorphous particles shown in the images in Figures 5.6G-I had a flake like or 
diffuse globular appearance with smooth edges.  
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Figure 5.5. The average number of particles found in 1 ml of lubricant recovered from mild 
and moderate mechanical degradation protocols. The values were normalised to each ml of 
lubricant. Data is presented as the mean (n=5) ±95% confidence limits.  The data was analysed 
using one way analysis of variance followed by determination of significant differences 
between groups using a Tukey post test; * equates to P≤ 0.05; *** equates to  to P≤ 0.001. 
*** 
* 
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  There were several images taken of the moderate condition lubricant that showed 
irregular globular rough particles (Figures 5.7 A-C). Smooth irregular globular particles were 
also observed (Figures 5.7D-F).  As was observed in the mild condition lubricant, diffuse 
globular particles were observed in the moderate condition lubricant (Figure 5.7G). Particles 
that appeared diffuse but did not appear to be globular due to their amorphous nature were 
observed alongside globular rough particles (Figure 5.7H). Globular smooth particles were also 
observed in moderate condition lubricants (Figure 5.7I).  
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Figure 5.6. A range of images taken of cartilage wear particles in Ringer’s solution 
lubricant recovered from mild condition mechanical degradation using ESEM. A-F. 
Typical images of cartilage particles which were clearly defined. Globular particles 
with smooth edges (asterisks) were observed alongside fibrillar particles (arrow 
heads), irregular particles with rough edges (arrow) and irregular shaped particles 
(crosses). G-I. Examples of images that included particles with semi-amorphous 
boundaries (arrows). Scale bar represents 50 µm. Magnification 1500X. 
* 
+ 
+ 
* 
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Particles that were observed in the control solutions are shown in Figure 5.8. The particles 
observed in the control lubricant did appear to have different characteristics to those found in 
the lubricants recovered after degradation although some globular particles were observed  
 
Figure 5.7. Image shows a range of typical contaminant particles that were found in 
control lubricants. A Image shows what may be a cartilage wear particle. B. The particle 
shown had an irregular shape. C. A small particle that had become trapped between the 
pores in the filter. D. A hair like fibre. 
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Figure 5.7. A range of images taken of cartilage wear particles in Ringer’s solution lubricant 
recovered from moderate condition mechanical degradation taken using ESEM. A-E. Typical 
screenshots showing particles recovered from moderate condition lubricant including globular 
particles with both smooth (arrow) and rough edges (crosses). F.  An amorphous globular 
particle is shown with pores of the filter visible through part of the particle (arrows). G-I.  
Images show screenshots that include examples of diffuse (arrow), globular (cross) and 
amorphous particles (asterisk). Scale bar represents 50 µm. Magnification 1500X.  
 
+ 
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(Figure 5.8A.) In addition to globular particles, straight fibrillar, spherical and irregular granular 
particles were observed (Figures 5.8B-D). 
 
 
 
 
A B
DC
 
Figure 5.8 Images showing typical contaminants in the control lubricant taken using ESEM. 
A. Occasionally, granular particles that appeared similar to the cartilage particles found in the 
recovered lubricants were observed in the control solutions. B. A sharp granular particle. C. A 
small spherical contaminant particle D. A straight fibrous hair like particle was observed. Scale 
bar represents 50 µm. Magnification 1500X. 
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5.5 Discussion 
Particle isolation and analysis revealed that the moderate degradation condition produced 
more wear particles than the mild degradation condition and the control. This implied that an 
increase in the wear of the cartilage under the heavier load had occurred. However, it was not 
possible to say conclusively that an increased volume of wear was observed under moderate 
conditions since the size of the particles was not determined due to time constraints and 
difficulties measuring amorphous particles. It was not possible to say if the particles were 
removed predominantly from the osteochondral pins or plates as damage was observed on 
both components after mechanical loading (Chapter 3). However, the protocol developed in 
this part of the study was suitable for visualising and analysing hydrated cartilage wear 
particles.  
  While other studies in the literature have not investigated the effect of variable load 
on particle numbers generated in vitro, Peng (2007) showed that an increase in the length of 
the loading cycle, resulted in an increased number of wear particles in the lubricant as 
determined by filtration. The increase in the length of the loading cycle also resulted in an 
increase in degradation to the cartilage tissue. Mendel et al. (2010) found that in synovial fluid 
samples extracted from human hip, knee and ankle joints, there was a higher number of 
particles in the synovial fluid from the most severely degraded joints compared to the samples 
from joints with lower grades of degradation and the control samples. 
  The major drawback of using the ESEM in a hydrated mode to image cartilage wear 
particles was that a number of the cartilage wear particles appeared to be semi-amorphous, 
which made drawing around the boundary of the particles during image analysis difficult. The 
humidity of the ESEM chamber was reduced from 100% during imaging to increase the 
resolution of the particles. However, it was observed that dropping the humidity below 84% 
resulted in the appearance of Ringer’s solution salt crystals, which implied that the particles 
were beginning to dry out at a humidity of 84% and below.  This was supported by the study of 
the effect of humidity which showed that it was not necessary to capture images at low 
humidity values to complete effective analysis of the particles. The majority of the particles 
were visible at the highest humidity. In addition to this, the increased number of features and 
sharper boundaries observed on the particles at a low humidity may not accurately reflect the 
appearance of the particles in a hydrated state. In future studies a humidity ranging between 
86 % and 90 % should allow adequate visualisation of all the particles on the filter while 
preventing a change in the size and morphology of the particles due to drying. 
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  Observation of a very low number of particles in the control lubricants led to the 
conclusion that the majority of particles imaged in the lubricants recovered from mechanical 
degradation studies were cartilage wear particles removed from the surface of the cartilage 
tissue, rather than environmental contaminants. However, it is clear that low level 
environmental contaminants were present in the recovered lubricant solutions. Approximately 
5.4% of particles in the mild condition lubricant were contaminant, while approximately 3.4% 
of the particles found in the lubricant recovered from moderate conditions were 
contaminants. The particles that were observed in the control lubricant often had a different 
shape to those found in the lubricants recovered from the degradation. 
  To reduce contamination, a closed cabinet could be used during the mechanical 
degradation protocol to prevent contamination entering the lubricant. It was also observed 
that some particles in the controls may have been cartilage particles, which were left on the 
filtration equipment after washing. Therefore a more thorough washing procedure would be 
required in future. It would also have been interesting to use an energy dispersive X-ray 
spectroscopy (EDS) detector to identify the composition of the wear particles. A high carbon 
and sulphur content would have indicated that the particles were composed of cartilage, 
whereas detection of calcium would have indicated that particles of bone were also present in 
the lubricant (Hakshur et al., 2011). 
  Future work would include examining an increased number of the particle features 
such as particle length and area. It would have also been interesting to investigate smaller 
particles using filters with smaller pores sizes, to provide a more complete picture of the size 
range of the wear particles. Determining the size of the wear particles may have shown a 
difference in the average particle size under the two different loading conditions. It would also 
have been interesting to examine the particles that were generated in serum lubricant under 
moderate conditions. However, alterations to the protocol would have been required to 
effectively remove the serum from the lubricant to enable visualisation of the particles.   
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5.6 Conclusion 
An increase in loading led to an increase in the number of cartilage wear particles released into 
the lubricant during mechanical degradation. The protocol that was devised, was suitable for 
visualising and analysing cartilage wear particles in a hydrated state.  
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Chapter 6 
General Discussion 
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6.1 Discussion 
Due to a lack of suitable methods for the tribological assessment of cartilage substitution 
materials, there is a requirement for the development of systems that can be used to 
determine the tribological properties of these novel therapeutics.  The aims of this project 
were to develop methodologies for the production of models of cartilage degeneration. These 
models of cartilage degeneration can be used to assess the tribological properties of novel 
cartilage substitution materials in an environment that mimics the biotribological conditions of 
degraded cartilage. To facilitate this, mechanical and biological cartilage degradation 
methodologies were developed which represented the two axis of cartilage degradation seen 
in vivo.  
  The mechanical degradation models aimed to represent the tribological condition of 
degraded cartilage tissues observed in vivo. The models were found to accurately replicate 
several features of degraded tissues seen in stages of cartilage degradation that are observed 
in osteoarthritic tissues, such as roughening of the cartilage surface and disruption of the 
collagen fibril network. The biological model was developed through the use of chondroitinase 
ABC, which removed large numbers of GAGs from the tissue. This accurately represented the 
large GAG loss seen in degraded cartilage tissues in vivo. However, the chondroitinase ABC 
enzyme had a substantial effect on the GAG content of the cartilage tissues. The use of more 
subtle degradative enzymes, such as cathepsins, in the future would increase the 
sophistication of the model. The wear of the cartilage degradation models was assessed via 
observation of cartilage wear particles taken from the lubricants used in the mechanical 
degradation protocols. The protocol that was developed for isolating and imaging the particles 
was successful in allowing visualisation and quantitation of cartilage wear in the lubricant. 
 Degradation models for tribological assessment of novel cartilage substitution 
materials solve a variety of problems associated with novel treatment strategies that are being 
developed for degraded cartilage tissues. There are a range of problems with early stage 
pharmacological treatments and end stage treatments for degenerative joint diseases such as 
osteoarthritis. For example, pharmacological treatments do not prevent cartilage degeneration 
and joint replacements are not suitable for young patients as they can fail due to the adverse 
effects of wear particles (Ingham and Fisher, 2000). Therefore, there is a gap to be bridged 
between early and end-stage treatment that involves novel cartilage substitution and 
regenerative therapies. Cartilage substitution materials can range from tissue engineered 
constructs to biomaterials (Johnstone et al., 2013), which can include polyurethanes (Santerre 
et al., 2005) and hydrogels (Cheung et al., 2007). Many of these materials do not closely mimic 
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the cartilage ultrastructure, or consist of a homogeneous structure. One of the major barriers 
to successful development and application of cartilage substitution and regenerative 
treatments is the limitations of methods for assessment of the functional biotribology of novel 
materials (Butler et al., 2000). Often studies focus heavily on only the physical, biological and 
biochemical properties (Guilak et al., 2001). 
  Therefore it is clear that there is a need for the development of models that replicate 
degenerated cartilage biotribology which can be used to investigate cartilage biotribology and 
its interaction with novel substitution materials, which includes detailed investigations into the 
characteristics of degraded tissues. This will result in improved in vitro pre-clinical test 
methods, for example a whole natural joint simulator for thorough assessment of novel 
substitution materials. A detailed understanding of the cartilage ECM and biotribology after 
degradation will assist in understanding how the tissue responds to different conditions which 
can also help to tailor the successful development of suitable novel materials. Improvements 
in in vitro testing will lead to improved assessment of materials long term, this will accelerate 
the translation of therapies to the patient. Essentially:  further understanding of cartilage 
biotribology will result in a move towards earlier functional interventions and approaches to 
preserving tissues using regenerative solutions.  
  A major objective of this study was to develop mechanical degradation methodologies 
for cartilage tissue. The purpose of the degradation models was to produce cartilage tissue 
that replicated the biotribological condition of cartilage at stages along the spectrum of 
cartilage degeneration. These models of degradation could be used to investigate cartilage 
biotribology or to investigate how degraded tissues respond to novel substitution materials. 
The development of the models also provided a set of parameters that can be used to produce 
cartilage degradation in future whole joint studies. This study built on previous in vitro studies 
that have been used to investigate cartilage biotribology under various conditions (Pickard et 
al., 1998; Pickard et al., 2000; Katta et al., 2007; Lizhang et al., 2011). 
  A simple configuration pin on plate rig was used to produce the cartilage on cartilage 
degradation models. The rig was chosen because its simplicity would facilitate the 
investigation of the biotribology of the degradation models and cartilage specimens in future 
studies with potential substitution materials. In addition, as this was a preliminary study, the 
simplicity of the rig was important to avoid over complication at the first stage. Despite its 
simplicity, the use of the rig produced a range of cartilage degradation states, and the 
conditions reproduced some features of the cartilage degradation process observed in 
degraded human cartilage tissues in vivo at a greatly increased rate. The study attempted to 
follow conditions found in-vivo in humans more closely than other studies through steps that 
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included cartilage on cartilage articulation, which produced degradation that could be 
corroborated with several published grading systems (International Cartilage Research Society 
grading system and Pritzker et al., 2006) for osteoarthritis at both a macroscopic and 
ultrastructural level. Many previous in vitro degradation studies have used conditions that do 
not represent those observed in vivo such as abnormal loading conditions and non-
physiological wear of cartilage tissues with sand paper (Tanaka et al., 2005; Wilson et al., 
2006). There are also several studies that have attempted to assess the tribological properties 
of cartilage substitution materials. However, many of these studies articulate potential 
cartilage substitution materials against metal and glass which does not accurately represent 
the tribological conditions found in vivo (Freeman et al., 2000 ; Covert, et al., 2003 ; Pan et al., 
2007 ; Blum et al, 2013). 
  The major findings of this part of the study were that loading had a significant effect 
on the rate of degradation of cartilage tissue. It was observed that the increase in load applied 
under the moderate condition (478N) significantly increased the damage to the osteochondral 
specimens compared with the mild condition (200N). Mechanical loading did not appear to 
have a significant effect on the total collagen (w/w) and COMP content of cartilage. However, 
it did alter the aggrecan network and led to a reduction in the GAG content (w/w) of the 
tissue. An increase in load during mechanical tests also significantly increased the surface 
roughness of cartilage specimens. Static loading did not result in a permanent decrease in the 
cartilage height. GAGs were lost from the tissue during mechanical degradation however the 
levels of collagen in the tissue remained at a similar level as a percentage of tissue weight. It 
was also shown that GAGs and collagen were present in the lubricant recovered after 
mechanical tests. This indicated that collagen was not leaching from the tissues as a reduction 
in the percentage of collagen per unit of tissue weight would have been observed. Rather the 
collagen detected in the lubricant must have been a result of cartilage wear particles. 
  The major limitation of the mechanical study was the diameter of the osteochondral 
pins, which were relatively small (9 mm). This resulted in an increased influence of edge effects 
on the tissue specimens. However, the small size of the specimens did facilitate the 
degradation process. To improve the study, osteochondral pins with a larger diameter could 
have been used to reduce the influence of edge effects on specimens. The results obtained 
with serum lubricant also highlighted a problem with the test regime due to the variability in 
the results that were obtained. In some cases the serum lubricant appeared to protect the 
cartilage from degradation, however, other specimens appeared to have degradation that was 
similar to the degradation observed on pins that had been subject to moderate loading 
degradation in Ringer’s solution. This may have been due to the geometry of the specimens, as 
certain specimen pairs may have had increased congruity which in combination with the serum 
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lubricant may have protected specimens from damage. Some specimens may have been 
extracted from the condyles at a slight angle which could have resulted in uneven loading of 
the pin edge on the osteochondral plate resulting in abrasive wear. To try and investigate this 
further, it would be useful for a greater number of replicates to be completed in addition to 
investigating the congruency of specimens which may be possible using surface profilometry 
techniques. 
  Aggrecan is a large proteoglycan that forms aggregates in the cartilage tissue. The 
structure of aggrecan was effectively observed using TEM alongside cupromeronic blue 
staining. This part of the study represented one of the first examples of comprehensive 
characterisation of mechanically degraded cartilage specimens. Cupromeronic blue has been 
used previously to investigate the ultrastructure of articular cartilage (Orford and Gardner, 
1985). However, it has not been used to investigate the alterations observed in the tissue 
caused by in vitro mechanical degradation regimes. In one study by Orford et al, (1985) it was 
observed that in canine tissues that had been degraded in vivo via a division of the anterior 
cruciate ligament, the collagen network became disrupted and GAGs were lost from the 
superficial zone of the tissue, which correlated with findings of this study. 
  The results of the immunohistochemical staining were also novel as staining for 
biglycan, COMP and collagen VI had not previously been studied in relation to mechanical 
degradation models, to the author’s knowledge. It was observed that COMP and collagen VI 
staining were not greatly altered by either the mild or moderate mechanical degradation 
regime, which may indicate that these components are lost through biological degradation of 
cartilage tissues. However, biglycan was reduced in tissues that had undergone loading under 
the moderate degradation protocol. The study also considered both biological and mechanical 
evaluation methodologies during tissue characterisation which facilitated a more complete 
understanding of how the tissues were affected during degradation.  
 The use of Ringer’s solution lubricant under low level loads did not produce a 
significant level of damage to the cartilage tissue during articulation. This may have partly 
been due to the salt concentration of the Ringer’s solution. The salt concentration may have 
allowed the cartilage to continue maintenance of fluid phase loading, which forms part of the 
biphasic loading capabilities of cartilage tissue. This therefore, may have protected the tissue 
from damage. It is also likely that boundary lubrication may have occurred via a layer of 
phospholipids and glycoproteins on the surface of the tissue. Under the moderate loading 
condition it appears that Ringer’s solution did not have a protective effect on the cartilage 
tissue. However, in serum lubricant half of the specimens appeared to be protected from 
severe wear on the surface of the tissues. The serum may have provided additional boundary 
lubrication to protect the tissue surface preventing it from becoming rough (Forsey et al., 
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2006; Bryan et al., 2010). In future tests, it may be useful to add hyaluronan to the serum 
lubricant to make the lubricant more physiologically relevant, as hyaluronan regulates the 
viscosity of the synovial fluid (Laurent et al., 1996). 
  The methodology that was used to treat cartilage specimens with chondroitinase ABC 
was developed at Leeds and has previously been utilised in a study that determined the effects 
of GAG loss on cartilage tribology (Katta et al., 2007). Therefore the novel aspect of this part of 
the study was in the extensive characterisation of the tissue that was carried out after enzyme 
treatment of the cartilage. The large range of techniques that was used to characterise the 
tissues provided a way of determining the most suitable methodologies for assessing changes 
to the cartilage tissues caused by enzyme digestion. Chondroitinase ABC was used to digest 
GAGs from the cartilage tissue as they are a major component of, and are integral to the 
correct functioning of biphasic lubrication in the tissue. As degraded cartilage tissues are found 
to have a reduced GAG content it was appropriate to use chondroitinase ABC. In future studies 
GAG depleted tissue will be useful for mimicking degraded cartilage tissues when assessing the 
tribology and characteristics of cartilage substitution materials. 
  The major findings in this part of the study were that biglycan staining was reduced in 
the treated tissue. There appeared to be a slight reduction in COMP staining and collagen VI 
was not affected significantly by chondroitinase ABC treatment. The aggrecan network in the 
tissue was disrupted and in some cases was no longer visible and the structure of the cartilage 
observed in the tissue sections became more amorphous after chondroitinase ABC treatment. 
This correlated with the reduction in GAG staining quantified in the biochemical assay and the 
reduction in GAG staining seen in the alcian blue images. In addition to this, the deformation 
of the cartilage was increased during indentation when the tissue had been treated with 
chondroitinase ABC. The increase in deformation may because the compressive stiffness of 
cartilage is regulated by the GAGs in the extracellular matrix (Mow and Huiskes, 2005).  The 
results for the indentation study and the quantitative GAG analysis correlated with the 
previous study by Katta et al., (2007). Cupromeronic blue staining has been used previously to 
investigate the ultrastructure of articular cartilage however it has not been used to investigate 
the alterations observed in the tissue caused by enzymatic degradation (Orford and Gardner, 
1985; Scott and Stockwell, 2006). 
  Limitations of this part of the study were that the process of chondroitinase digestion 
was started at the surface and progressed linearly through the tissue to the middle zone 
whereas in vivo GAG loss has been shown to begin around chondrocytes in the pericellular 
environment (Loeser et al., 2003). Additionally chondroitinase ABC is not an enzyme that is 
produced by chondrocytes in vivo. Enzymes that promote the catabolic destruction of cartilage 
tissue in a physiologically relevant way such as collagenases (Salminen et al., 2002) are 
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commercially available; however, they are prohibitively expensive for use on a large scale. Use 
of physiologically relevant enzymes may have made the study more representative of the 
scenario occurring in vivo during cartilage degradation. For example, the use of a collagenase 
(MMP-13) would have initiated cleavage of collagen in the tissue which alongside use of the 
chondroitinase ABC could have represented biologically based cartilage degradation in a more 
physiologically relevant way (Ehrlich et al., 1978). Despite the chondroitinase ABC treatment 
removing a large volume of GAGs from the cartilage surface, the model remains useful as it 
reflects the large reduction in GAGs that is observed in degraded cartilage tissues. 
  The methodology that was used for isolating cartilage wear particles was based on a 
method previously developed at Leeds for polymeric particles. However, due to the low 
volume of lubricant filtered compared with lubricants containing polymeric particles, particle 
isolation equipment for smaller volumes was used. The method worked well for isolating the 
cartilage wear particles in the Ringer’s solution lubricant with some adaptations to the 
methodology. The number of particles in each lubricant was successfully determined revealing 
that a higher number of particles were released into the lubricant under moderate loading 
conditions compared with mild loading conditions. The increased wear observed under the 
higher loading condition correlated with an increase in the surface roughness of the cartilage 
tissue which was also confirmed quantitatively using histology.  
  The wear particles observed in the lubricant in this study may have been a result of 
fatigue wear in the cartilage tissue. The collagen and aggrecan networks in the tissue were 
disrupted which would weaken the tissue structure resulting in particles of tissue being 
removed from the cartilage surface. The production of the wear particles through fatigue wear 
may have also led to the occurrence of adhesive wear, in the form of three body wear, which 
may have aggravated wear of the cartilage surface (Nordin & Frankel, 2001). 
  The shape of the cartilage wear particles was assessed quantitatively using the 
American Society for Testing and Materials (ASTM; ASTM Standards, 2005) guide to standard 
practice for characterisation of particles. Many of the particles did fit with the particle shapes 
observed and described in the standard. However, it was clear that not all of the cartilage wear 
particles could be described accurately using the standards. This was especially true for the 
amorphous particles that were observed which did not fit any of the particle descriptions fully. 
This may be because the standard has not been developed for assessment of wear particles 
from biological tissues. In future, it would be useful to develop additional guidelines that can 
be used alongside the ASTM guide to effectively characterise cartilage wear. For example, a 
semi-quantitative way of recording amorphous particles could be developed through 
indication of the presence or absence of amorphous particles on the image. 
232 
 
  A major limitation that was encountered while imaging the cartilage wear particles 
was the time taken to capture images using the ESEM. This drastically reduced the number of 
images that could be taken during each session. One way to overcome this would be to filter a 
larger volume of lubricant onto the filter so that a greater concentration of particles could be 
observed in the same amount of time. However, this may lead to issues with particles 
clumping together, which was not an issue with the methodology used in the current study. 
   This study is the first in which cartilage wear particles have been studied in an 
unaltered state using ESEM. Mendel et al. (2010) used ESEM to image particles coupled with 
SEM imaging, but it was not clear to what extent the ESEM imaging was used in the final 
results and no images taken using ESEM were published. Previous studies have used SEM 
imaging; which involves coating the particles, laser scanning confocal microscopy or atomic 
force microscopy to study cartilage wear particles (Podisadlo et al., 1997; Kuster et al., 1998; 
Peng, 2007; Hakshur et al., 2011; Wang et al., 2013). Laser scanning confocal microscopy 
requires the particles to be dyed and is also not suitable for imaging particles of a small size 
due to issues with resolution (≤2 µm). Some studies have used ferrography to isolate particles 
rather than filtering. It is difficult to say which methodology is superior without a direct 
comparison between the methods being available. In addition, drawing around particles by 
hand on images using image analysis software may lead to errors and the methodology is also 
highly time consuming. However, it is also possible during ferrographical analysis for particles 
to overlap each other, which lead to errors in the particle sizes and the number of particles 
that are recorded during SEM. 
   In future the mechanical degradation protocol could be used to generate cartilage 
wear particles for further studies. It would be interesting to compare the cartilage particles 
generated by the mechanical degradation protocol to particles recovered from human synovial 
fluid samples that have been generated in vivo. This could give an indication of the 
comparability of the wear produced by an in vitro model and the wear seen in vivo. 
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6.1.1 Future work 
Future work could include testing of novel cartilage substitution materials such as tissue 
engineered constructs with the mechanical and enzyme degradation models. For example, the 
degraded cartilage tissue models could be articulated with substitution materials in the pin-on-
plate rig, followed by analysis and characterisation of the tissue (Figure 6.1). Eventually, the 
simple configuration pin-on-plate model can be developed for use with whole joints via the 
application of the mechanical test conditions used in this study, to large joint components 
using a simulator. It may also be possible to combine the mechanical and enzymatic models in 
whole joints via the use of more subtle degradative enzymes such as cathepsins. Following 
degradation of the large joint components using the conditions defined in this study, plugs of 
cartilage substitution materials could be fitted into the tissue, in the condyles, for example and 
articulated in a simulator. Following an appropriate number of loading cycles, the joint tissues 
could be analysed using the large range of appropriate characterisation methodologies, which 
were determined in this study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Future development of degradation models for assessment of cartilage substitution materials
Simple configuration testing Whole joint simulator development
• A natural joint model of mechanical degradation can be
developed through direct application of the conditions
used in this simple configuration study, to whole joint
components using an appropriate simulator.
• Preparation of tissues for a natural joint model of
enzymatic degradation can be developed via application
of the appropriate enzymes to the cartilage surface of
whole joint components.
• The use of enzymes that have a more subtle
degradative effect on tissues compared with
chondroitinase ABC may make the combination of
mechanical and enzymatic models feasible.
Figure 6.1. Future development of degradation models for assessment of cartilage 
substitution materials. It will be possible to use the simple configuration degradation models 
for assessment of cartilage substitution in a range of formats. A. Osteochondral pin against 
cartilage substitution plate. B. Osteochondral pin against osteochondral plate with cartilage 
substitution material insert.  C. Cartilage substitution material pin against osteochondral plate. 
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Further testing of the lubricants using antibody based assays for specific proteins such as 
enzyme linked immunosorbent assays (ELISA) would also be very interesting because such 
methods could be developed for assessing levels of cartilage tissue damage by solely 
examining lubricants. Good targets for ELISA would include aggrecan and small leucine rich 
proteoglycans. Additionally, in a future study it may be possible to quantitatively assess the 
levels of minor cartilage components through fluorescence labelling of components such as 
COMP and biglycan.  
 Another protocol that requires development is a method for collagen detection in 
serum lubricants. Currently, an acid hydrolysis step is used in the collagen detection assay. 
When serum lubricants with cartilage particles were acid hydrolysed, a large volume of 
caramelisation was observed which was a result of a reaction between proteins and sugars in 
the solution via a process known as the Maillard reaction. This made analysis of the collagen in 
the serum unfeasible. To overcome this issue, an investigation into removal of GAGs from the 
lubricant to prevent caramelisation, using guanidine hydrochloride extraction was undertaken. 
However, there was not enough time to complete the study. Part of the problem in the 
development of the protocol was that guanidine hydrochloride must be thoroughly washed 
from specimens to allow the collagen assay to work correctly. However, during the wash step, 
test tubes containing the guanidine extracted samples were firstly centrifuged before 
supernatant containing the GAGs was removed. This could have meant some particles 
containing collagen may have been removed. One way of assessing whether the centrifugation 
step was sufficiently effective, could be via mass spectroscopy of the extracted supernatant, to 
assess whether any peaks indicative of cartilage or collagen were observed. It could also be 
possible to use chondroitinase ABC instead of guanidine hydrochloride to extract the GAGs 
from the tissue and into the supernatant, which may not require such an extensive number of 
washing steps.  
  To obtain further information about the biomechanical properties of the 
chondroitinase ABC treated tissue, finite element analysis of the tissue could be performed on 
tissues. This would have allowed further tissue properties to be derived, for example the 
permeability and elastic modulus of the tissue. 
  It would be interesting to investigate the macrophage response to cartilage wear 
particles to examine if there is a link between cartilage wear particles and inflammation. 
Previously, biomaterial particles of certain sizes and certain topographical features have been 
shown to initiate an inflammatory response in cells (Sieving et al., 2003; Papageorgiou et al., 
2007). In addition to this, features of particles from osteoarthritic joints and control joints have 
been shown to alter (Podsiadlo et al., 1997). Therefore it would also be useful to complete a 
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more thorough investigation of the particle features, such as size and surface topography. This 
may allow a link between the type of particle observed and the level of damage to the tissue to 
be established. It would also be interesting to determine the size distribution of particles using 
filters with smaller pore sizes. This could lead to the establishment of a link between contact 
stress and the average size of wear particle produced from the tissue. In addition it may be 
possible to determine whether a certain particle shape or size is produced from a specific zone 
of the tissue. It would be useful to develop a protocol for imaging of particles in serum 
lubricant. However, it would be necessary to give some thought as to what defines a particle, 
as some particles were very amorphous and appeared more as gel like deposits than particles, 
despite their amorphous appearance remaining as the humidity in the ESEM was dropped. 
    In future it will be possible for the degradation models developed in this study 
to be used for in vitro analysis of novel cartilage substitution materials such as tissue 
engineered constructs or biomaterials. It will also be possible for the models to be developed 
into whole full joint simulators with living tissue which could be used as a precursor to pre-
clinical testing. This may reduce the number of animals used for testing novel materials. In 
addition, the range of characterisation methods that were developed and adapted for use in 
the study will be useful for comprehensive analysis of degraded cartilage tissues generated by 
different degradation regimes.  
  The study has also highlighted which methods require further development to give an 
even greater understanding of the processes occurring in mechanically and enzymatically 
degraded tissues. For example, in future height measurements should be taken using 
alternative equipment such as a Vernier height gauge as readings at the edge of the pin do not 
accurately detect the tissue loss occurring in the centre of the pin.  
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 6.1.2 Conclusion 
The mechanical degradation models that were developed in this study represent two stages of 
cartilage degeneration which can be used to investigate the tribological properties of novel 
cartilage substitution materials. The enzyme model may also be used to assess novel 
substitution materials or may be further developed via the use of additional degradative 
enzymes. The enzyme model may also be useful for assessment of therapies which aim to 
restore GAGs to degraded cartilage tissues. 
  The investigation of cartilage wear has provided an interesting insight into a relatively 
novel area. The protocol developed for investigating cartilage wear could be used to further 
study cartilage wear particles and their features. This may reveal more about potential links 
between cartilage wear particles and the cartilage degeneration process. 
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